
<html lang="en"     class="pb-page"  data-request-id="408d567c-b0cd-4ffc-8c39-4945af6081f5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm101450p;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2011.54.issue-7;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates" /></meta><meta name="dc.Creator" content="Isaac T.  Schiefer" /></meta><meta name="dc.Creator" content="Samer  Abdul-Hay" /></meta><meta name="dc.Creator" content="Huali  Wang" /></meta><meta name="dc.Creator" content="Michael  Vanni" /></meta><meta name="dc.Creator" content="Zhihui  Qin" /></meta><meta name="dc.Creator" content="Gregory R. J.  Thatcher" /></meta><meta name="dc.Description" content="Poor blood−brain barrier penetration of nonsteroidal anti-inflammatory drugs (NSAIDs) has been blamed for the failure of the selective amyloid lowering agent (SALA) R-flurbiprofen in phase 3 clinic..." /></meta><meta name="Description" content="Poor blood−brain barrier penetration of nonsteroidal anti-inflammatory drugs (NSAIDs) has been blamed for the failure of the selective amyloid lowering agent (SALA) R-flurbiprofen in phase 3 clinic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101450p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101450p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101450p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101450p" /></link>
        
    
    

<title>Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101450p" /></meta><meta property="og:title" content="Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0009.jpeg" /></meta><meta property="og:description" content="Poor blood−brain barrier penetration of nonsteroidal anti-inflammatory drugs (NSAIDs) has been blamed for the failure of the selective amyloid lowering agent (SALA) R-flurbiprofen in phase 3 clinical trials for Alzheimer’s disease (AD). NO-donor NSAIDs (NO-NSAIDs) provide an alternative, gastric-sparing approach to NSAID SALAs, which may improve bioavailability. NSAID analogues were studied for anti-inflammatory activity and for SALA activity in N2a neuronal cells transfected with human amyloid precursor protein (APP). Flurbiprofen (1) analogues were obtained with enhanced anti-inflammatory and antiamyloidogenic properties compared to 1, however, esterification led to elevated Aβ1−42 levels. Hybrid nitrate prodrugs possessed superior anti-inflammatory activity and reduced toxicity relative to the parent NSAIDs, including clinical candidate CHF5074. Although hybrid nitrates elevated Aβ1−42 at higher concentration, SALA activity was observed at low concentrations (≤1 μM): both Aβ1−42 and the ratio of Aβ1−42/Aβ1−40 were lowered. This biphasic SALA activity was attributed to the intact nitrate drug. For several compounds, the selective modulation of amyloidogenesis was tested using an immunoprecipitation MALDI-TOF approach. These data support the development of NO-NSAIDs as an alternative approach toward a clinically useful SALA." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101450p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101450p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101450p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101450p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101450p&amp;href=/doi/10.1021/jm101450p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2293-2306</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1014378" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101470k" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+T.++Schiefer">Isaac T. Schiefer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samer++Abdul-Hay">Samer Abdul-Hay</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huali++Wang">Huali Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Vanni">Michael Vanni</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihui++Qin">Zhihui Qin</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+R.+J.++Thatcher">Gregory R. J. Thatcher</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 312-355-5282. Fax: 312 996 7107. E-mail: <a href="/cdn-cgi/l/email-protection#f98d91988d9a919c8bb98c909ad79c9d8c"><span class="__cf_email__" data-cfemail="a3d7cbc2d7c0cbc6d1e3d6cac08dc6c7d6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101450p&amp;href=/doi/10.1021%2Fjm101450p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2293–2306</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 November 2010</li><li><span class="item_label"><b>Published</b> online</span>15 March 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101450p" title="DOI URL">https://doi.org/10.1021/jm101450p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2293%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIsaac%2BT.%2BSchiefer%252C%2BSamer%2BAbdul-Hay%252C%2BHuali%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D7%26contentID%3Djm101450p%26title%3DInhibition%2Bof%2BAmyloidogenesis%2Bby%2BNonsteroidal%2BAnti-inflammatory%2BDrugs%2Band%2BTheir%2BHybrid%2BNitrates%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2306%26publicationDate%3DApril%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101450p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1670</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101450p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;T. Schiefer&quot;},{&quot;first_name&quot;:&quot;Samer&quot;,&quot;last_name&quot;:&quot;Abdul-Hay&quot;},{&quot;first_name&quot;:&quot;Huali&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Vanni&quot;},{&quot;first_name&quot;:&quot;Zhihui&quot;,&quot;last_name&quot;:&quot;Qin&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;R. J. Thatcher&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;2293-2306&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101450p&quot;},&quot;abstract&quot;:&quot;Poor blood−brain barrier penetration of nonsteroidal anti-inflammatory drugs (NSAIDs) has been blamed for the failure of the selective amyloid lowering agent (SALA) R-flurbiprofen in phase 3 clinical trials for Alzheimer’s disease (AD). NO-donor NSAIDs (NO-NSAIDs) provide an alternative, gastric-sparing approach to NSAID SALAs, which may improve bioavailability. NSAID analogues were studied for anti-inflammatory activity and for SALA activity in N2a neuronal cells transfected with human amyloid precursor protein (APP). Flurbiprofen (1) analogues were obtained with enhanced anti-inflammatory and antiamyloidogenic properties compared to 1, however, esterification led to elevated Aβ1−42 levels. Hybrid nitrate prodrugs possessed superior anti-inflammatory activity and reduced toxicity relative to the parent NSAIDs, including clinical candidate CHF5074. Although hybrid nitrates elevated Aβ1−42 at higher concentration, SALA activity was observed at low concentrations (≤1 μM): both Aβ1−42 and the ratio of Aβ1−42/Aβ1&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101450p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101450p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101450p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101450p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101450p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101450p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101450p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101450p&amp;href=/doi/10.1021/jm101450p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101450p" /></input><a href="/doi/pdf/10.1021/jm101450p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101450p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101450p%26sid%3Dliteratum%253Aachs%26pmid%3D21405086%26genre%3Darticle%26aulast%3DSchiefer%26date%3D2011%26atitle%3DInhibition%2Bof%2BAmyloidogenesis%2Bby%2BNonsteroidal%2BAnti-inflammatory%2BDrugs%2Band%2BTheir%2BHybrid%2BNitrates%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D7%26spage%3D2293%26epage%3D2306%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291191" title="Antiinflammatories">Antiinflammatories</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jmcmar.2011.54.issue-7/production/jmcmar.2011.54.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Poor blood−brain barrier penetration of nonsteroidal anti-inflammatory drugs (NSAIDs) has been blamed for the failure of the selective amyloid lowering agent (SALA) <i>R</i>-flurbiprofen in phase 3 clinical trials for Alzheimer’s disease (AD). NO-donor NSAIDs (NO-NSAIDs) provide an alternative, gastric-sparing approach to NSAID SALAs, which may improve bioavailability. NSAID analogues were studied for anti-inflammatory activity and for SALA activity in N2a neuronal cells transfected with human amyloid precursor protein (APP). Flurbiprofen (<b>1</b>) analogues were obtained with enhanced anti-inflammatory and antiamyloidogenic properties compared to <b>1</b>, however, esterification led to elevated Aβ<sub>1−42</sub> levels. Hybrid nitrate prodrugs possessed superior anti-inflammatory activity and reduced toxicity relative to the parent NSAIDs, including clinical candidate CHF5074. Although hybrid nitrates elevated Aβ<sub>1−42</sub> at higher concentration, SALA activity was observed at low concentrations (≤1 μM): both Aβ<sub>1−42</sub> and the ratio of Aβ<sub>1−42</sub>/Aβ<sub>1−40</sub> were lowered. This biphasic SALA activity was attributed to the intact nitrate drug. For several compounds, the selective modulation of amyloidogenesis was tested using an immunoprecipitation MALDI-TOF approach. These data support the development of NO-NSAIDs as an alternative approach toward a clinically useful SALA.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), the major cause of dementia in the elderly population, is a neurodegenerative disorder characterized by the abnormal accumulation of amyloid plaques and neurofibrillary tangles.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> According to the amyloid cascade hypothesis, β-amyloid (Aβ) peptide, the main constituent of amyloid plaques, is the cause of the observed neurodegeneration in AD patients.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In 2001, Weggen et al. discovered that certain NSAIDs were able to selectively lower the levels of Aβ<sub>1−42</sub> without affecting levels of Aβ<sub>1−40</sub>; these drugs were referred to as SALAs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The importance of this discovery lay in evidence that the 42 amino acid fragment, Aβ<sub>1−42</sub>, aggregates more rapidly and is a much more potent neurotoxin than the more abundant Aβ<sub>1−40</sub>.<a onclick="showRef(event, 'ref3 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref5">(3, 5)</a> Aβ<sub>1−42</sub> is widely viewed as the causative molecule in AD. The enzymes responsible for the production of Aβ, namely β- and γ-secretase, remain primary drug targets for the treatment of AD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Changes in the levels of Aβ elicited by NSAID SALAs in vitro and in vivo have been attributed to modulation of Aβ production,<a onclick="showRef(event, 'ref4 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref7 ref8 ref9 ref10 ref11">(4, 7-11)</a> via: modulation of γ-secretase activity,<a onclick="showRef(event, 'ref4 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref7">(4, 7)</a> downregulation of β-secretase,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> or Rho kinase inhibition.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In addition, NSAIDs including flurbiprofen (<b>1</b>) have been reported to inhibit amyloidosis by stabilizing transthyretin.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The N2a neuronal cell line stably transfected with human βAPP695 bearing the Swedish mutation (N2a.hAPP) provides a model for amyloidogenesis, producing Aβ peptides associated with human pathophysiology. Studies on this cell line demonstrated that NSAID SALAs stimulate metalloprotease degradation of Aβ<sub>1−40</sub> and Aβ<sub>1−42</sub>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The enhanced proteolysis of Aβ is currently seen as a preferred drug discovery strategy.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a></div><div class="NLM_p">The effect of NSAID SALAs on Aβ levels was shown previously to be independent of the cyclooxygenase (COX) inhibitory activity, a dissociation of actions considered crucial for drug development, because NSAID gastrotoxicity is associated with COX inhibition.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Supported by epidemiological studies that reported a decreased risk of developing AD after chronic treatment with NSAIDs,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> the COX-inactive <i>R</i>-flurbiprofen was studied in phase 3 clinical trials as a gastric-sparing therapeutic agent for AD (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In 2008, this trial was reported as a failure due to lack of efficacy, possibly linked to poor bioavailability.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Nevertheless, CHF5074 (<b>11d</b>), a new COX-inactive analogue of flurbiprofen (<b>1</b>) appears to be on course for clinical development.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> An alternative approach to developing a gastric-sparing NSAID has been to incorporate a gastroprotective organic nitrate moiety in a so-called NO-donating NSAID (NO-NSAID) to counteract the NSAID-induced inhibition of prostaglandin synthesis.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> HCT-1026 (<b>2</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> an NO-NSAID prodrug of <b>1</b>, has been reported: (i) to reduce Aβ load in an amyloid transgenic mouse model,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (ii) to reverse cognitive deficits in mice under cholinergic blockade,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and (iii) to reduce inflammatory markers, including iNOS, in adult rats injected with Aβ<sub>1−42</sub>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The purpose of this study was to assay libraries of indomethacin (<b>3</b>), sulindac (<b>4</b>), and flurbiprofen analogues, including novel compounds and preclinical agents (e.g., CHF5022, <b>11c</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and <b>11d</b>), as a basis for development of new NSAID hybrid nitrates as SALAs. Anti-inflammatory activity and toxicity were assayed in cell culture and for selected compounds inhibition of amyloidogenesis was assayed in neuronal cell cultures. On the basis of these data, prototype hybrid nitrate analogues of <b>1</b> were synthesized and studied for SALA activity, revealing further insight into the mechanism of SALA activity associated with NO-NSAIDs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div class="NLM_p">Synthesis was directed at the generation of a library of compounds possessing variations at the terminal phenyl ring (R<sub>1</sub>), α-carbon (R<sub>2</sub> and R<sub>2</sub>′), and isosteric replacement of the carboxylic acid (R<sub>3</sub>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><div class="NLM_p">Synthesis began with allylic bromination of the commercially available 4-bromo-3-fluorotoluene <b>6</b>, with <i>N</i>-bromosuccinimide using a catalytic amount of dibenzoyl peroxide to yield <b>7</b>, which was then reacted with potassium cyanide to give <b>8</b>. Exposure to either iodoethane or 1,2-dibromoethane yielded alkylated products <b>9a</b> and <b>9b</b> that were then oxidized to the carboxylic acid followed by Suzuki coupling to the appropriate boronic acids to give biarylcarboxylic acids <b>11a</b>−<b>d</b> in moderate yields (60−70%). Quantitative yield was attained through direct coupling of the cyano analogues <b>8</b> and <b>9b</b>, yielding the α-cyano-biaryls <b>12a</b> and <b>12b</b>, along with <b>13a</b> and <b>13b</b>. Fluorination of <b>13a</b> and <b>13b</b> was accomplished via reaction with <i>t</i>-BuLi followed by fluorination with <i>N</i>-fluorobenzenesulfonimide (NFSi) to give <b>14a</b>−<b>b</b> and <b>15a</b>−<b>b</b>. While base catalyzed oxidation of <b>14a</b>, <b>14b</b>, <b>15a</b>, and <b>15b</b> gave the corresponding biaryl fluoro-amides <b>16a</b>, <b>16b</b>, <b>17a</b>, and <b>17b</b>, the desired biaryl-fluorinated carboxylic acids were not isolated. Acid catalyzed hydrolysis of <b>14a</b> and <b>14b</b> yielded <b>18a</b> and <b>18b</b> as products that were also evaluated for inhibition of amyloidogenesis and anti-inflammatory activity. Base and acid catalyzed oxidation of the diethyl derivative <b>12a</b> was hindered by solubility issues, therefore, the corresponding acid was synthesized by first oxidizing <b>13a</b> to give the acid <b>19</b>, which was then reacted with bromoethane in aqueous NaOH and toluene to give <b>20</b>, followed by hydrolysis with LiOH to yield the desired acid <b>21</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) NBS, CCl<sub>4</sub>; (ii) KCN, EtOH; (iii) 1,2 dibromoethane for <b>9a</b> or CH<sub>3</sub>CH<sub>2</sub>I for <b>9b,</b> NaOH, toluene−H<sub>2</sub>O; (iv) NaOH, MeOH, 100 °C; (v) R<sub>1</sub>B(OH)<sub>2</sub>, Pd(OAc)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, TBAB, H<sub>2</sub>O, 120 °C; (vi) NFSi, <i>t</i>-BuLi, THF, −78 °C; (vii) K<sub>2</sub>CO<sub>3</sub>, DMSO, H<sub>2</sub>O<sub>2</sub>, 0 °C yields <b>16a</b>−<b>b</b> and <b>17a</b>−<b>b</b>, or H<sub>2</sub>SO<sub>4</sub> (49%), 90 °C to give <b>18a</b>−<b>b</b>; (viii) K<sub>2</sub>CO<sub>3</sub>, DMSO, H<sub>2</sub>O<sub>2</sub>, 0 °C; (ix) CH<sub>3</sub>CH<sub>2</sub>Br, NaOH, toluene−H<sub>2</sub>O; (x) LiOH, THF/H<sub>2</sub>O/MeOH, 0 °C.</p></p></figure><div class="NLM_p">To synthesize the biaryl mono carboxylic acids <b>23a</b> and <b>23b</b>, a synthetic pathway was adopted in which <b>1</b> or <b>19</b> were reacted with <i>t</i>-butyldimethylsilyl chloride (TBSCl) and lithium bis(trimethylsilyl)amide (LiHMDS) at 0 °C to give the desired bis-ketenes <b>22a</b> and <b>22b</b>, which were then reacted with Selectfluor followed by acid−base workup to give the desired fluorinated acids, <b>23a</b> and <b>23b</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Flurbiprofen derivatives and analogues were synthesized from <b>1</b>, <b>11a</b>, <b>11c</b>, and <b>11d</b> through alkylation with 1,2-dibromoethane for <b>11a</b>, <b>11c</b>, and <b>11d</b> to give intermediates <b>25a</b>−<b>c</b>, or via alkylation of <b>1</b> with 1,4-dibromobutane to yield <b>24a</b>. The bromides were then transformed to the corresponding nitrates with AgNO<sub>3</sub> to yield <b>2</b> and <b>26a</b>−<b>c</b>. In a similar manner, the amide <b>27</b> was synthesized by coupling of <b>1</b> with 4-aminobutanol, followed by treatment with tetrabromomethane to give <b>24b</b> and subsequent nitration with AgNO<sub>3</sub> to afford the nitrate <b>27</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) TBSCl, LiHMDS, THF, 0 °C, 12 h; (ii) Selectfluor, CH<sub>3</sub>CN, <50 °C.</p></p></figure><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) NaOCH<sub>3</sub>, CH<sub>3</sub>OH; (ii) Br(CH<sub>2</sub>)<sub>4</sub>Br for <b>24a</b>, Br(CH<sub>2</sub>)<sub>2</sub>Br for <b>25a</b>−<b>c</b>, or 4-aminobutanol followed by PPh<sub>3</sub> with CBr<sub>4</sub> for <b>24b</b>, DMF; (iii) AgNO<sub>3</sub>, CH<sub>3</sub>CN, reflux.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Activity</h3><div class="NLM_p">Three structural approaches to analogues of <b>1</b> were developed: (1) variations at the terminal phenyl ring (R<sub>1</sub>), (2) modification of the α-carbon (R<sub>2</sub> and R<sub>2</sub>′), and (3) isosteric replacement of the carboxylic acid (R<sub>3</sub>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Derivatization of the α-carbon is known to be a subtle modification resulting in reduction or ablation of COX activity, whereas replacement of the carboxylate group is expected to be important in enhancing blood− brain barrier penetration. For these modifications to be successful, enhanced SALA activity was desired without loss of NSAID anti-inflammatory activity. Mouse macrophage-like RAW 264.7 cells, treated with lipopolysaccharide (LPS) bacterial endotoxin, undergo induction of COX-2, inducible NO synthase (iNOS), and other inflammatory mediators.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, the RAW 264.7 cell line is routinely used to examine the ability of agents to inhibit cellular inflammatory response. iNOS activity is readily assessed by measuring the levels of inorganic nitrite, the major product of NO oxidative metabolism, quantified using the Griess assay.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Flurbiprofen (<b>1</b>) itself was a modest inhibitor of iNOS induction in RAW cells treated with LPS, and no evidence of toxicity was seen at the lower concentration tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref28 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref28 ref32 ref33">(28, 32, 33)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Anti-inflammatory Effects of Selected <b>1</b> Analogues (10 μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub>, R<sub>2</sub>′</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">NO<sub>2</sub><sup>−</sup> as %<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">cell viability as %<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DMSO</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H, CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±"><b>80.7</b> ± <b>3.6</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>102</b> ± <b>2.7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">86.4 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">napthyl</td><td class="colsep0 rowsep0" align="left">ethyl, ethyl</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">91.3 ± 4.6</td><td class="colsep0 rowsep0" align="char" char="±">107 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">H, F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">65.3 ± 9.0</td><td class="colsep0 rowsep0" align="char" char="±">84.5 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">F, F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">75.7 ± 9.1</td><td class="colsep0 rowsep0" align="char" char="±">98.2 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">H, F</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">74.7 ± 7.2</td><td class="colsep0 rowsep0" align="char" char="±">90.6 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, F</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">82.2 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">F, F</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">84.1 ± 5.3</td><td class="colsep0 rowsep0" align="char" char="±">98.8 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H, OH</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">59 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">89.1 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">H, OH</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">76.3 ± 4.9</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">80.8 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">99.7 ± 3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">81.5 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">92.7 ± 4.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Griess assay.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">MTT assay.</p></div></div></div><div class="NLM_p">In comparison with <b>1</b>, several analogues gave a significantly greater anti-inflammatory response, although in the case of <b>14b</b> and <b>18a</b>, this was associated with somewhat increased toxicity. These data demonstrate that the three structural modifications can be accommodated while maintaining or enhancing anti-inflammatory activity toward iNOS induction, relative to <b>1</b>. At higher concentration, anti-inflammatory activity was increased relative to <b>1</b> again without toxicity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Cyclopropyl analogues <b>11a</b> and <b>11c</b> gave similar responses; however, <b>11d</b> was highly toxic toward RAW cells. Comparison with other test compounds showed that toxicity was not a feature associated with one of the three structural motifs (R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>) but a property of the molecule as a whole.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Anti-inflammatory Effects of <b>1</b> and Analogues (100 μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0005.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub>, R<sub>2</sub>′</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">NO<sub>2</sub><sup>−</sup> as %<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">cell viability as %<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DMSO</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H, CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±"><b>69.1</b> ± <b>3.2</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>109</b> ± <b>2.7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H, CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>4</sub>ONO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">49.8 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">108 ± 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">60.7 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">62.4 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">3,4 dichlorophenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">19.1 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>2</sub>Br</td><td class="colsep0 rowsep0" align="char" char="±">18.9 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">109 ± 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25b</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>2</sub>Br</td><td class="colsep0 rowsep0" align="char" char="±">14.7 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">113 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25c</b></td><td class="colsep0 rowsep0" align="left">3,4 dichlorophenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>2</sub>Br</td><td class="colsep0 rowsep0" align="char" char="±">27.8 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">114 ± 3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>2</sub>ONO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">47.3 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">113 ± 6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26b</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>2</sub>ONO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">42.8 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">128 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26c</b></td><td class="colsep0 rowsep0" align="left">3,4 dichlorophenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COO(CH<sub>2</sub>)<sub>2</sub>ONO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">40 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">135 ± 2.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Griess assay.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">MTT assay.</p></div></div></div><div class="NLM_p">We have previously reported use of the Griess assay in measurement of the anti-inflammatory activity of nitrates toward LPS-induced RAW cells.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> There is a potential pitfall with this approach, because metabolic denitration of nitrate drugs directly yields NO<sub>2</sub><sup>−</sup>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> However, a complete analysis of denitration in induced and noninduced RAW cells demonstrated that simple aliphatic mononitrates, such as isosorbide mononitrate (ISMN) and <b>2</b>, release <3% of the theoretical yield of NO<sub>2</sub><sup>−</sup> after 24 h.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> We previously reported that <b>2</b> was significantly more potent than <b>1</b> in attenuating induction of iNOS activity, whereas the classical mononitrate, ISMN, showed no significant inhibition of iNOS activity, and in combination with <b>1</b> was no more efficacious than <b>1</b> alone.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These observations extend to the hybrid nitrate derivatives, <b>26a</b>−<b>c</b>, which were observed to be significantly more potent than their parent flurbiprofen analogue (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Interestingly, conversion of the cytotoxic <b>11d</b> to a hybrid nitrate (<b>26c</b>) completely ablated toxicity. However, neither the anti-inflammatory activity nor the ablated toxicity could be ascribed to the nitrate group because the precursor bromo-derivatives, <b>25a</b>−<b>c</b>, were the most potent anti-inflammatory agents, reducing NO<sub>2</sub><sup>−</sup> production 4-fold relative to the parent carboxylic acids in the absence of any cytotoxicity.</div><div class="NLM_p">Approaches to the design of improved analogues of <b>1</b> as antiamyloidogenic agents have been published previously. Modification of the α-carbon through the incorporation of a cyclopropyl group<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> or a dimethyl group<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> were reported to lead to increased potency for lowering Aβ while eliminating COX activity. Previous work published by Peretto et al. focused mainly on substituting the terminal phenyl ring (R<sub>1</sub>) of the cyclopropyl analogue of <b>2</b>, leading to compound <b>11d</b>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The murine N2a.hAPP cell line has previously been employed by various investigators to assay SALAs using ELISA to measure Aβ<sub>1−40</sub> and/or Aβ<sub>1−42</sub>.<a onclick="showRef(event, 'ref16 ref28 ref35'); return false;" href="javascript:void(0);" class="ref ref16 ref28 ref35">(16, 28, 35)</a> In this assay, confluent N2a/APPsw cells were treated with drug for 24 h, following which the supernatant was collected and Aβ<sub>1−42</sub> measured by ELISA. Compound <b>11d</b>, observed to be toxic in RAW cells at higher concentration (100 μM), was not toxic toward N2a cells at lower concentration (1 μM). However, in contrast to reports of the activity of this compound tested at higher concentrations (i.e., 50−500 μM),<a onclick="showRef(event, 'ref30 ref36'); return false;" href="javascript:void(0);" class="ref ref30 ref36">(30, 36)</a> at the low concentration tested herein (1 μM), <b>11d</b> did not reduce levels of Aβ<sub>1−42</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Carboxylate analogues possessing a phenyl R<sub>1</sub> substituent uniformly lowered Aβ<sub>1−42</sub>, with the exception of the diethyl analogue <b>21</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of <b>1</b> and Analogues (1 μM) on Aβ<sub>1-42</sub> Levels</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0006.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub>, R<sub>2</sub>′</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">Aβ<sub>1−42</sub> as %</th><th class="colsep0 rowsep0" align="center" char="±">cell viability as %<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DMSO</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">100 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H, CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±"><b>86.6</b> ± <b>0.9</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>101</b> ± <b>0.9</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">69.5 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">103 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">90.4 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">99.3 ± 10.7</td><td class="colsep0 rowsep0" align="char" char="±">97.2 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">3,4 dichlorophenyl</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">125 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">92.9 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">ethyl, ethyl</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">125 ± 5.1</td><td class="colsep0 rowsep0" align="char" char="±">97.3 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">naphthyl</td><td class="colsep0 rowsep0" align="left">ethyl, ethyl</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">105 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">91.6 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">65.6 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">93.1 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">F, H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">69.4 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">F, F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char="±">125 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">98.2 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, H</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">101 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">102.8 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">4-F- phenyl</td><td class="colsep0 rowsep0" align="left">F, H</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">-</td><td class="colsep0 rowsep0" align="char" char="±">69.1 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, F</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">115 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">F, F</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">109 ± 5.8</td><td class="colsep0 rowsep0" align="char" char="±">95.9 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">OH, H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">82.5 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">OH, H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">106 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">99.7 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">ethyl, ethyl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">124 ± 7.1</td><td class="colsep0 rowsep0" align="char" char="±">95.5 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">98.8 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">F, H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">91.8 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">98.7 ± 1.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">MTT assay.</p></div></div></div><div class="NLM_p">A number of derivatives (i.e., <b>11b</b>, <b>18a</b>, and <b>23b</b>) demonstrated antiamyloidogenic activity, comparable to <b>1</b>, in the absence of substantial toxicity. These compounds all contain the NSAID carboxylate group but are otherwise structurally diverse. Two compounds stood out as superior to <b>1</b>, <b>11a</b> and <b>14a</b>, both bearing an unsubstituted phenyl R<sub>1</sub> substituent. The activity of the nitrile <b>14a</b> was of interest because the observation of antiamyloidogenic activity shows that the carboxylate group is not an absolute requirement. This was the most interesting of the novel α-fluoro analogues but obviously was not suitable for further study as a hybrid nitrate.</div><div class="NLM_p">Given the ability of at least one analogue, lacking a carboxylate group, to lower Aβ<sub>1−42</sub>, and several such examples inhibiting iNOS activity, it was of interest to assay analogues of <b>3</b> and <b>4</b>, which contained examples with amides in place of carboxylic acids. The derivatives of <b>3</b> provided the expected anti-inflammatory activity and the expected antiamyloid activity for <b>3</b>, itself, was observed at high concentration (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Other activity of note was the amyloid raising activity of the amide derivative, <b>34</b>, which was of the same magnitude as seen for so-called selective amyloid raising agents (SARAs) such as fenofibrate (<b>39</b>). Derivatives of <b>4</b> (<b>28</b>−<b>33</b>) provided one compound with a good profile of anti-inflammatory and antiamyloidogenic activity without cytotoxicity, the desmethylated derivative <b>28</b>. Amide derivatives did not reduce Aβ<sub>1−42</sub> and were comparable to <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Anti-amyloidogenic Inhibitory Activity and Anti-Inflammatory Activity of <b>3</b> Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0007.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">Aβ<sub>1−42</sub> as %<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">NO<sub>2</sub><sup>−</sup> as %<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">cell viability as %<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DMSO</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">100 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 7.4</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">108 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">70.9 ± 7.4</td><td class="colsep0 rowsep0" align="char" char="±">98.7 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> (100 μM)</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">76.7 ± 2.9</td><td class="colsep0 rowsep0" align="char" char="±">39.8 ± 10.5</td><td class="colsep0 rowsep0" align="char" char="±">92.0 ± 7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CONH-4-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">295 ± 27.2</td><td class="colsep0 rowsep0" align="char" char="±">68.6 ± 6.3</td><td class="colsep0 rowsep0" align="char" char="±">92.2 ± 5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 5.3</td><td class="colsep0 rowsep0" align="char" char="±">65.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">97.9 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char="±">118 ± 9.4</td><td class="colsep0 rowsep0" align="char" char="±">52.5 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CONHCH<sub>2</sub>CH<sub>2</sub>-3-pyridine</td><td class="colsep0 rowsep0" align="char" char="±">135 ± 8.7</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 7.4</td><td class="colsep0 rowsep0" align="char" char="±">95.6 ± 2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">1 μM.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Griess assay; 10 μM unless otherwise stated.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">MTT assay in RAW cells; 10 μM unless otherwise stated.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Anti-amyloidogenic Activity and Anti-inflammatory Activity of <b>4</b> Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0008.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">Aβ<sub>1−42</sub> as %<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">NO<sub>2</sub><sup>−</sup> as %<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="left" char="±">cell viability as %<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DMSO</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">100 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 11.4</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">SOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">85.7 ± 9.3</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">SCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">82.6 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">SCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">80.8 ± 4.3</td><td class="colsep0 rowsep0" align="char" char="±">47.5 ± 7.2</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">SOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">91.6 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">SCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CONHCH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="char" char="±">94.5 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">58.4 ± 12.5</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">SCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CONHCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">95.7 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">80.4 ± 11.1</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">91 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">29.2 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">SCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char="±">99.4 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 6.3</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">1 μM.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Griess assay at 10 μM.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">MTT assay in RAW cells at 10 μM.</p></div></div></div><div class="NLM_p">For selected agents, the dependence of antiamyloidogenesis on concentration was tested further, again using N2a.hAPP cell cultures treated with agents for 24 h, followed by ELISA assay of the supernatant. The flurbiprofen analogue <b>11a</b> was compared to <b>1</b> itself and shown to be a more potent SALA, lowering Aβ<sub>1−42</sub> by 40% at the highest concentration studied, with no significant toxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). In contrast, the hybrid nitrate derivative <b>2</b>, as we have reported previously,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> showed biphasic activity. The full concentration−response data for <b>2</b> showed SALA activity more potent than <b>1</b> and similar to <b>11a</b> at low concentrations and, in contrast, SARA activity at >10 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B).</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Flurbiprofen and derivatives showed varied SALA and SARA activity in neuronal cell incubations. Levels of Aβ<sub>1−42</sub> from N2a/APPsw cell supernatants were measured by ELISA and normalized to DMSO vehicle treated control after incubation with different concentrations of compounds <b>1</b> and <b>11a</b> (A) or <b>1</b> and <b>2</b> (B). The average level of Aβ<sub>1−42</sub> in the DMSO treated groups was ∼500 pg/mL. The data show mean and SEM from at least four separate experiments performed using separate cell passages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It was important to determine whether this biphasic activity was peculiar to compound <b>2</b> or if, indeed, this was common to related NSAID hybrid nitrates. Therefore, nitrate <b>26a</b> was studied over a range of concentrations, revealing a similar response, albeit with less efficacy as a SALA than <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). To determine if the nitrate group was relevant to the observed biphasic activity of these NSAID hybrid nitrates, the antiamyloidogenic activity of the nitrate <b>2</b> was compared with that of the simple ethyl ester <b>38</b> in N2a.hAPP cell culture incubations (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). The ester behaved as a typical SARA agent increasing Aβ<sub>1−42</sub> 2.5-fold at 10 μM, indicating the importance of the nitrate for SALA activity at low concentrations. However, this SALA activity of hybrid nitrate NSAIDs toward Aβ<sub>1−42</sub> modulation is unlikely to be associated with NO bioactivity delivered by the nitrate functionality since we have previously noted that the classical nitrate ISMN is without activity in this assay.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The alkyl ester linker of the hybrid nitrates, <b>2</b> and <b>26a</b>, is expected to be labile toward nonspecific esterase activity; therefore, it was important to test a hybrid nitrate with a stable linker. The amide linked nitrate, <b>27</b>, was synthesized expressly to test if the more labile ester linker of <b>2</b> and <b>26a</b> was essential for the observed antiamyloidogenic activity. The antiamyloidogenic activity at low concentration (0.5 μM) was retained compared to <b>26a</b>, indicating that the intact nitrate is required for SALA activity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). This appears to be only the second example where biological activity can be attributed to the intact NO-NSAID, rather than to the NO-NSAID acting as a prodrug releasing NSAID, aliphatic nitrate, and/or NO.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hybrid nitrate flurbiprofen derivatives caused biphasic regulation of Aβ<sub>1−42</sub> in neuronal cell incubations, acting as SALAs at lower concentration. Levels of Aβ<sub>1−42</sub> from N2a/APPsw cell supernatants were measured by ELISA and normalized to DMSO vehicle treated control after incubation with different concentrations of compounds <b>2</b> and <b>26a</b> (A), <b>2</b> and <b>38</b> (B), or <b>26a</b> (0.5 μM) and <b>27</b> (0.5 μM) (C). The average level of Aβ<sub>1−42</sub> in DMSO treated group was ∼500 pg/mL. The data show mean and sem from at least four separate experiments performed using separate cell passages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The NO-flurbiprofens, NCX-2216 and HCT-1026 (<b>2</b>), have been reported to lower Aβ in mouse models, however, NCX-2216 was not detected in brain tissue,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and both plasma and brain levels of HCT-1026 were reported to be below detection limits.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Hydrolysis of HCT-1026 yields 4-hydroxybutyl nitrate, and it is possible that this metabolite has brain bioavailaibility because animal studies have shown that the level of inorganic nitrite in the brain increases after oral administration of HCT-1026.<a onclick="showRef(event, 'ref29 ref40'); return false;" href="javascript:void(0);" class="ref ref29 ref40">(29, 40)</a> It was of interest both to confirm the increased stability of the amide linked hybrid nitrate <b>27</b> relative to the ester linked homologue, <b>2</b>, and to determine if unlike <b>2</b>, the NO-flurbiprofen, <b>27</b>, was detectable in the brain. Therefore, <b>27</b> (10 mg/kg) was delivered by ip injection to male C75/BL6 mice (25 g) and brain and plasma levels detected by LC-MS/MS at 30 and 120 min after injection. The brain/plasma ratio of <b>27</b> was 37% and 13% at 30 and 120 min, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Most importantly, <b>27</b> was present in detectable amounts both in the brain and plasma 2 h after administration, in contrast to reports on <b>2</b>.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hybrid nitrate <b>27</b> has brain bioavailaibility and in vivo stability after administration to mice (10 mg/kg ip) 30 or 120 min prior to sacrifice. Quantitation of <b>27</b> by LC-MS/MS used MRM analysis of the <i>m</i>/<i>z</i> transition 361 → 200. (A) Representative MRM chromatogram of <b>27</b> from mouse brain sample 120 min after administration, showing fragment observed as protonated cation (<i>m</i>/<i>z</i> = 200) in MRM. (B) Quantitative analysis of brain and plasma levels at 30 and 120 min using LC-MS/MS detection. Data (<i>N</i> = 4) show mean and SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The SARA activity of flurbiprofen derivatives <b>2</b>, <b>26a</b>, and <b>38</b> at higher concentrations has precedent in SARA agents, including NSAIDs such as celecoxib, and other drugs, such as <b>39</b>, that have been reported to elevate Aβ<sub>1−42</sub> levels while lowering the level of other fragments including Aβ<sub>1−38</sub>.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41-43)</a> To study the effect of agents on amyloidogenesis in more detail, we determined the profile of Aβ fragment production from N2a.hAPP cells for selected compounds using an immunoprecipitation MALDI-TOF technique introduced in 2009.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This technique quantifies the amyloid fragments Aβ<sub>1−37</sub>, Aβ<sub>1−38</sub>, Aβ<sub>1−40</sub>, and Aβ<sub>1−42</sub>, using Aβ<sub>1−43</sub> as an internal standard, because this fragment is not a product of amyloidogenesis. In the N2a.hAPP amyloidogenesis assay, we observed that the known SARA <b>39</b> (200 μM) increased Aβ<sub>1−42</sub> levels 3-fold but had modest effects on Aβ<sub>1−37</sub> and Aβ<sub>1−38</sub> although lowering the level of the latter fragment (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In contrast, fibric acid, the free acid form of <b>39</b>, was reported to lower the levels of Aβ<sub>1−42</sub>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A similar observation on Aβ<sub>1−42</sub> modulation was made herein with <b>1</b> and its ester, <b>38</b>. Whereas, the ester acted as a SARA, the free acid, <b>1</b>, at 100 μM, selectively lowered Aβ<sub>1−42</sub> and elevated Aβ<sub>1−37</sub> relative to the vehicle control (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Indeed, the amyloid peptide product profiles for the three carboxylate esters, <b>2</b>, <b>25c</b>, and <b>39</b> are very similar at high concentrations; all act as SARAs, significantly and selectively increasing Aβ<sub>1−40</sub>, Aβ<sub>1−42</sub> and the ratio Aβ<sub>1−42</sub>/Aβ<sub>1−40</sub>. In contrast, the hybrid nitrate ester, <b>2</b>, behaves quite differently; at low concentrations, <b>2</b> lowers total Aβ generation with similar efficacy to the flurbiprofen analogue, <b>11a</b>, although with less selectivity for Aβ<sub>1−42</sub>.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Quantitative analysis of Aβ<sub>1−37</sub>, Aβ<sub>1−38</sub>, Aβ<sub>1−40</sub>, and Aβ<sub>1−42</sub> in neuronal cell supernatant after drug treatment. For each individual experiment, peak heights from IP-MALDI-TOF spectra were normalized to the peak height of the Aβ<sub>1−43</sub> standard after incubation of drugs with N2a/APPsw cells. These normalized values were then expressed relative to the DMSO vehicle control in each set of experiments. See ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a> for full details. The data show mean and sem from at least four separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sulindac (<b>4</b>) is known to act as an NSAID SALA. The expected selective lowering of Aβ<sub>1−42</sub> and raising of both Aβ<sub>1−37</sub> and Aβ<sub>1−38</sub> levels was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Flurbiprofen derivative <b>11a</b> was a more potent SALA than both <b>1</b> and <b>4</b> (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), moreover, the profile of Aβ modulation by <b>11a</b> was very different from that of <b>4</b>. The concept that NSAID SALAs act as γ-secretase modulators was initially rationalized by a shift in secretase cleavage from producing Aβ<sub>1−42</sub> to production of Aβ<sub>1−37</sub>, however, current opinion is that SALAs do not operate universally via this synchronized shift from Aβ<sub>1−42</sub> production to Aβ<sub>1−38</sub> production.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> As we have seen, the well-established SALA and SARA activity of several drugs is recapitulated in the N2a.hAPP model system. However, a simple “control experiment” has shown that in this system, the SALA and SARA activity is not related to γ-secretase modulation. In this experiment, wild-type N2a cells were treated with drug or vehicle for 24 h, at which time, conditioned media (CM) was removed from the culture dish and added to media containing a freshly made solution of Aβ<sub>1−42</sub> and Aβ<sub>1−40</sub>. CM delivered the same modulation of Aβ<sub>1−42</sub>, Aβ<sub>1−40</sub>, and Aβ<sub>1−42</sub>/Aβ<sub>1−40</sub> observed when drugs were incubated in N2a.hAPP cell cultures. Further experiments showed that the modulation of Aβ<sub>1−42</sub> and Aβ<sub>1−40</sub> levels by SARA and SALA drugs was mediated by expression of metalloprotease activity induced by drug treatment of cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Levels of Aβ<sub>1−42</sub> and Aβ<sub>1−40</sub> were measured by the MALDI-TOF method after treatment of N2a cells with drugs for 24 h and transfer of the CM to a solution of Aβ<sub>1−42</sub> and Aβ<sub>1−40</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The results of this experiment confirm that <b>1</b>, <b>2</b>, and <b>28</b> are able to act as SALAs by increasing degradation of Aβ<sub>1−42</sub> and Aβ<sub>1−40</sub> and decreasing the ratio of Aβ<sub>1−42</sub>/Aβ<sub>1−40</sub>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SALA activity was observed in mixtures of Aβ<sub>1−40</sub> + Aβ<sub>1−42</sub> treated with conditioned media (CM) from drug treated N2a/WT cells. Cells were treated with <b>1</b> (100 μM), <b>2</b> (1 μM), and <b>28</b> (10 μM) for 24 h before the collection of the CM. CM was added to a mixture of Aβ<sub>1−40</sub> + Aβ<sub>1−42</sub> and incubated for 8 h. CM from cell free wells (media) was used as the control. Aβ was quantified by IP-MALDI-TOF and normalized to “media” control. Data show mean and sd from two separate cell cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The poor blood−brain barrier penetration common to most NSAIDs has been blamed for the failure of the SALA <i>R-</i>flurbiprofen in phase 3 clinical trial for AD. Hybrid nitrate NO-NSAIDs provide an alternative, gastric-sparing approach to NSAID SALAs of use in AD. Because these compounds contain an ester linkage in place of the carboxylate anion, improved CNS bioavailability is expected. In this work, analogues of indomethacin and sulindac did not show a significantly improved profile of anti-inflammatory activity nor Aβ<sub>1−42</sub> lowering. However, analogues of flurbiprofen, <b>1</b>, were prepared with superior anti-inflammatory and antiamyloidogenic activity to the parent NSAID. A number of examples were converted to hybrid nitrate ester prodrugs, including a prodrug of the AD drug candidate, <b>11d</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The hybrid nitrates possessed superior anti-inflammatory activity to the parent NSAID. Esterification of <b>1</b> led to elevated Aβ<sub>1−42</sub>, however, this SARA activity was observed only at high concentrations for the hybrid nitrates, whereas at low concentrations (<1 μM), Aβ<sub>1−42</sub> and the ratio of Aβ<sub>1−42</sub>/Aβ<sub>1−40</sub> were lowered. Interestingly, the intact hybrid nitrate was found to be necessary for the SALA activity of these NO-NSAIDs. An amide-linked NO-NSAID SALA, <b>27</b>, was shown to have brain bioavailability and to be detectable in brain and plasma 120 min after administration. These data support the optimization of hybrid nitrate SALAs, based upon modified flurbiprofen scaffolds that retain anti-inflammatory activity, and provide enhanced brain bioavailability.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless stated otherwise. Murine biotinylated antihuman Aβ 4G8 and 6E10 antibodies produced by Signet were purchased from Covance Research Products, Inc. (Dedham, MA). All cell culture supplies, human Aβ ELISA kit, and streptavidin Dynabeads T1 were purchased from Invitrogen (Carlsbad, CA).</div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell Culture and Treatments</h3><div class="NLM_p last">The murine neuroblastoma N2a cells obtained from American Type Culture Collection (Manassas, VA) were cultured in 1:1 Dulbecco’s Modified Eagle’s Medium (DMEM) and OPTI-MEM supplemented with 5% fetal bovine serum, 100 U/mL penicillin, and 100 U/mL streptomycin. N2a cells stably transfected with the Swedish mutant of human APP (N2a/APPsw were kind gift of Dr. Gopal Thinakaran, University of Chicago) were additionally supplemented with 200 μg/mL G418 but omitted during all experiments. RAW 264.7 mouse macrophage-like cells, provided by Dr. J. Cook (University of Illinois at Chicago, Chicago, IL), were maintained in DMEM, supplemented with 1% penicillin−streptomycin, and 10% fetal bovine serum. Cells were maintained at 37 °C and 5% CO<sub>2</sub>.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Griess Assay</h3><div class="NLM_p last">RAW cells were plated at a concentration of 25 × 10<sup>4</sup> cells/well in a 24-well plate and incubated at 37 °C for 24 h. The medium was changed, and the cells were drug treated, followed 30 min later by the addition of lipopolysaccharide (LPS) from <i>Escherichia coli</i> 055:B5 (LPS; Sigma-Aldrich). Twenty-four h later, 100 μL of the supernatant was removed and incubated with the Griess reagent (100 μL; 0.5% sulfanilamide, 0.05% (<i>N</i>-1-naphthyl)ethylenediamine dihydrochloride, 2.5% H<sub>3</sub>PO<sub>4</sub>, and 97% H<sub>2</sub>O by weight) for 30 min at rt in the dark. The absorbance was measured at 530 nm on a Dynex MRX II microplate spectrophotometer and calibrated using a standard curve constructed with sodium nitrite to yield nitrite concentration.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Amyloid β Measurement from N2a/APPsw Cells Supernatant</h3><div class="NLM_p last">N2a/APPsw cells were plated 24 h before the experiment at a density of 25 × 10<sup>4</sup> cells/well in a 24-well plate. Cells were washed with phosphate buffered saline (PBS; 50 mM, pH 7.4) before the addition of 500 μL of DMEM supplemented with 0.2% fetal bovine serum (FBS) followed by drug treatment. Cells were incubated for a period of 24 h. CM was collected, followed by the addition of NaN<sub>3</sub> (0.01% final concentration) and a mixture of protease inhibitors (10 mM phenanthroline and P2714 protease inhibitor cocktail from Sigma containing 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, aprotinin, bestatin, E-64, leupeptin, and ethylenediaminetetraacetate (EDTA)), and centrifuged for 2 min at a speed of 10 000<i>g</i>. Aβ<sub>1−42</sub> levels were determined by sandwich ELISA using human Aβ<sub>1−42</sub> ELISA kit and following the supplied protocol. For immunoprecipitation, cells were treated as described above but plated in a 6-well plate at a density of 100 × 10<sup>4</sup> cells/well in 2 mL media. Twenty-four h after treatment, 1 mL of the CM is collected, followed by the addition of NaN<sub>3</sub> and protease inhibitors and spiked with Aβ<sub>1−43</sub> at approximately 1 ng/mL final concentration as an internal standard before performing immunoprecipitation. A stock of 200 ng/mL Aβ<sub>1−43</sub> was prepared in sodium bicarbonate (50 mM, pH 9.0) and stored in aliquots in 1.5 mL low binding eppendorf tubes at −80 °C; once defrosted, any remaining Aβ<sub>1−43</sub> stock was discarded. Following immunoprecipitation the samples were analyzed in a MALDI-TOF instrument as described below for the purpose of measuring the relative abundance of Aβ peptides. In all experiments, Aβ levels were assayed relative to vehicle controls by treating all the groups with the identical sample of Aβ<sub>1−43</sub> internal standard.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Aβ Degradation Associated with N2a/WT Cells</h3><div class="NLM_p last">N2a/WT cells were plated 24 h before the experiments at a density of 100 × 10<sup>4</sup> cells/well in 6-well plates. Cells were washed with PBS before the addition of 2 mL of DMEM supplemented with 0.2% FBS followed by drug treatment. Eighteen h after drug treatment, CM was collected and treated with NaN<sub>3</sub> and centrifuged at 10 000<i>g</i>; the mixture of Aβ<sub>1−40</sub> and Aβ<sub>1−42</sub> was added and further incubated for 8 h at 37 °C. The CM was then treated with the protease inhibitor mixture and spiked with Aβ<sub>1−43</sub> as an internal standard followed by immunoprecipitation and MALDI-TOF analysis.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Immunoprecipitation and MALDI/TOF Analysis</h3><div class="NLM_p last">Immunoprecipitation of Aβ was performed by the addition of a mixture of 0.25 μL of biotinylated 4G8 antibody and 0.25 μL of biotinylated 6E10 antibody, samples were then rotated at room temperature for 4 h followed by the addition of 4 μL T1 streptavidin coated magnabeads and rotated for an additional 2 h. Beads were washed three times with NH<sub>4</sub>CO<sub>3</sub> (10 mM, pH 8.0), and the Aβ peptides were eluted using 4 μL of a mixture of 75% acetonitrile and 0.5% TFA in H<sub>2</sub>O, followed by the addition of 3 μL of a saturated matrix solution (α-cyano-4-hydroxycinnamic acid in 1:1 acetonitrile and H<sub>2</sub>O). One μL of this mixture was spotted onto a MALDI plate and analyzed using a MALDI-TOF instrument (Applied Biosystems). Mass spectra were acquired automatically in a linear positive mode at 1950 shot per spectrum. For each individual experiment, peak heights were normalized to the peak height of the Aβ<sub>1−43</sub> standard; these normalized values were then expressed relative to the DMSO vehicle control in each set of experiments.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> MTT Assay</h3><div class="NLM_p last">The MTT assay was performed by incubating the cells in a culture media containing 0.5 mg/mL solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) for 4 h, the cells were then washed with PBS and the formed purple formazan crystals were solubilized in DMSO. The plate was shaken on a plate rocker for 30 min, and then the absorbance was measured at 570 nm using 630 nm as a reference wavelength on a Dynex MRX II microplate spectrophotometer.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Bioavailability</h3><div class="NLM_p last">Use of animals was approved by the Institutional Animal Care and Use Committee at the University of Illinois at Chicago. Nitrate <b>27</b> was dissolved in DMSO/H<sub>2</sub>O (1:1 v/v) and administrated at 10 mg/kg via ip injection to male C57BL/6 mice (25 g). Animals were sacrificed at 30 and 120 min, and both blood and whole brain were collected for analysis. Two equal portions of each brain or blood sample were processed for analysis. Brain tissue was homogenized in methanol manually and then centrifuged at 4 °C, 13000 rpm for 10 min. The remaining pellet was washed with methanol (0.3 mL) and supernatants combined. After concentration under N<sub>2</sub>, reconstitution in MeOH/H<sub>2</sub>O (1:1, v/v), and centrifugation at 4 °C, 13000 rpm for 15 min, samples were analyzed by LC-MS/MS. Plasma was extracted in a similar way prior to analysis by LC-MS/MS, except acetonitrile was used instead of methanol. LC separation was achieved using a Waters Xbridge C18 3.0 mm × 100 mm, 3.5 μm column, and a linear gradient mobile phase from 55% to 95% MeOH in 0.1% formic acid over 21 min at a flow rate of 350 μL/min. MS/MS analysis was performed on a Sciex API 3000 triple-quad instrument monitoring the transition <i>m</i>/<i>z</i> = 361 → <i>m</i>/<i>z</i> = 200 in positive ion mode. Quantitative extraction from plasma was estimated by spiking untreated samples. Concentrations were interpolated from a standard curve constructed from analyte in MeOH/H<sub>2</sub>O (4−500 ng/mL).</div></div><div id="sec11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Methods</h3><div class="NLM_p">Unless stated otherwise, all reactions were carried out under an atmosphere of dry argon in oven-dried glassware. Indicated reaction temperatures refer to those of the reaction bath, while room temperature (rt) is noted as 25 °C. CH<sub>2</sub>Cl<sub>2</sub> was distilled over CaH<sub>2</sub>, and THF was distilled over Na(s)/benzophenone. All other solvents were of anhydrous quality purchased from Aldrich Chemical Co. and used as received. Commercially available starting materials and reagents were purchased from Aldrich, TCI, and Fisher Scientific and were used as received unless specified otherwise. Indomethacin and sulindac libraries were provided by Prof. Larry Marnett of Vanderbilt University. Analytical thin layer chromatography (TLC) was performed with Sorbent Silica glass backed TLC plates (20 cm × 20 cm, 60 Å, 250 μm) with UV detection at 254 nm. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on either a Bruker Avance 400 MHz spectrometer or a Bruker DPX 400 MHz spectrometer. Chemical shifts are reported in ppm with the solvent resonance as internal standard ([CDCl<sub>3</sub> 7.27 ppm, 77.23 ppm] [DMSO-<i>d</i><sub>6</sub> 2.5 ppm, 39.51 ppm] and [MeOD-<i>d</i><sub>4</sub> 4.78, 49.0] for <sup>1</sup>H, <sup>13</sup>C, respectively). Data are reported as follows: chemical shift, number of protons, multiplicity (s = singlet, d = doublet, dd = doublet of doublet, t = triplet, q = quartet, bs = broad singlet, m = multiplet), and coupling constants. Compounds submitted for biological testing were found to be >95% pure via analytical HPLC analysis using Shimadzu HPLC. High resolution mass spectral data was collected in-house using Shimadzu LCMS IT-TOF.</div><div id="sec11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-Bromo-4-bromomethyl-2-fluorobenzene (<b>7</b>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></h4><div class="NLM_p last"><i>N</i>-Bromosuccinimide (11.39 g, 640 mmol) was added to a solution of 1-bromo-2-fluoro-4-methylbenzene <b>6</b> (5.36 mL, 8.01 g, 42 mmol) in CCl<sub>4</sub> (100 mL). The mixture was heated to 80 °C, and then dibenzoyl peroxide (0.27 g, 32 mmol) was added. The mixture was stirred at this temperature for 1 h and then cooled to rt and washed in sequence with H<sub>2</sub>O (2 × 80 mL) and brine (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford red oil (∼14 g), which was purified by column chromatography (hexane/ethyl acetate [10:1]) to give <b>7</b> as a yellow crystalline solid (12.2 g, yield 75.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.55−7.53 (t, 1H), 7.19−7.17 (dd, 1H), 7.08−7.06 (dd, 1H), 4.42 (s, 2H).</div></div><div id="sec11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-Bromo-3-fluorophenyl)acetonitrile (<b>8</b>)</h4><div class="NLM_p last">A solution of <b>7</b> (12.0 g, 41 mmol) and KCN (2 g, 0.04 mol) in ethanol (100 mL) was heated to 80 °C for 2 h and then cooled to rt and concentrated under vacuo. The residue was suspended in H<sub>2</sub>O (200 mL) and extracted with ethyl acetate (3 × 150 mL). Combined organic extracts were washed with brine (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford a brown oil. Column chromatography (hexane/ethyl acetate [7:1]) yielded <b>8</b> as a light-yellow solid (5.0 g, yield 52%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.57 (dd, 1H), 7.13 (dd, 1H), 7.02 (dd, 1H), 3.72 (s, 2H).</div></div><div id="sec11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-(4-Bromo-3-fluorophenyl)cyclopropanecarbonitrile (<b>9a</b>)</h4><div class="NLM_p last">To a solution of <b>8</b> (5.0 g, 23 mmol) and 1,2-dibromoethane (3 mL, 35 mmol) in toluene (20 mL), 50% NaOH (20 mL), and TBAB (1.6 g, 5 mmol) were added. The mixture was vigorously stirred at rt for 4 h and then diluted with H<sub>2</sub>O (20 mL) and extracted with ethyl acetate (3 × 150 mL). The organic layer was washed with 1 M HCl (25 mL) and then with brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford a brown solid (5.7 g). Column chromatography (hexane/ethyl acetate [5:1]) afforded <b>9a</b> as yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.54−7.50 (t, 1H), 7.05−7.03 (dd, 1H, <i>J</i> = 7.48 Hz), 7.00−6.98 (dd, 1H, <i>J</i> = 7.48 Hz), 1.80−1.77 (q, 2H), 1.43−1.40 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 160.42 (d, <i>J</i> = 240 Hz), 138.01 (d, <i>J</i> = 6.9 Hz), 133.94, 122.54 (d, <i>J</i> = 3.5 Hz), 121.49, 114.07 (d, <i>J</i> = 8.4 Hz), 108.23 (d, 20.8 Hz), 18.71, 13.50.</div></div><div id="sec11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(4-Bromo-3-fluorophenyl)diethylcarbonitrile (<b>9b</b>)</h4><div class="NLM_p last">To a solution of <b>8</b> (235 mg, 1.1 mmol) and iodoethane (240 mg, 2.2 mmol) in toluene (20 mL), 50% NaOH (20 mL) and TBAB (420 mg, 2.8 mmol) were added. The mixture was vigorously stirred at rt for 4 h and then diluted with H<sub>2</sub>O (20 mL) and extracted with ethyl acetate (3 × 100 mL). The organic solution was washed with 1 M HCl and then with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford a brown solid (950 mg). Column chromatography (hexane/ethyl acetate [5:1]) afforded <b>9b</b> as white solid (278 mg, yield 93.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.73−7.70 (t, 1H), 7.18−7.15 (dd, 1H, <i>J</i> = 7.48 Hz), 7.12−7.09 (dd, 1H, <i>J</i> = 7.48 Hz), 2.10−2.01 (m, 2H), 1.92−1.83 (m, 2H), 0.95−0.91 (t, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 160.11 (d, <i>J</i> = 240 Hz), 139.82 (d, <i>J</i> = 6.9 Hz), 133.46, 122.83 (d, <i>J</i> = 3.5 Hz), 120.97, 114.28 (d, <i>J</i> = 2.4 Hz), 107.96 (d, 21.1 Hz), 49.19, 33.33, 9.82.</div></div><div id="sec11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic Acid (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>9a</b> (5.1 g, 21 mmol) in methanol (10 mL), 35% NaOH (40 mL) was added and the mixture was heated to 100 °C for 8 h. After cooling to rt, the mixture was acidified (pH 2) with 2 M HCl, and the precipitate was filtered off, washed with H<sub>2</sub>O, and redissolved in 5% NaHCO<sub>3</sub>. Insoluble materials were filtered off and the solution acidified with 2 M HCl. The precipitate was filtered, washed with H<sub>2</sub>O, and dried under reduced pressure to afford <b>10</b> as a white solid (4.0 g, 72.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 11.82 (bs, 1H), 7.51−7.47 (t, 1H), 7.14−7.12 (dd, 1H, <i>J</i> = 9.39 Hz), 7.05−7.03 (dd, 1H, <i>J</i> = 9.39 Hz), 1.73−1.70 (q, 2H), 1.29−1.22 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 180.50, 159.83 (d, <i>J</i> = 246.1 Hz), 140.25 (d, <i>J</i> = 7.0 Hz), 133.15, 127.28 (d, <i>J</i> = 3.4 Hz), 118.78 (d, <i>J</i> = 22.2 Hz), 107.20 (d, <i>J</i> = 20.7 Hz), 28.30, 17.54.</div></div><div id="sec11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedure for Biaryl Suzuki Coupling</h4><div class="NLM_p last">A suspension of the appropriate aryl bromide (1 equiv), arylboronic acid (2 equiv), TBAB (1.1 equiv), and Pd(OAc)<sub>2</sub> (catalytic amount) in 2 M Na<sub>2</sub>CO<sub>3</sub> (5−10 mL) was heated to 120 °C in a sealed tube for a period of 1−4 h. After cooling to rt, 2 M HCl (3 mL) and ethyl acetate (10 mL) were added and the mixture filtered through a Celite pad. The organic layer was separated, washed with brine (2 × 30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified by flash chromatography (hexane/ethyl acetate [1:1]) to afford the corresponding biaryl compounds.</div></div><div id="sec11_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(2-Fluorobiphenyl-4-yl)cyclopropanecarboxylic Acid (<b>11a</b>)</h4><div class="NLM_p last">The general procedure using <b>10</b> (259 mg, 1 mmol), phenylboronic acid (244 mg, 2 mmol), TBAB (340 mg, 1 mmol), and Pd(OAc)<sub>2</sub> (30 mg) afforded the title compound as a white solid (yield 73.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.63−7.55 (t, 4H), 7.50−7.36 (m, 2H), 7.24−7.16 (q, 2H), 1.76−1.73 (q, 2H), 1.35−1.33 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 178.68, 160.63 (<i>J</i> = 243.2 Hz), 140.60 (d, <i>J</i> = 8.0 Hz), 135.70, 130.56, 129.15, 129.13, 128.61, 128.21, 128.08, 127.84, 126.56 (d, <i>J</i> = 3.0 Hz), 118.45 (d, <i>J</i> = 23.0 Hz), 28.01, 17.90. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>13</sub>FO<sub>2</sub>, 255.0826; observed, 255.0832.</div></div><div id="sec11_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(2,4′-Difluorobiphenyl-4-yl)cyclopropanecarboxylic Acid (<b>11b</b>)</h4><div class="NLM_p last">The general procedure using <b>10</b> (150 mg, 0.58 mmol), 4-F-phenylboronic acid (162 mg, 1.16 mmol), TBAB (206 mg, 0.64 mmol), and Pd(OAc)<sub>2</sub> (20 mg) afforded the title compound as a white solid (yield 75.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.70−7.33 (m, 5H), 7.24−7.17 (q, 2H), 1.76−1.70 (q, 2H), 1.34−1.32 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 179.96, 140.99, 132.57, 131.95, 131.32, 130.69, 130.08 (d, <i>J</i> = 3.6 Hz), 128.90, 128.21 (d, <i>J</i> = 3.4 Hz) 127.16, 126.54, 127.61, 118.51 (d, <i>J</i> = 22.8 Hz), 28.35, 17.54. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>12</sub>F<sub>2</sub>O<sub>2</sub>, 273.0733; observed, 273.0746.</div></div><div id="sec11_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(2-Fluoro-4′-(trifluoromethyl)biphenyl-4-yl)cyclopropanecarboxylic Acid (<b>11c</b>)</h4><div class="NLM_p last">The general procedure using <b>10</b> (259 mg, 1.0 mmol), 4-CF<sub>3</sub>-phenylboronic acid (228 mg, 1.2 mmol), TBAB (322 mg, 1.0 mmol), and Pd(OAc)<sub>2</sub> (40 mg) afforded the title compound as a white solid (yield 67.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 11.91 (bs, 1H), 7.72−7.65 (q, 4H), 7.42−7.38 (t, 1H), 7.26−7.19 (q, 2H), 1.76 (s, 2H), 1.35 (s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 180.29, 160.06, 157.58, 140.68 (d, <i>J</i> = 3.2 Hz), 138.65, 129.95, 129.55, 129.22, 128.89 (d, <i>J</i> = 1.3 Hz), 126.47 (d, <i>J</i> = 13.3 Hz), 126.21 (d, 2.9 Hz), 125.02 (d, <i>J</i> = 3.8 Hz), 118.13, 117.90, 28.04, 17.20. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>12</sub>F<sub>4</sub>O<sub>2</sub>, 323.0701; observed, 323.0710.</div></div><div id="sec11_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(3′,4′-Dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic Acid (<b>11d</b>)</h4><div class="NLM_p last">The general procedure using <b>10</b> (259 mg, 1.0 mmol), 3,4-dichlorophenylboronic acid (190 mg, 1.2 mmol), TBAB (322 mg, 1.0 mmol), and Pd(OAc)<sub>2</sub> (25 mg) afforded the title compound as a white solid (yield 72.9%) <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.52−7.49 (t, 2H), 7.37−7.33 (t, 1H), 7.23−7.01 (m, 4H), 1.75−1.72 (q, 2H), 1.35−1.32 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 179.96, 160.10 (d, <i>J</i> = 246.5 Hz), 140.99 (d, 9.2 Hz), 132.57, 130.69, 130.06, 129.55, 129.22, 128.90, 128.19, 127.61, 126.54, 118.45 (d, <i>J</i> = 22.8 Hz), 28.35, 17.54. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>11</sub>Cl<sub>2</sub>FO<sub>2</sub>, 323.0047; observed, 323.0050.</div></div><div id="sec11_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Ethyl-2-(2-fluorobiphenyl-4-yl)butanenitrile (<b>12a</b>)</h4><div class="NLM_p last">The general procedure using <b>9b</b> (150 mg, 0.56 mmol), phenylboronic acid (177.3 mg, 0.83 mmol), TBAB (206 mg, 0.64 mmol), and Pd(OAc)<sub>2</sub> (20 mg) afforded the title compound as a white solid (140 mg, yield 94.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.56−7.54 (d, 2H), 7.47−7.43 (m, 3H), 7.40−7.36 (t, 1H), 7.27−7.25 (d, 1H), 7.25−7.19 (d, 1H), 2.12−2.03 (m, 2H), 1.97−1.88 (m, 2H), 0.98−0.90 (t, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 160.05 (d, <i>J</i> = 242.8 Hz), 139.36 (d, <i>J</i> = 7.0 Hz), 135.42, 131.44, 129.35 (d, <i>J</i> = 4.0 Hz), 129.59, 128.94, 127.52, 122.50, 121.91, 118.5 (d, <i>J</i> = 22.8 Hz) 113.79, 113.55, 51.17, 33.38, 10.51.</div></div><div id="sec11_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Ethyl-2-(3-fluoro-4-(naphthalen-1-yl)phenyl)butanenitrile (<b>12b</b>)</h4><div class="NLM_p last">The general procedure using <b>9b</b> (51 mg, 0.19 mmol), 2-napthylboronic acid (120 mg, 0.70 mmol), TBAB (125 mg, 0.21 mmol), and Pd(OAc)<sub>2</sub> (20 mg) afforded the title compound as a yellow solid (45 mg, yield 75.1%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.03 (s, 1H), 7.93−7.88 (m, 3H), 7.58−7.50 (m, 4H), 7.31−7.24 (q, 2H), 2.15−2.05 (m, 2H), 2.03−1.88 (m, 2H), 0.98−0.89 (t, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 162.09 (d, <i>J</i> = 246.2 Hz), 140.29 (d, <i>J</i> = 9.8 Hz), 133.75, 133.17, 133.87, 131.69 (d, <i>J</i> = 5.5 Hz), 128.80, 128.65, 128.50, 128.07, 127.18 (d, <i>J</i> = 4.1 Hz), 126.80 (d, <i>J</i> = 3.7 Hz), 124.22, 122.81 (d, <i>J</i> = 4.7 Hz), 122.21, 121.15, 115.60, 50.01, 34.21, 10.16.</div></div><div id="sec11_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(2-Fluorobiphenyl-4-yl)acetonitrile (<b>13a</b>)</h4><div class="NLM_p last">The general procedure using <b>8</b> (428 mg, 2.0 mmol), phenylboronic acid (490 mg, 4.0 mmol), TBAB (710 mg, 2.2 mmol), and Pd(OAc)<sub>2</sub> (67 mg) afforded the title compound as a yellow solid (350 mg, yield 82.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.55−7.42 (m, 6H), 7.18−7.10 (m, 2H), 3.75 (s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 159.40 (d, <i>J</i> = 249.7 Hz), 134.52, 131.10 (d, <i>J</i> = 3.8 Hz), 130.61 (d, <i>J</i> = 8.0 Hz), 129.26, 128.58, 128.55, 128.21, 127.93, 127.67, 123.56 (d, <i>J</i> = 3.4 Hz), 116.93, 115.53 (d, <i>J</i> = 24.5 Hz), 22.76.</div></div><div id="sec11_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(2,4′-Difluorobiphenyl-4-yl)acetonitrile (<b>13b</b>)</h4><div class="NLM_p last">The general procedure using <b>8</b> (500 mg, 2.1 mmol), 4-F-phenylboronic acid (560 mg, 4.0 mmol), TBAB (710 mg, 2.2 mmol), and Pd(OAc)<sub>2</sub> (45 mg) afforded the title compound as a yellow solid (480 mg, yield 90%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.51−7.39 (m, 3H), 7.19−7.11 (m, 4H), 3.81 (s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 162.21 (d, <i>J</i> = 247.6 Hz), 158.04, 130.91 (d, <i>J</i> = 3.6 Hz), 130.70 (d, <i>J</i> = 8.0 Hz), 130.44, 130.29 (d, <i>J</i> = 2.9 Hz), 130.20 (d, <i>J</i> = 2.9 Hz), 127.59 (d, <i>J</i> = 13.5 Hz), 124.80, 123.61 (d, <i>J</i> = 3.5 Hz), 116.84, 115.57 (d, <i>J</i> = 24.6 Hz), 115.18 (d, <i>J</i> = 21.7 Hz), 22.75.</div></div><div id="sec11_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Preparation of Fluoromethylnitriles (<b>14a</b>, <b>14b</b>, <b>15a</b>, <b>15b</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h4><div class="NLM_p last">To a solution of the appropriate benzylic nitrile in anhydrous THF (approximately 5−10 mL of THF/1 mmol of nitrile) at −78 °C, <i>t</i>-BuLi (2.2 equiv for difluorination, 1.1 equiv for monofluorination) was added over a period of 2 min. The resulting orange to dark-red solution was stirred for 1 h at −78 °C. A solution of NFSi (2.5 equiv for difluorination, 1.3 equiv for monofluorination) in anhydrous THF (approximately 2−4 mL of THF/mmol of NFSi) was added over 2 min. After this addition, the solution was stirred for 3 h at −78 °C. The reaction was quenched with 0.01 M HCl, and the resulting solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The combined organic layers were washed with 5% NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give a yellow residue. Purification was achieved using silica gel flash chromatography (hexane/ethyl acetate [5:1]).</div></div><div id="sec11_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Fluoro-2-(2-fluorobiphenyl-4-yl)acetonitrile (<b>14a</b>)</h4><div class="NLM_p last">The general procedure using <b>13a</b> (192 mg, 0.91 mmol), <i>t</i>-BuLi (1.2 mL, 2.0 mmol), and NFSi (710 mg, 2.4 mmol), yielding after purification a mixture of <b>14a</b> (yellow solid, 42 mg, yield 20.1%) and <b>15a</b> (yellow solid, 111 mg, yield 49.4%). <b>14a</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.59−7.38 (m, 8H), 6.11−6.09 (d, 1H, <i>J</i> = 11.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 159.73 (d, <i>J</i> = 250.5 Hz), 134.34, 132.15 (d, <i>J</i> = 6.7 Hz), 132.11, 128.98, 128.79, 128.65, 128.49, 127.92, 123.25 (d, <i>J</i> = 3.9 Hz), 115.39 (d, <i>J</i> = 25.2 Hz), 114.77 (d, <i>J</i> = 33.3 Hz), 79.18 (d, <i>J</i> = 182.8 Hz), 60.37. APCI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>9</sub>F<sub>2</sub>N, 228.0630; observed, 228.0625.</div></div><div id="sec11_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2,2-Difluoro-2-(2-fluorobiphenyl-4-yl)acetonitrile (<b>15a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.55−7.32 (m, 8H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 159.58 (d, <i>J</i> = 251.0 Hz), 133.79, 133.74 (d, <i>J</i> = 13.6 Hz), 131.93 (d, <i>J</i> = 3.8 Hz), 131.76 (d, <i>J</i> = 7.8 Hz), 129.00 (d, <i>J</i> = 3.0 Hz), 128.78, 128.34, 124.93, 121.33 (q, <i>J</i> = 5.0 Hz), 116.82, 113.58 (d, <i>J</i> = 26.6 Hz), 112.19 (t, <i>J</i> = 47.9 Hz), 107.92 (t, <i>J</i> = 245.0 Hz). APCI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>8</sub>F<sub>3</sub>N, 246.0536; observed, 246.0515.</div></div><div id="sec11_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(2,4′-Difluorobiphenyl-4-yl)-2-fluoroacetonitrile (<b>14b</b>)</h4><div class="NLM_p last">Synthesized via the general procedure using <b>13b</b> (115 mg, 0.5 mmol), <i>t</i>-BuLi (0.65 mL, 1.1 mmol), and NFSi (394 mg, 1.5 mmol), yielding after purification a mixture of <b>14b</b> (yellow solid, 56 mg, yield 42.1%) and <b>15b</b> (yellow solid, 32 mg, yield 32%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.54−7.30 (m, 5H), 7.15 (t, 2H, <i>J</i> = 8.4 Hz), 6.08 (d, 1H, <i>J</i> = 46.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 162.50 (d, <i>J</i> = 248.6 Hz), 159.25 (d, <i>J</i> = 250.9 Hz), 131.82 (dd, <i>J</i> = 21.0 Hz, 7.7 Hz), 131.29, 130.74 (dd, <i>J</i> = 13.5 Hz, 2.9 Hz), 130.43 (d, <i>J</i> = 2.7 Hz), 130.34 (d, <i>J</i> = 2.9 Hz), 128.84, 122.96 (t, <i>J</i> = 3.8 Hz), 115.45, 115.24, 115.06 (dd, <i>J</i> = 25.4 Hz, 4.4 Hz), 114.41 (d, <i>J</i> = 33.2 Hz), 78.88 (d, <i>J</i> = 183.0 Hz). APCI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>8</sub>F<sub>3</sub>N, 246.0536; observed, 246.0511.</div></div><div id="sec11_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(2,4′-Difluorobiphenyl-4-yl)-2,2-difluoroacetonitrile (<b>15b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.52−7.37 (m, 5H), 7.09 (t, 2H, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 163.04 (d, <i>J</i> = 249.2 Hz), 159.45 (d, <i>J</i> = 251.7 Hz), 132.68 (d, <i>J</i> = 13.2 Hz), 131.86 (d, <i>J</i> = 8.0 Hz), 131.73 (d, <i>J</i> = 3.6 Hz), 130.83 (d, <i>J</i> = 3.0 Hz), 130.75 (d, <i>J</i> = 3.0 Hz), 129.92, 129.88, 121.40 (q, <i>J</i> = 4.9 Hz), 115.83 (d, <i>J</i> = 21.6 Hz), 113.64 (dt, <i>J</i> = 26.6 Hz, 5.1 Hz), 112.12 (d, <i>J</i> = 48.3 Hz), 107.79 (t, <i>J</i> = 244.3 Hz). APCI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>7</sub>F<sub>4</sub>N, 264.0442; observed, 264.0460.</div></div><div id="sec11_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Procedure for Fluoromethylnitrile (<b>14a</b>,<b>b</b> and <b>15a</b>,<b>b</b>) to Fluoromethylamide (<b>16a</b>,<b>b</b> and <b>17a</b>,<b>b</b>)</h4><div class="NLM_p last">To a stirred solution of fluoronitrile in DMSO (30 mg/1.5 mL) was added K<sub>2</sub>CO<sub>3</sub> and the mixture was cooled to 0 °C. To this mixture was added dropwise H<sub>2</sub>O<sub>2</sub> at the same temperature, and the reaction mixture was stirred for 45 min at rt under N<sub>2</sub>. The reaction was quenched by adding cold H<sub>2</sub>O, and the mixture was extracted three times with ethyl acetate (3 × 75 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH [95:5]) to give corresponding fluoroamides.</div></div><div id="sec11_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Fluoro-2-(2-fluorobiphenyl-4-yl)acetamide (<b>16a</b>)</h4><div class="NLM_p last">White solid, yield 75.4%. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.59−7.38 (m, 8H), 6.11−6.09 (d, 1H, <i>J</i> = 11.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 171.10, 159.73 (d, <i>J</i> = 250.5 Hz), 136.52, 134.34, 132.15 (d, <i>J</i> = 6.7 Hz), 132.11, 128.98, 128.79, 128.65, 128.49, 123.25 (d, <i>J</i> = 3.9 Hz), 115.39 (d, <i>J</i> = 25.2 Hz), 114.77 (d, <i>J</i> = 33.3 Hz), 79.18 (d, <i>J</i> = 182.8 Hz). ESI-HRMS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>14</sub>H<sub>11</sub>F<sub>2</sub>NO, 270.0701; observed, 270.0709.</div></div><div id="sec11_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(2,4′-Difluorobiphenyl-4-yl)-2-fluoroacetamide (<b>16b</b>)</h4><div class="NLM_p last">White solid, yield 82.4%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.54−7.30 (m, 5H), 7.15−7.13 (t, 2H, <i>J</i> = 8.4 Hz), 6.08−6.02 (d, 1H, <i>J</i> = 46.8 Hz,). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 171.52, 162.50 (d, <i>J</i> = 248.6 Hz), 159.25 (d, <i>J</i> = 250.9 Hz), 131.82 (dd, <i>J</i> = 21.0 Hz, 7.7 Hz), 131.29, 130.74 (dd, <i>J</i> = 13.5 Hz, 2.9 Hz), 130.43 (d, <i>J</i> = 2.7 Hz), 130.34 (d, <i>J</i> = 2.9 Hz), 128.84, 122.96 (t, <i>J</i> = 3.8 Hz), 115.45, 115.06 (dd, <i>J</i> = 25.4 Hz, 4.4 Hz), 114.41 (d, <i>J</i> = 33.2 Hz), 78.88 (d, <i>J</i> = 183.0 Hz). ESI-HRMS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>14</sub>H<sub>10</sub>F<sub>3</sub>NO, 288.0607; observed, 288.0609.</div></div><div id="sec11_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2,2-Difluoro-2-(2-fluorobiphenyl-4-yl)acetamide (<b>17a</b>)</h4><div class="NLM_p last">White solid, yield 81.0%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.43 (s, 1H), 8.11 (s, 1H), 7.71−7.69 (t, 1H, <i>J</i> = 8.0 Hz), 7.76−7.46 (m, 7H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): 171.60, 160.63 (d, <i>J</i> = 242.5 Hz), 134.58, 131.22 (d, 3.8 Hz), 128.99 (d, <i>J</i> = 2.9 Hz), 128.58, 128.32, 127.90, 127.63, 125.63, 121.55 (d, <i>J</i> = 3.9 Hz), 117.59, 114.09 (d, <i>J</i> = 10.06 Hz), 113.96 (d, <i>J</i> = 19.5 Hz). ESI-HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>10</sub>F<sub>3</sub>NO, 266.0787; observed, 266.0797.</div></div><div id="sec11_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(2,4′-Difluorobiphenyl-4-yl)-2,2-difluoroacetamide (<b>17b</b>)</h4><div class="NLM_p last">White solid, yield 87.9%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.42 (s, 1H), 8.10 (s, 1H), 7.71−7.62 (m, 3H), 7.53−7.49 (m, 2H), 7.34 (t, 2H, <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): 164.77 (t, <i>J</i> = 30.7 Hz), 162.20 (d, <i>J</i> = 245.8 Hz), 158.61 (d, = 247.4 Hz), 134.62 (td, <i>J</i> = 25.7 Hz, 8.1 Hz), 131.50 (d, <i>J</i> = 3.2 Hz), 131.12 (d, <i>J</i> = 2.7 Hz), 131.03 (d, <i>J</i> = 3.0 Hz), 130.36, 129.78 (d, <i>J</i> = 13.0 Hz), 127.64, 121.78, 115.71 (d, <i>J</i> = 21.5 Hz), 113.81 (t, <i>J</i> = 254.0 Hz), 113.82 (dt, <i>J</i> = 25.8 Hz, 6.4 Hz). ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>9</sub>F<sub>4</sub>NO, 282.0547; observed, 282.0544.</div></div><div id="sec11_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> General Procedure for Acid Hydrolysis of Fluoromethylnitriles (<b>16a</b>, <b>16b</b>) to Fluoromethylacetic Acids (<b>18a</b>, <b>18b</b>)</h4><div class="NLM_p last">A vigorously stirred emulsion of the fluoromethylnitrile in a 49% aqueous solution of H<sub>2</sub>SO<sub>4</sub> (5 mL per 100 mg of substrate) was heated at 80 °C for 3 h. After being cooled to rt, the aqueous phase was extracted with diethyl ether (3 × 50 mL). Acids were washed out from the combined organic phases with satd NaHCO<sub>3</sub>. The aqueous phase was acidified to pH 2 and extracted with Et<sub>2</sub>O (3 × 50 mL). The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was recrystallized from chloroform: petroleum ether.</div></div><div id="sec11_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(2-Fluorobiphenyl-4-yl)-2-hydroxyacetic Acid (<b>18a</b>)</h4><div class="NLM_p last">White solid, yield 56.0%. <sup>1</sup>H NMR (MeOD-<i>d</i><sub>4</sub>, 400 MHz): δ 7.54−7.33 (m, 8H), 5.21 (s, 1H). <sup>13</sup>C NMR (MeOD-<i>d</i><sub>4</sub>, 100 MHz): 175.72, 165.27, 162.83, 159.73, 143.03 (d, <i>J</i> = 7.8 Hz), 142.95, 133.13, 132.12, 131.84 (d, <i>J</i> = 3.3 Hz), 129.08 (d, <i>J</i> = 13.6 Hz), 122.20 (d, <i>J</i> = 3.1 Hz), 116.54 (d, <i>J</i> = 21.8 Hz), 115.58 (d, <i>J</i> = 24.3 Hz), 73.42. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>11</sub>FO<sub>3</sub>, 245.0609; observed, 245.0639.</div></div><div id="sec11_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(2,4′-Difluorobiphenyl-4-yl)-2-hydroxyacetic Acid (<b>18b</b>)</h4><div class="NLM_p last">White solid, yield 41.5%. <sup>1</sup>H NMR (MeOD-<i>d</i><sub>4</sub>, 400 MHz): δ 7.56−7.54 (t, <i>J</i> = 6.8 Hz, 1H), 7.46−7.44 (t, 1H, <i>J</i> = 8.0 Hz), 7.39−7.31 (m, 3H), 7.18−7.16 (t, 2H, <i>J</i> = 8.8 Hz), 5.21 (s, 1H). <sup>13</sup>C NMR (MeOD-<i>d</i><sub>4</sub>, 100 MHz): 175.72, 164.05 (d, <i>J</i> = 245.7 Hz), 160.95, 160.18, 142.99 (d, <i>J</i> = 7.8 Hz), 133.13, 132.11 (d, <i>J</i> = 3.2 Hz), 132.04, 131.82 (d, <i>J</i> = 3.3 Hz), 129.01 (d, <i>J</i> = 13.7 Hz), 124.17 (d, <i>J</i> = 3.1 Hz), 116.43 (d, <i>J</i> = 21.8 Hz), 115.46 (d, <i>J</i> = 24.3 Hz), 73.42. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>10</sub>F<sub>2</sub>O<sub>3</sub>, 263.0525; observed, 263.0575.</div></div><div id="sec11_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(2-Fluorobiphenyl-4-yl)acetonitrile (<b>19</b>)</h4><div class="NLM_p last">The acid catalyzed hydrolysis procedure used in the preparation of <b>18a</b>, starting with <b>13a</b> (510 mg, 2.41 mmol) in the presence of H<sub>2</sub>SO<sub>4</sub> (100 mL) afforded the product as a white solid (480 mg, yield 86.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.55−7.37 (m, 6H), 7.21−7.15 (m, 2H), 3.80 (s, 2H).</div></div><div id="sec11_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Preparation of the Biaryl-Biethyl Ester (<b>20</b>)</h4><div class="NLM_p last">To a solution of <b>19</b> (350 mg, 1.5 mmol) and bromoethane (500 mg, 5 mmol) in toluene (20 mL), 50% NaOH (20 mL) and TBAB (700 mg, 5 mmol) were added. The mixture was vigorously stirred at rt for 8 h and then diluted with H<sub>2</sub>O (25 mL) and extracted with ethyl acetate (3 × 50 mL). The organic solution was washed with 1 M HCl (1 × 50 mL) and then with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford a brown solid. Purification was achieved using silica gel flash chromatography to give the product as a white solid (300 mg, 70.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.50−7.36 (m, 7H), 7.05−7.01 (m, 1H), 4.34−4.32 (q, 2H), 2.12−2.02 (m, 2H), 1.99−1.90 (m, 2H), 1.01−0.98 (t, 6H), 0.71−0.70 (t, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 174.30, 165.40, 140.05, 130.69, 130.28, 129.61, 128.93, 128.40, 127.58, 125.48, 122.69 (d, <i>J</i> = 4.82 Hz), 117.42, 113.56, 61.33, 52.09, 26.67, 14.30, 8.43.</div></div><div id="sec11_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Preparation of Biaryl-Diethyl Acid (<b>21</b>)</h4><div class="NLM_p last">The ester <b>20</b> (200 mg, 0.5 mmol) was dissolved in CH<sub>3</sub>CN (15 mL) with a few drops of H<sub>2</sub>O. TEA (0.2 mL, 1.5 mmol) was then added, followed by LiBr (430 mg, 5 mmol), and the reaction was vigorously stirred at reflux for 6 h. The reaction was cooled to rt and extracted with diethyl ether (3 × 50 mL). The aqueous layer was then acidified to pH ∼ 2 with 1 M HCl and extracted with ethyl acetate (3 × 50 mL). Combined organic extracts were washed with brine (2 × 30 mL) and H<sub>2</sub>O (1 × 25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the product as a white solid (56 mg, 39% conversion). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.59−7.41 (m, 6H) 7.29−7.19 (m, 2H), 2.14−2.07 (m, 2H), 1.99−1.92 (m, 2H), 1.01−0.94 (t, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 178.25, 160.67 (d, <i>J</i> = 245.6 Hz), 139.39 (d, <i>J</i> = 7.4 Hz), 134.62, 130.65 (d, <i>J</i> = 3.9 Hz), 129.52, 128.55 (d, <i>J</i> = 2.8 Hz), 127.99, 127.54, 121.92 (d, <i>J</i> = 3.3 Hz), 121.42, 117.20, 113.82 (d, <i>J</i> = 24.8 Hz), 49.19, 33.38, 9.35. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>FO<sub>2</sub>, 285.1296; observed, 285.1273.</div></div><div id="sec11_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Preparation of Bis-TBS Ketene Acetals (<b>22a</b> and <b>22b</b>)</h4><div class="NLM_p last">The appropriate biaryl acid (1 equiv) and TBDSCl (2.3 equiv) were dissolved in THF at rt. LiHMDS (2.2 equiv) was introduced dropwise at 0 °C for 15 min. The resulting reaction mixture was allowed to warm to rt and stirred overnight before being concentrated under vacuum. The residual oil was redissolved in hexanes, filtered, and concentrated. After confirmation of the olefinic proton and TBDS protection by <sup>1</sup>H NMR, the product was used in the next step without further purification.</div></div><div id="sec11_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> General Procedure for Fluorination of the α-Carbon Using Selectfluor.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></h4><div class="NLM_p last">The bis-TBS ketene acetal (1.0 equiv) in MeCN (10 mL) was added dropwise to Selectfluor (1.5 equiv) in MeCN for 15 min while maintaining reaction <50 °C. The reaction was allowed to warm to rt and stirred for an additional 15 min. The reaction was then diluted with 1 M HCl (25 mL) and extracted with ethyl acetate (3 × 50 mL). The combined organic layer was extracted with 1 M NaOH (3 × 50 mL). The aqueous layer was washed with ethyl acetate (3 × 50 mL), followed by acidification of the aqueous layer to pH ∼1 with 3 M HCl. The acidic aqueous layer was extracted with ethyl acetate (3 × 75 mL), and combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated.</div></div><div id="sec11_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-Fluoro-2-(2-fluorobiphenyl-4-yl)propanoic Acid (<b>23a</b>)</h4><div class="NLM_p last">Synthesized using fluorination general procedure using the following values: <b>22a</b> (232 mg, 0.491 mmol), Selectfluor (226 mg, 0.638 mmol), yielding <b>23a</b> as a white solid (42 mg, yield 32.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 10.15 (bs, 1H), 7.44−7.27 (m, 6H), 7.14−7.05 (m, 2H), 1.52 (d, 3H, <i>J</i> = 7.18 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 171.90, 161.52 (d, <i>J</i> = 242.2 Hz), 141.98 (d, <i>J</i> = 7.4 Hz), 134.80, 132.21, 129.84, 129.60, 128.97, 128.94, 128.46, 127.98, 123.60, 115.42 (d, <i>J</i> = 24.8 Hz), 81.81, 19.02. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>12</sub>F<sub>2</sub>O<sub>2</sub>, 261.0733; observed, 261.0706.</div></div><div id="sec11_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-Fluoro-2-(2-fluorobiphenyl-4-yl)acetic Acid (<b>23b</b>)</h4><div class="NLM_p last">Synthesized using fluorination general procedure using the following values: <b>22b</b> (58 mg, 0.13 mmol), Selectfluor (40 mg, 0.10 mmol), yielding <b>23b</b> as a white solid (12 mg, yield 38.2%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.55−7.52 (m, 2H), 7.43−7.32 (m, 4H), 7.14−7.09 (m, 2H), 5.40−4.28 (d, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 174.9, 161.0 (d, <i>J</i> = 242.2 Hz), 141.9 (d, <i>J</i> = 7.4 Hz), 135.50, 132.05, 130.9 (d, <i>J</i> = 3.2 Hz), 129.52, 129.03 (d, <i>J</i> = 13.7 Hz), 128.51, 128.0, 127.83, 123.62, 115.40 (d, <i>J</i> = 24.8 Hz), 72.60. ESI-HRMS (<i>m</i>/<i>z</i>): [M − H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>10</sub>F<sub>2</sub>O<sub>2</sub>, 247.0576; observed, 247.0601.</div></div><div id="sec11_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-Bromobutyl <i>R</i>-(−)-2-Fluoro-a-methyl-4-diphenylacetate (<b>24a</b>)</h4><div class="NLM_p last">Flurbiprofen (1.0 g, 4.09 mmol) was dissolved in methanol (10 mL), and then 0.5 M sodium methoxide in methanol (8.18 mL, 4.09 mmol) was added. The reaction mixture was stirred at rt for 10 min, and then the solvent was evaporated under reduced pressure, yielding the sodium salt (1.08 g, 4.09 mmol), which was suspended in dimethylformide (10 mL) and stirred for 10 min, followed by dropwise addition of 1,4-dibromobutane (1.5 mL, 2.74 g, 12.6 mmol). The reaction mixture was stirred at rt for an additional 48 h. The reaction mixture was poured into H<sub>2</sub>O (100 mL) and extracted with ethyl acetate (3 × 50 mL). The organic layers were washed with H<sub>2</sub>O (3 × 30 mL) and brine (3 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure. The resulting residue was purified by column chromatography (hexane/CH<sub>2</sub>Cl<sub>2</sub> [1/1]) to give the product as yellow oil (1.35 g, 87.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.53−7.50 (m, 2H), 7.45−7.34 (m, 4H), 7.14−7.07 (m, 2H), 4.11−4.09 (t, 2H, <i>J</i> = 6.15 Hz), 3.73−3.71 (q, 1H, <i>J</i> = 7.15 Hz), 3.34−3.32 (t, 2H, <i>J</i> = 6.28 Hz), 1.86−1.73 (m, 4H), 1.52−1.50 (d, 3H, <i>J</i> = 7.17 Hz).</div></div><div id="sec11_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(4-Bromobutyl)-2-(2-fluorobiphenyl-4-yl)propanamide (<b>24b</b>)</h4><div class="NLM_p last">A solution of (<i>R</i>)-2-(2-fluorobiphenyl-4-yl)propanoic acid (0.60 g, 2.4 mmol) in SOCl<sub>2</sub> (4.4 g, 36.9 mmol) was heated at reflux. After 2 h, the reaction mixture was allowed to cool to rt and the excess of SOCl<sub>2</sub> removed under vacuum. Both a solution of the residual material in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and a solution of NaOH (98.3 mg, 2.40 mmol) in H<sub>2</sub>O (0.32 mL) were simultaneously added to a cooled (−20 °C) solution of 4-amino-1-butanol (438.2 mg, 4.92 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) under vigorous stirring. The reaction was kept at −20 °C for 2 h and allowed to warm to rt overnight. The organic layer was washed with H<sub>2</sub>O, NaHCO<sub>3</sub>, and brine, and concentrated to afford the intermediate alcohol (50% yield) as an oil, which was used in the subsequent procedure without further purification. The intermediate alcohol (390 mg, 1.24 mmol) and PPh<sub>3</sub> (356.3 mg, 1.36 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) were cooled to 5 °C, and a solution of tetrabromomethane (493 mg, 1.48 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was added dropwise over 10 min. The resulting clear solution was stirred at rt for 4 h, before removal of solvent under vacuum. The concentrate was purified by flash chromatography (hexane/ethyl acetate [20:80]) to yield pure <b>24b</b> (64% yield) as an oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): 7.56−7.53 (m, 2H), 7.47−7.35 (m, 4H), 7.16−7.11 (m, 2H), 3.57−3.54 (q, 1H), 3.39−3.37 (t, 2H), 3.31−3.24 (m, 2H), 1.87−1.78 (m, 2H), 1.67−1.60 (m, 2H), 1.55−1.53 (d, 3H, <i>J</i> = 6.9 Hz).</div></div><div id="sec11_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> General Procedure for Alkylation of Biaryl Cyclopropyl Acids (<b>11a</b>, <b>11c</b>, <b>11d</b>)</h4><div class="NLM_p last">To a solution of the appropriate carboxylic acid (1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> was added oxalyl chloride (5 eq, 2.0 M in CH<sub>2</sub>Cl<sub>2</sub>), and the mixture was stirred at rt for 5 h. The mixture was concentrated and redissolved in CH<sub>2</sub>Cl<sub>2</sub> containing TEA (2.5 equiv), followed by the dropwise addition of 2-bromoethanol (1.0−1.5 equiv). After stirring overnight, the solution was concentrated and purified by column chromatography.</div></div><div id="sec11_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-Bromoethyl-1-(2-fluorobiphenyl-4-yl)cyclopropanecarboxylate (<b>25a</b>)</h4><div class="NLM_p last">Synthesized using general procedure with the following values: <b>11a</b> (130 mg, 0.50 mmol), oxalyl chloride (1.25 mL, 2.5 mmol), 2-bromoethanol (0.1 mL, 0.8 mmol), and TEA (0.5 mL) afforded <b>25a</b> as colorless oil (160 mg, yield 86.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.59−7.39 (m, 6H), 7.25−7.21 (qs, 2H), 4.41−4.38 (t, 2H), 3.50−3.46 (t, 2H), 1.75−1.71 (q, 2H), 1.33−1.29 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 173.68, 159.8 (d, <i>J</i> = 246.6 Hz), 140.57 (d, <i>J</i> = 8.0 Hz), 135.70, 130.56, 129.15, 129.13, 128.61, 128.21, 128.08, 127.84, 126.56, 126.53, 118.32 (d, <i>J</i> = 23.1 Hz), 64.39, 28.87, 17.19. ESI-HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>16</sub>BrFO<sub>2</sub>, 363.0390; observed, 363.0396.</div></div><div id="sec11_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Bromoethyl-1-(2-fluoro-4′-(trifluoromethyl)biphenyl-4-yl)cyclopropanecarboxylate (<b>25b</b>)</h4><div class="NLM_p last">Synthesized using general procedure with the following values: <b>11c</b> (270 mg, 0.83 mmol), oxalyl chloride (2.1 mL, 4.15 mmol), 2-bromoethanol (0.3 mL, 2.4 mmol), and TEA (1.0 mL) afforded <b>25b</b> as colorless oil (280 mg, yield 78%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.73−7.67 (q, 4H), 7.43−7.39 (t, 1H), 7.28−7.21 (qs, 2H), 4.42−4.39 (t, 2H), 3.50−3.47 (t, 2H), 1.80−1.73 (q, 2H), 1.33−1.26 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 173.31, 160.44 (d, 246.6 Hz), 141.55, 139.11, 130.25, 130.21, 129.86, 129.27, 129.24, 126.62, 126.59, 125.34, 125.30, 122.80, 118.46, 64.26, 28.60, 16.99. ESI-HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>15</sub>BrF<sub>4</sub>O<sub>2</sub>, 431.0264; observed, 431.0264.</div></div><div id="sec11_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-Bromoethyl-1-(3′,4′-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylate (<b>25c</b>)</h4><div class="NLM_p last">Synthesized using general procedure with the following values: <b>11d</b> (260 mg, 0.80 mmol), oxalyl chloride (2.0 mL, 4.0 mmol), 2-bromoethanol (0.1 mL, 0.8 mmol), and TEA (0.5 mL) afforded <b>25c</b> as a white solid (300 mg, yield 87.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.69 (s, 1H), 7.65−7.59 (d, 1H), 7.54−7.18 (m, 4H), 4.40−4.37 (t, 2H), 4.14−4.12 (t, 2H), 1.73−1.70 (q, 2H), 1.29−1.24 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 172.92, 159.92 (d, <i>J</i> = 242.0 Hz), 141.14 (d, <i>J</i> = 8.0 Hz), 135.04, 132.17, 131.50, 130.35, 129.72, 129.61, 129.57, 127.84, 126.25, 125.12, 118.12 (d, <i>J</i> = 23.0 Hz), 63.89, 28.32, 16.66. ESI-HRMS (<i>m</i>/<i>z</i>): [M]<sup>+</sup> calcd for C<sub>18</sub>H<sub>14</sub>BrCl<sub>2</sub>FO<sub>2</sub>, 430.9538; observed, 430.9611.</div></div><div id="sec11_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> General Procedure for Nitration of the Ethyl Bromide Esters (<b>25a</b>−<b>c</b>)</h4><div class="NLM_p last">To a solution of the appropriate bromide (1 equiv) in anhydrous MeCN was added AgNO<sub>3</sub> (2−5 equiv), and the reaction was stirred at reflux for 2 h. The mixture was filtered through Celite, the filtrate concentrated, and the resulting crude oil purified by column chromatography (hexane/ethyl acetate [3:1]) to give the desired nitrates characterized below.</div></div><div id="sec11_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-(Nitrooxy)ethyl 1-(2-Fluorobiphenyl-4-yl)cyclopropanecarboxylate (<b>26a</b>)</h4><div class="NLM_p last">Synthesized using general nitration procedure with the following values: <b>25a</b> (120 mg, 0.33 mmol) and AgNO<sub>3</sub> (112 mg, 0.66 mmol) afforded <b>26a</b> as yellow oil (85 mg, yield 74.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.58−7.38 (m, 6H), 7.27−7.14 (m, 2H), 4.64−4.63 (t, 2H), 4.36−4.35 (t, 2H), 1.70−1.68 (m, 2H), 1.32−1.30 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 173.35, 159.90 (d, <i>J</i> = 242.0 Hz), 141.12(d, <i>J</i> = 8.0 Hz), 139.83, 135.11, 130.07, 129.53, 128.59, 128.06, 127.31, 125.93, 117.79, 117.56, 69.67, 60.75, 28.13, 16.76. ESI-HRMS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>18</sub>H<sub>16</sub>FNO<sub>5</sub>, 368.0905; observed, 368.0911.</div></div><div id="sec11_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(Nitrooxy)ethyl 1-(2-Fluoro-4′-(trifluoromethyl)biphenyl-4-yl)cyclopropanecarboxylate (<b>26b</b>)</h4><div class="NLM_p last">Synthesized using general nitration procedure with the following values: <b>25b</b> (220 mg, 0.49 mmol) and AgNO<sub>3</sub> (415 mg, 2.44 mmol) afforded <b>26b</b> as colorless oil (190 mg, yield 90.1%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.73−7.67 (q, 4H), 7.43−7.39 (t, 1H), 7.25−7.18 (qs, 2H), 4.67−4.64 (t, 2H), 4.38−4.36 (t, 2H), 1.73−1.70 (q, 2H), 1.33−1.31 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 173.54, 160.46 (d, <i>J</i> = 240.2 Hz), 141.33(d, <i>J</i> = 8.0 Hz), 139.10, 130.36 (d, <i>J</i> = 3.6 Hz), 129.85, 129.29 (d, <i>J</i> = 3.1 Hz), 128.23, 126.58 (d, <i>J</i> = 3.3 Hz), 125.38 (q, <i>J</i> = 11.2 Hz), 124.10, 122.83, 118.35, 118.12, 70.00, 61.20, 28.54, 17.09. ESI-HRMS (<i>m</i>/<i>z</i>): [M-NO<sub>3</sub>]<sup>+</sup> calcd for C<sub>18</sub>H<sub>16</sub>FNO<sub>5</sub>,: 351.1008; observed, 351.1029.</div></div><div id="sec11_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-(Nitrooxy)ethyl 1-(3′,4′-Dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylate (<b>26c</b>)</h4><div class="NLM_p last">Synthesized using general nitration procedure with the following values: <b>25c</b> (300 mg, 0.69 mmol) and AgNO<sub>3</sub> (589 mg, 3.47 mmol) afforded <b>26c</b> as colorless oil (210 mg, yield 73.0%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.65−7.16 (m, 6H), 4.66−4.64 (t, 2H), 4.38−4.35 (t, 2H), 1.75−1.68 (q, 2H), 1.35−1.28 (q, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 172.92, 159.92 (d, <i>J</i> = 242.0 Hz), 141.14 (d, <i>J</i> = 8.0 Hz), 135.04, 132.17, 131.50, 130.35 (d, <i>J</i> = 1.8 Hz), 130.01, 129.72, 129.61, 127.88 (d, <i>J</i> = 4.0 Hz), 126.28 (d, <i>J</i> = 3.8 Hz), 125.26, 118.12 (d, <i>J</i> = 23.0 Hz), 69.59, 60.84, 28.16, 16.76. ESI-HRMS (<i>m</i>/<i>z</i>): [M − NO<sub>3</sub>]<sup>+</sup> calcd for C<sub>18</sub>H<sub>14</sub>Cl<sub>2</sub>FNO<sub>5</sub>, 351.0349; observed 351.0536.</div></div><div id="sec11_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(Nitrooxy)butyl 2-(2-fluorobiphenyl-4-yl)propanoate (<b>2</b>)</h4><div class="NLM_p last">The bromide <b>24a</b> (1.34 g, 3.58 mmol) was dissolved in anhydrous MeCN (20 mL), and then AgNO<sub>3</sub> (1.84 g, 10.74 mmol) was added. The suspension was stirred at rt for 1 h and then at reflux 14 h. The solid was filtered through Celite, and the solvent was removed under vacuum. Flash column chromatography of the residue (hexane/ethyl acetate [7:3]) afforded the desired product as yellow oil (1.11 g, 85.9%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.53−7.50 (m, 2H), 7.43−7.32 (m, 4H), 7.14−7.09 (m, 2H), 4.37 (t, 2H, <i>J</i> = 6.28 Hz), 4.11 (t, 2H, <i>J</i> = 6.15 Hz), 3.73 (q, 1H, <i>J</i> = 7.15 Hz), 1.86−1.73 (m, 4H), 1.52 (d, 3H, <i>J</i> = 7.17 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 173.9, 161.0, 158.5, 141.9, 135.5, 132.18, 130.9, 129.0, 128.5, 127.83, 123.6, 115.4, 115.1, 72.6, 64.1, 45.1, 25.0, 23.6, 18.3. ESI-HRMS (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>FNO<sub>5</sub>, 384.1218; observed, 384.1227.</div></div><div id="sec11_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-[[2-(2-Fluorobiphenyl-4-yl)propanoyl]amino]butyl Nitrate (<b>27</b>)</h4><div class="NLM_p last">The bromide <b>24b</b> (0.24 mmol) was dissolved in CH<sub>3</sub>CN, and AgNO<sub>3</sub> (82.39 mg, 0.48 mmol) was added. The suspension was stirred at rt for 14 h and then at reflux for 2 h. The solid was filtered through Celite pad, and the solvent was removed under vacuum. The resulting residue was purified by column chromatography (hexane/ethyl acetate [60:40]) to afford the product as yellow oil (63% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.55−7.52 (m, 2H), 7.47−7.34 (m, 4H), 7.15−7.09 (m, 2H), 4.43 (t, 2H), 3.56 (q, 1H), 3.30−3.24 (m, 2H), 1.77−1.53 (m, 7H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 173.85, 161.00, 158.53, 124.85, 135.33, 131.02, 128.90 128.50, 127.90, 127.76, 123.55, 115.32, 115.09, 73.98, 47.58, 40.37, 26.05, 24.13, 18.49. ESI-HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>4</sub>, 361.1558; observed, 361.1568.</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory R. J. Thatcher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a3d7cbc2d7c0cbc6d1e3d6cac08dc6c7d6"><span class="__cf_email__" data-cfemail="c5b1ada4b1a6ada0b785b0aca6eba0a1b0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac T. Schiefer</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samer Abdul-Hay</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huali Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Vanni</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihui Qin</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, MC 781, 833 South Wood Street, Chicago, Illinois 60612-7231, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm101450p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Prof. Larry Marnett of Vanderbilt University is thanked for the indomethacin and sulindac libraries. This work was funded by NIH grant AG027425.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> Abbreviations Used</h2><tr><td class="NLM_term">SALA</td><td class="NLM_def"><p class="first last">selective amyloid lowering agent</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid peptide</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible NO synthase</p></td></tr><tr><td class="NLM_term">ISMN</td><td class="NLM_def"><p class="first last">isosorbide mononitrate</p></td></tr><tr><td class="NLM_term">SARA</td><td class="NLM_def"><p class="first last">selective amyloid raising agent</p></td></tr><tr><td class="NLM_term">CM</td><td class="NLM_def"><p class="first last">conditioned media</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’S Modified Eagle’S Medium</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetate</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NFSI</td><td class="NLM_def"><p class="first last"><i>N</i>-fluorobenzenesulfonimide</p></td></tr><tr><td class="NLM_term">TBSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">The disordered neuronal cytoskeleton in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=653-656&author=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=The+disordered+neuronal+cytoskeleton+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DThe%2520disordered%2520neuronal%2520cytoskeleton%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1992%26volume%3D2%26spage%3D653%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0liCM8WCDiS24A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+Abeta42+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520Abeta42%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Findeis, M. A.</span><span> </span><span class="NLM_article-title">The role of amyloid beta peptide 42 in Alzheimer’s disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.pharmthera.2007.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=17716740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSltLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=266-286&author=M.+A.+Findeis&title=The+role+of+amyloid+beta+peptide+42+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amyloid β peptide 42 in Alzheimer's disease</span></div><div class="casAuthors">Findeis, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">266-286</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  During the last 20 years, an expanding body of research has elucidated the central role of amyloid precursor protein (APP) processing and amyloid β peptide (Aβ) prodn. in the risk, onset, and progression of the neurodegenerative disorder Alzheimer's disease (AD), the most common form of dementia.  Ongoing research is establishing a greater level of detail for our understanding of the normal functions of APP, its proteolysis products, and the mechanisms by which this processing occurs.  The importance of this processing machinery in normal cellular function, such as Notch processing, has revealed specific concerns about targeting APP processing for therapeutic purposes.  Aspects of AD that are now well studied include direct and indirect genetic and other risk factors for AD, APP processing, and Aβ prodn.  Emerging from these studies is the particular importance of the long form of Aβ, Aβ42.  Elevated Aβ42 levels, as well as particularly the elevation of the ratio of Aβ42 to the shorter major form Aβ40, has been identified as important in early events in the pathogenesis of AD.  The specific pathol. importance of Aβ42 has drawn attention to seeking drugs that will selectively lower the levels of this peptide through reduced prodn. or increased clearance while allowing normal protein processing to remain substantially intact.  An increasing variety of compds. that modulate APP processing to reduce Aβ levels are being identified, some with Aβ42 selectivity.  Such compds. are now reaching clin. evaluation to det. how they may be of benefit in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxuc6RpBkbGrVg90H21EOLACvtfcHk0liCM8WCDiS24A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSltLjI&md5=89b760a8dfdc1691a7bfba2d2434fef5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26atitle%3DThe%2520role%2520of%2520amyloid%2520beta%2520peptide%252042%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D116%26spage%3D266%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Reinhard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid-beta precursor protein: integrating structure with biological function</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3996</span><span class="NLM_x">–</span> <span class="NLM_lpage">4006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=3996-4006&author=C.+Reinhardauthor=S.+S.+Hebertauthor=B.+De+Strooper&title=The+amyloid-beta+precursor+protein%3A+integrating+structure+with+biological+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinhard%26aufirst%3DC.%26aulast%3DHebert%26aufirst%3DS.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid-beta%2520precursor%2520protein%253A%2520integrating%2520structure%2520with%2520biological%2520function%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26spage%3D3996%26epage%3D4006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=440-449&author=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=T.+E.+Smithauthor=S.+Weggenauthor=P.+Dasauthor=D.+C.+McLendonauthor=V.+V.+Ozolsauthor=K.+W.+Jessingauthor=K.+H.+Zavitzauthor=E.+H.+Kooauthor=T.+E.+Golde&title=NSAIDs+and+enantiomers+of+flurbiprofen+target+gamma-secretase+and+lower+Abeta+42+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DMcLendon%26aufirst%3DD.%2BC.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DJessing%26aufirst%3DK.%2BW.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DNSAIDs%2520and%2520enantiomers%2520of%2520flurbiprofen%2520target%2520gamma-secretase%2520and%2520lower%2520Abeta%252042%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D440%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Narlawar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span> </span><span class="NLM_article-title">Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7588</span><span class="NLM_x">–</span> <span class="NLM_lpage">7591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7588-7591&author=R.+Narlawarauthor=B.+I.+Perez+Revueltaauthor=C.+Haassauthor=H.+Steinerauthor=B.+Schmidtauthor=K.+Baumann&title=Scaffold+of+the+cyclooxygenase-2+%28COX-2%29+inhibitor+carprofen+provides+Alzheimer+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0610200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610200%26sid%3Dliteratum%253Aachs%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DPerez%2BRevuelta%26aufirst%3DB.%2BI.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DK.%26atitle%3DScaffold%2520of%2520the%2520cyclooxygenase-2%2520%2528COX-2%2529%2520inhibitor%2520carprofen%2520provides%2520Alzheimer%2520gamma-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7588%26epage%3D7591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colavito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arrigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalle Carbonare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroc, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">1-(3′,4′-Dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer’s disease without causing peripheral toxicity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1124%2Fjpet.107.129007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=17895400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=822-830&author=B.+P.+Imbimboauthor=E.+Del+Giudiceauthor=D.+Colavitoauthor=A.+D%E2%80%99Arrigoauthor=M.+Dalle+Carbonareauthor=G.+Villettiauthor=F.+Facchinettiauthor=R.+Voltaauthor=V.+Pietriniauthor=M.+F.+Barocauthor=L.+Serneelsauthor=B.+De+Strooperauthor=A.+Leon&title=1-%283%E2%80%B2%2C4%E2%80%B2-Dichloro-2-fluoro%5B1%2C1%E2%80%B2-biphenyl%5D-4-yl%29-cyclopropanecarboxylic+acid+%28CHF5074%29%2C+a+novel+gamma-secretase+modulator%2C+reduces+brain+beta-amyloid+pathology+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease+without+causing+peripheral+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity</span></div><div class="casAuthors">Imbimbo, Bruno P.; Del Giudice, Elda; Colavito, Davide; D'Arrigo, Antonello; Dalle Carbonare, Maurizio; Villetti, Gino; Facchinetti, Fabrizio; Volta, Roberta; Pietrini, Vladimiro; Baroc, Maria F.; Serneels, Lutgarde; De Strooper, Bart; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Some nonsteroidal anti-inflammatory drugs has been shown to allosterically modulate the activity of γ-secretase, the enzymic complex responsible for the formation of β-amyloid (Aβ).  1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074) is a new γ-secretase modulator, devoid of anticyclooxygenase (COX) and Notch-interfering activities in vitro.  We evaluated the effects of chronic CHF5074 treatment on brain Aβ pathol. in Tg2576 transgenic mice.  Twenty-eight animals of 9.5 to 10.5 mo of age received CHF5074-medicated diet (375 ppm) or std. diet for 17 wk.  Compared with controls, CHF5074 treatment significantly reduced the area occupied by plaques and the no. of plaques in cortex (-52.2±5.6%, p = 0.0003 and -48.9±6.6%, p = 0.0004, resp.) and hippocampus (-76.7±6.4%, p = 0.004 and -66.2±10.3%, p = 0.037, resp.).  Biochem. anal. confirmed the histopathol. measures, with CHF5074-treated animals showing reduced total brain Aβ40 (-49.2±9.2%, p = 0.017) and Aβ42 (-43.5±9.7%, p = 0.027) levels.  In a human neuroglioma cell line expressing Swedish mutated form of amyloid precursor protein (H4swe), CHF5074 reduced Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, resp., values consistent with those measured in the brain of the CHF5074-treated Tg2576 mice (6.4±0.4 μM).  At 5 μM, no effects were obsd. on Notch intracellular cleavage in human embryonic kidney 293swe cells.  CHF5074 was well tolerated by Tg2576 mice.  No abnormal findings were obsd. upon histopathol. examn. of the gastrointestinal tract, indicating the absence of COX-related toxicity.  Semiquant. histochem. evaluation of goblet cells in the ileum of vehicle- and CHF5074-treated animals yielded similar results, suggesting no effects on Notch pathway.  CHF5074 is therefore a promising therapeutic agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0R1sOAuyJCrVg90H21EOLACvtfcHk0ljxZoWIiMCXKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgsLvI&md5=6c20484e0d8f696858d459fdea0b9c1d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.129007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.129007%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DColavito%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DA.%26aulast%3DDalle%2BCarbonare%26aufirst%3DM.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DPietrini%26aufirst%3DV.%26aulast%3DBaroc%26aufirst%3DM.%2BF.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3D1-%25283%25E2%2580%25B2%252C4%25E2%2580%25B2-Dichloro-2-fluoro%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-yl%2529-cyclopropanecarboxylic%2520acid%2520%2528CHF5074%2529%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520reduces%2520brain%2520beta-amyloid%2520pathology%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520without%2520causing%2520peripheral%2520toxicity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D822%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peachey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jacques, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer’s disease modifying agent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2219</span><span class="NLM_x">–</span> <span class="NLM_lpage">2223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2219-2223&author=N.+Stockauthor=B.+Munozauthor=J.+D.+Wrigleyauthor=M.+S.+Shearmanauthor=D.+Beherauthor=J.+Peacheyauthor=T.+L.+Williamsonauthor=G.+Bainauthor=W.+Chenauthor=X.+Jiangauthor=R.+St-Jacquesauthor=P.+Prasit&title=The+geminal+dimethyl+analogue+of+Flurbiprofen+as+a+novel+Abeta42+inhibitor+and+potential+Alzheimer%E2%80%99s+disease+modifying+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DPeachey%26aufirst%3DJ.%26aulast%3DWilliamson%26aufirst%3DT.%2BL.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSt-Jacques%26aufirst%3DR.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DThe%2520geminal%2520dimethyl%2520analogue%2520of%2520Flurbiprofen%2520as%2520a%2520novel%2520Abeta42%2520inhibitor%2520and%2520potential%2520Alzheimer%25E2%2580%2599s%2520disease%2520modifying%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2219%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raveglia, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigogno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biscaioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catinella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzoni, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(−)(42) secretion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5705</span><span class="NLM_x">–</span> <span class="NLM_lpage">5720</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5705-5720&author=I.+Perettoauthor=S.+Radaelliauthor=C.+Pariniauthor=M.+Zandiauthor=L.+F.+Ravegliaauthor=G.+Dondioauthor=L.+Fontanellaauthor=P.+Misianoauthor=C.+Bigognoauthor=A.+Rizziauthor=B.+Riccardiauthor=M.+Biscaioliauthor=S.+Marchettiauthor=P.+Pucciniauthor=S.+Catinellaauthor=I.+Rondelliauthor=V.+Cenacchiauthor=P.+T.+Bolzoniauthor=P.+Carusoauthor=G.+Villettiauthor=F.+Facchinettiauthor=E.+Del+Giudiceauthor=N.+Morettoauthor=B.+P.+Imbimbo&title=Synthesis+and+biological+activity+of+flurbiprofen+analogues+as+selective+inhibitors+of+beta-amyloid%281%29%28%E2%88%92%29%2842%29+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DParini%26aufirst%3DC.%26aulast%3DZandi%26aufirst%3DM.%26aulast%3DRaveglia%26aufirst%3DL.%2BF.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DFontanella%26aufirst%3DL.%26aulast%3DMisiano%26aufirst%3DP.%26aulast%3DBigogno%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DBiscaioli%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DS.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DCatinella%26aufirst%3DS.%26aulast%3DRondelli%26aufirst%3DI.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DBolzoni%26aufirst%3DP.%2BT.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520flurbiprofen%2520analogues%2520as%2520selective%2520inhibitors%2520of%2520beta-amyloid%25281%2529%2528%25E2%2588%2592%2529%252842%2529%2520secretion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5705%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14586007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=9796-9804&author=M.+Sastreauthor=I.+Dewachterauthor=G.+E.+Landrethauthor=T.+M.+Willsonauthor=T.+Klockgetherauthor=F.+van+Leuvenauthor=M.+T.+Heneka&title=Nonsteroidal+anti-inflammatory+drugs+and+peroxisome+proliferator-activated+receptor-gamma+agonists+modulate+immunostimulated+processing+of+amyloid+precursor+protein+through+regulation+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase</span></div><div class="casAuthors">Sastre, Magdalena; Dewachter, Ilse; Landreth, Gary E.; Willson, Timothy M.; Klockgether, Thomas; van Leuven, Fred; Heneka, Michael T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk for Alzheimer's disease (AD).  To det. the mechanisms by which inflammation affects AD and how NSAIDs protect against it, we stimulated neuroblastoma cells stably transfected with amyloid precursor protein (APP) with proinflammatory cytokines, which increased the secretion of amyloid-β and APP ectodomain.  Addn. of ibuprofen, indomethacin, peroxisome proliferator-activated receptor-γ (PPARγ) agonists, or cotransfection with PPARγ cDNA reversed this effect.  The inhibitory action of ibuprofen and indomethacin was suppressed by PPARγ antagonists.  Finally, we obsd. that the mRNA levels, expression, and enzymic activity of β-secretase were increased by immunostimulation and normalized by NSAIDs.  In conclusion, proinflammatory cytokines activate β-secretase, and NSAIDs inhibit this effect through PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOe3IumnqzorVg90H21EOLACvtfcHk0lhUT3_u_WLRmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKis7w%253D&md5=b7e010a3cc3774b7f42444da3a49324a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3Dvan%2BLeuven%26aufirst%3DF.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520and%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520agonists%2520modulate%2520immunostimulated%2520processing%2520of%2520amyloid%2520precursor%2520protein%2520through%2520regulation%2520of%2520beta-secretase%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghgraef, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evert, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumitrescu-Ozimek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=443-448&author=M.+Sastreauthor=I.+Dewachterauthor=S.+Rossnerauthor=N.+Bogdanovicauthor=E.+Rosenauthor=P.+Borghgraefauthor=B.+O.+Evertauthor=L.+Dumitrescu-Ozimekauthor=D.+R.+Thalauthor=G.+Landrethauthor=J.+Walterauthor=T.+Klockgetherauthor=F.+van+Leuvenauthor=M.+T.+Heneka&title=Nonsteroidal+anti-inflammatory+drugs+repress+beta-secretase+gene+promoter+activity+by+the+activation+of+PPARgamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DE.%26aulast%3DBorghgraef%26aufirst%3DP.%26aulast%3DEvert%26aufirst%3DB.%2BO.%26aulast%3DDumitrescu-Ozimek%26aufirst%3DL.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3Dvan%2BLeuven%26aufirst%3DF.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520repress%2520beta-secretase%2520gene%2520promoter%2520activity%2520by%2520the%2520activation%2520of%2520PPARgamma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D2006%26volume%3D103%26spage%3D443%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-DeWhitt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfanova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1215-1217&author=Y.+Zhouauthor=Y.+Suauthor=B.+Liauthor=F.+Liuauthor=J.+W.+Ryderauthor=X.+Wuauthor=P.+A.+Gonzalez-DeWhittauthor=V.+Gelfanovaauthor=J.+E.+Haleauthor=P.+C.+Mayauthor=S.+M.+Paulauthor=B.+Ni&title=Nonsteroidal+anti-inflammatory+drugs+can+lower+amyloidogenic+Abeta42+by+inhibiting+Rho"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGonzalez-DeWhitt%26aufirst%3DP.%2BA.%26aulast%3DGelfanova%26aufirst%3DV.%26aulast%3DHale%26aufirst%3DJ.%2BE.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DNi%26aufirst%3DB.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520can%2520lower%2520amyloidogenic%2520Abeta42%2520by%2520inhibiting%2520Rho%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1215%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Miller, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekijima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1038%2Flabinvest.3700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14968122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=545-552&author=S.+R.+Millerauthor=Y.+Sekijimaauthor=J.+W.+Kelly&title=Native+state+stabilization+by+NSAIDs+inhibits+transthyretin+amyloidogenesis+from+the+most+common+familial+disease+variants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants</span></div><div class="casAuthors">Miller, Sean R.; Sekijima, Yoshiki; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-552</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transthyretin (TTR) tetramer dissocn. and misfolding affords a monomeric amyloidogenic intermediate that misassembles into aggregates including amyloid fibrils.  Amyloidogenesis of wild-type (WT) TTR causes senile systemic amyloidosis (SSA), whereas fibril formation from one of the more than 80 TTR variants leads to familial amyloidosis, typically with earlier onset than SSA.  Several nonsteroidal anti-inflammatory drugs (NSAIDs) stabilize the native tetramer, strongly inhibiting TTR amyloid fibril formation in vitro.  Structure-based designed NSAID analogs are even more potent amyloid inhibitors.  The effectiveness of several NSAIDs, including diclofenac, diflunisal, and flufenamic acid, as well as the diclofenac analog, 2-[(3,5-dichlorophenyl) amino] benzoic acid (inhibitor 1), has been demonstrated against WT TTR amyloidogenesis.  Herein, the efficacy of these compds. at preventing acid-induced fibril formation and urea-induced tetramer dissocn. of the most common disease-assocd. TTR variants (V30M, V122I, T60A, L58H, and I84S) was evaluated.  Homotetramers of these variants were employed for the studies within, realizing that the tetramers in compd. heterozygote patients are normally composed of a mixt. of WT and variant subunits.  The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmLSOJy5npbLVg90H21EOLACvtfcHk0lgCPx3NTs18dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtF2isb8%253D&md5=d219c5af68d3a6e65f033b88e5b23201</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3700059%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BR.%26aulast%3DSekijima%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DNative%2520state%2520stabilization%2520by%2520NSAIDs%2520inhibits%2520transthyretin%2520amyloidogenesis%2520from%2520the%2520most%2520common%2520familial%2520disease%2520variants%26jtitle%3DLab.%2520Invest.%26date%3D2004%26volume%3D84%26spage%3D545%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edirisinghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1471-4159.2009.06355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19702658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=683-695&author=S.+O.+Abdul-Hayauthor=P.+Edirisingheauthor=G.+R.+Thatcher&title=Selective+modulation+of+amyloid-beta+peptide+degradation+by+flurbiprofen%2C+fenofibrate%2C+and+related+compounds+regulates+Abeta+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels</span></div><div class="casAuthors">Abdul-Hay, Samer O.; Edirisinghe, Praneeth; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">683-695</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gamma-secretase modulators (GSMs) include selected non-steroidal anti-inflammatory drugs such as flurbiprofen that selectively lowers the neurotoxic amyloid-β peptide Aβ1-42.  GSMs are attractive targets for Alzheimer's disease, in contrast to 'inverse GSMs,' such as fenofibrate, which selectively increase the level of Aβ1-42.  A methodol. for screening of Aβ modulating drugs was developed utilizing an Aβ-producing neuroblastoma cell line stably transfected with mutant human amyloid precursor protein, immunopptn. of Aβ peptides, and mass spectroscopic quantitation of Aβ1-37/Aβ1-38/Aβ1-40/Aβ1-42 using an Aβ internal std.  The unexpected conclusion of this work was that in this system, drug effects are independent of γ-secretase.  The methodol. recapitulated reported results for modulation of Aβ by GSMs.  However, control expts. in which exogenous Aβ1-40/Aβ1-42 was added (i) to drug-treated wild-type cells or (ii) to conditioned media from these wild-type cells, gave comparable patterns of Aβ modulation.  These results, suggesting that drugs modulate the ability of cell-derived factors to degrade Aβ, was interrogated by adding protease inhibitors and performing mol. wt. cut-off fractionation.  The results confirmed that modulation of Aβ1-40/Aβ1-42 was mediated by selective proteolysis.  Treatment of N2a cells with flurbiprofen or fenofibric acid selectively enhanced Aβ1-42 clearance by extracellular proteolysis; treatment with HCT-1026 or fenofibrate (esters of flurbiprofen and fenobric acid) inhibited clearance of Aβ1-40 and Aβ1-42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVSboU5xjr9LVg90H21EOLACvtfcHk0lgCPx3NTs18dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN&md5=57d300269647eb3336290c27f7b7b574</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06355.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DEdirisinghe%26aufirst%3DP.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DSelective%2520modulation%2520of%2520amyloid-beta%2520peptide%2520degradation%2520by%2520flurbiprofen%252C%2520fenofibrate%252C%2520and%2520related%2520compounds%2520regulates%2520Abeta%2520levels%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D683%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1152%2Fphysrev.00023.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20393191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=465-494&author=B.+De+Strooper&title=Proteases+and+proteolysis+in+Alzheimer+disease%3A+a+multifactorial+view+on+the+disease+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-494</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is characterized by the accumulation of abnormally folded protein fragments, i.e., amyloid beta peptide (Aβ) and tau that ppt. in amyloid plaques and neuronal tangles, resp.  In this review we discuss the complicated proteolytic pathways that are responsible for the generation and clearance of these fragments, and how disturbances in these pathways interact and provide a background for a novel understanding of Alzheimer disease as a multifactorial disorder.  Recent insights evolve from the static view that the morphol. defined plaques and tangles are disease driving towards a more dynamic, biochem. view in which the intermediary sol. Aβ oligomers and sol. tau fragments are considered as the main mediators of neurotoxicity.  The relevance of proteolytic pathways, centered on the generation and clearance of toxic Aβ, on the cleavage and nucleation of tau, and on the general proteostasis of the neurons, then becomes obvious.  Blocking or stimulating these pathways provide, or have the potential to provide, interesting drug targets, which raises the hope that we will be able to provide a cure for this dreadful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrstXCXtuTzCrVg90H21EOLACvtfcHk0lgCPx3NTs18dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF&md5=be45257bc56a5779b6ef7e18e98b0738</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DProteases%2520and%2520proteolysis%2520in%2520Alzheimer%2520disease%253A%2520a%2520multifactorial%2520view%2520on%2520the%2520disease%2520process%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D465%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chow, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleichmann, M.</span><span> </span><span class="NLM_article-title">An overview of APP processing enzymes and products</span> <span class="citation_source-journal">Neuromol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1007%2Fs12017-009-8104-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20232515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislyktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1-12&author=V.+W.+Chowauthor=M.+P.+Mattsonauthor=P.+C.+Wongauthor=M.+Gleichmann&title=An+overview+of+APP+processing+enzymes+and+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of APP Processing Enzymes and Products</span></div><div class="casAuthors">Chow, Vivian W.; Mattson, Mark P.; Wong, Philip C.; Gleichmann, Marc</div><div class="citationInfo"><span class="NLM_cas:title">NeuroMolecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">NMEEAN</span>;
        ISSN:<span class="NLM_cas:issn">1535-1084</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The generation of amyloid β-peptide (Aβ) by enzymic cleavages of the β-amyloid precursor protein (APP) has been at the center of Alzheimer's disease (AD) research.  While the basic process of β- and γ-secretase-mediated generation of Aβ is text book knowledge, new aspects of Aβ and other cleavage products have emerged in recent years.  Also our understanding of the enzymes involved in APP proteolysis has increased dramatically.  All of these discoveries contribute to a more complete understanding of APP processing and the physiol. and pathol. roles of its secreted and intracellular protein products.  Understanding APP processing is important for any therapeutic strategy aimed at reducing Aβ levels in AD.  In this review, we provide a concise description of the current state of understanding the enzymes involved in APP processing, the cleavage products generated by different processing patterns, and the potential functions of those cleavage products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlnCFJkMuULVg90H21EOLACvtfcHk0lgCPx3NTs18dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislyktrs%253D&md5=2df203edd1ac0e3073498753067a75a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs12017-009-8104-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12017-009-8104-z%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DV.%2BW.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DGleichmann%26aufirst%3DM.%26atitle%3DAn%2520overview%2520of%2520APP%2520processing%2520enzymes%2520and%2520products%26jtitle%3DNeuromol.%2520Med.%26date%3D2010%26volume%3D12%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rich, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmusson, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1995&pages=51-55&author=J.+B.+Richauthor=D.+X.+Rasmussonauthor=M.+F.+Folsteinauthor=K.+A.+Carsonauthor=C.+Kawasauthor=J.+Brandt&title=Nonsteroidal+anti-inflammatory+drugs+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DJ.%2BB.%26aulast%3DRasmusson%26aufirst%3DD.%2BX.%26aulast%3DFolstein%26aufirst%3DM.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BA.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3DBrandt%26aufirst%3DJ.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1995%26volume%3D45%26spage%3D51%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stewart, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metter, E. J.</span><span> </span><span class="NLM_article-title">Risk of Alzheimer’s disease and duration of NSAID use</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1997&pages=626-632&author=W.+F.+Stewartauthor=C.+Kawasauthor=M.+Corradaauthor=E.+J.+Metter&title=Risk+of+Alzheimer%E2%80%99s+disease+and+duration+of+NSAID+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DW.%2BF.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3DCorrada%26aufirst%3DM.%26aulast%3DMetter%26aufirst%3DE.%2BJ.%26atitle%3DRisk%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520duration%2520of%2520NSAID%2520use%26jtitle%3DNeurology%26date%3D1997%26volume%3D48%26spage%3D626%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">in t’ Veld, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stijnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breteler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, B. H.</span><span> </span><span class="NLM_article-title">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1056%2FNEJMoa010178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=11794217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2001&pages=1515-1521&author=B.+A.+in+t%E2%80%99+Veldauthor=A.+Ruitenbergauthor=A.+Hofmanauthor=L.+J.+Launerauthor=C.+M.+van+Duijnauthor=T.+Stijnenauthor=M.+M.+Bretelerauthor=B.+H.+Stricker&title=Nonsteroidal+antiinflammatory+drugs+and+the+risk+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease</span></div><div class="casAuthors">In't Veld, Bas A.; Ruitenberg, Annemieke; Hofman, Albert; Launer, Lenore J.; van Duijn, Cornelia M.; Stijnen, Theo; Bretteler, Monique M. B.; Stricker, Bruno H. C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1515-1521</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease.  The results, however, have been inconsistent.  Methods: We studied the assocn. between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 yr of age or older who were free of dementia at base line.  The risk of Alzheimer's disease was estd. in relation to the use of NSAIDs as documented in pharmacy records.  We defined four mutually exclusive categories of use: non-use, short-term use (1 mo or less of cumulative use), intermediate-term use (more than 1 but less than 24 mo of cumulative use), and long-term use (24 mo or more of cumulative use).  Adjustments were made by Cox regression anal. for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H2-receptor antagonists, antihypertensive agents, and hypoglycemic agents.  Results: During an av. follow-up period of 6.8 yr, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia.  The relative risk of Alzheimer's disease was 0.95 (95% confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95% confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95% confidence interval, 0.05 to 0.83) in those with long-term use.  The risk did not vary according to age.  The use of NSAIDs was not assocd. with a redn. in the risk of vascular dementia.  Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Ao_Olp-rxrVg90H21EOLACvtfcHk0ljdJaI_j6bnqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D&md5=d9c721051ba69eb547622be825531202</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa010178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa010178%26sid%3Dliteratum%253Aachs%26aulast%3Din%2Bt%25E2%2580%2599%2BVeld%26aufirst%3DB.%2BA.%26aulast%3DRuitenberg%26aufirst%3DA.%26aulast%3DHofman%26aufirst%3DA.%26aulast%3DLauner%26aufirst%3DL.%2BJ.%26aulast%3Dvan%2BDuijn%26aufirst%3DC.%2BM.%26aulast%3DStijnen%26aufirst%3DT.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%26aulast%3DStricker%26aufirst%3DB.%2BH.%26atitle%3DNonsteroidal%2520antiinflammatory%2520drugs%2520and%2520the%2520risk%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D345%26spage%3D1515%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wilcock, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swabb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, M. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of tarenflurbil in mild to moderate Alzheimer’s disease: a randomised phase II trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2FS1474-4422%2808%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=18450517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlSjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=483-493&author=G.+K.+Wilcockauthor=S.+E.+Blackauthor=S.+B.+Hendrixauthor=K.+H.+Zavitzauthor=E.+A.+Swabbauthor=M.+A.+Laughlin&title=Efficacy+and+safety+of+tarenflurbil+in+mild+to+moderate+Alzheimer%E2%80%99s+disease%3A+a+randomised+phase+II+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomized phase II trial</span></div><div class="casAuthors">Wilcock, Gordon K.; Black, Sandra E.; Hendrix, Suzanne B.; Zavitz, Kenton H.; Swabb, Edward A.; Laughlin, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">483-493</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The amyloid-β peptide Aβ42 has been implicated in the pathogenesis of Alzheimer's disease (AD).  We aimed to test the effects of tarenflurbil, a selective Aβ42-lowering agent (SALA), on cognition and function in patients with mild to moderate AD.  210 patients living in the community who had a mini-mental state examn. (MMSE) score of 15-26 were randomly assigned to receive tarenflurbil twice per day (400 mg [n=69] or 800 mg [n=70]) or placebo (n=71) for 12 mo in a phase II, multicentre, double-blind study.  Primary efficacy outcomes were the AD assessment scale cognitive subscale (ADAS-cog), the Alzheimer's Disease Cooperative Study activities of daily living scale (ADCS-ADL), and the clin. dementia rating sum of boxes (CDR-sb).  In a 12-mo extended treatment phase, patients who had received tarenflurbil continued to receive the same dose, and patients who had received placebo were randomly assigned to tarenflurbil at 800 mg or 400 mg twice per day.  Primary efficacy analyses were done by intention to treat.  This trial is registered with Health Canada (084527) and the Medicines and Healthcare products Regulatory Agency in the UK (20365/0001/A 69316).  A prespecified interaction anal. revealed that patients with mild AD (baseline MMSE 20-26) and moderate AD (baseline MMSE 15-19) responded differently to tarenflurbil in the ADAS-cog and the ADCS-ADL (p≤0.10); therefore, these groups were analyzed sep.  Patients with mild AD in the 800 mg tarenflurbil group had lower rates of decline than did those in the placebo group in activities of daily living (ADCS-ADL difference in slope 3.98 [95% CI 0.33 to 7.62] points per yr, effect size [redn. from placebo decline rate] 46.4%, Cohen's d 0.45; p=0.033) and global function (CDR-sb difference -0.80 [-1.57 to -0.03] points per yr, effect size 35.7%, Cohen's d 0.42; p=0.042); slowing of cognitive decline did not differ significantly (ADAS-cog difference -1.36 [-4.07 to 1.36] points per yr, effect size 33.7%, Cohen's d 0.20; p=0.327).  In patients with moderate AD, 800 mg tarenflurbil twice per day had no significant effects on ADCS-ADL and ADAS-cog and had a neg. effect on CDR-sb (-52%, Cohen's d -1.08; p=0.003).  The most common adverse events were diarrhea (in seven, nine, and five patients in the 800 mg, 400 mg, and placebo groups, resp.), nausea (in seven, seven, and four patients), and dizziness (in five, nine, and four patients).  Patients with mild AD who were in the 800 mg tarenflurbil group for 24 mo had lower rates of decline for all three primary outcomes than did patients who were in the placebo group for months 0-12 and a tarenflurbil group for months 12-24 (all p<0.001), and had better outcomes than did patients who were in the placebo group for months 0-12 and the 800 mg tarenflurbil group for months 12-24 (all p<0.05).  800 mg tarenflurbil twice per day was well tolerated for up to 24 mo of treatment, with evidence of a dose-related effect on measures of daily activities and global function in patients with mild AD.  Funding: Myriad Pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZrgbwtQWpU7Vg90H21EOLACvtfcHk0ljdJaI_j6bnqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlSjtL8%253D&md5=9006d4e44b3134ba2b2bea39c6c4d09a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2808%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252808%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DWilcock%26aufirst%3DG.%2BK.%26aulast%3DBlack%26aufirst%3DS.%2BE.%26aulast%3DHendrix%26aufirst%3DS.%2BB.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DLaughlin%26aufirst%3DM.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520tarenflurbil%2520in%2520mild%2520to%2520moderate%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520randomised%2520phase%2520II%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2008%26volume%3D7%26spage%3D483%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Marder, K.</span><span> </span><span class="NLM_article-title">Tarenflurbil in patients with mild Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1007%2Fs11910-010-0130-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20571933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A280%3ADC%252BC3cnnvVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=336-337&author=K.+Marder&title=Tarenflurbil+in+patients+with+mild+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tarenflurbil in patients with mild Alzheimer's disease</span></div><div class="casAuthors">Marder Karen</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">336-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgW4uTixYl1z69zv1FsJFMfW6udTcc2eZ79P5_YOnvabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnnvVOhsQ%253D%253D&md5=608f7af70d41fed0332407a6184773ff</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11910-010-0130-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-010-0130-6%26sid%3Dliteratum%253Aachs%26aulast%3DMarder%26aufirst%3DK.%26atitle%3DTarenflurbil%2520in%2520patients%2520with%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2010%26volume%3D10%26spage%3D336%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivilia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gusciglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arrigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calza, L.</span><span> </span><span class="NLM_article-title">CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20164581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksV2msL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=159-173&author=B.+P.+Imbimboauthor=L.+Giardinoauthor=S.+Siviliaauthor=A.+Giulianiauthor=M.+Gusciglioauthor=V.+Pietriniauthor=E.+Del+Giudiceauthor=A.+D%E2%80%99Arrigoauthor=A.+Leonauthor=G.+Villettiauthor=L.+Calza&title=CHF5074%2C+a+novel+gamma-secretase+modulator%2C+restores+hippocampal+neurogenesis+potential+and+reverses+contextual+memory+deficit+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">CHF5074, a Novel γ-Secretase Modulator, Restores Hippocampal Neurogenesis Potential and Reverses Contextual Memory Deficit in a Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Imbimbo, Bruno P.; Giardino, Luciana; Sivilia, Sandra; Giuliani, Alessandro; Gusciglio, Marco; Pietrini, Vladimiro; Del Giudice, Elda; D'Arrigo, Antonello; Leon, Alberta; Villetti, Gino; Calza, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The effects of compds. interfering with γ-secretase, the enzymic complex responsible of the formation of the amyloid-β (Aβ) peptide from amyloid-β protein precursor (AβPP), on plaque deposition in transgenic mouse models of Alzheimer's disease are known but scanty data are available on the effects of these drugs on brain plasticity.  We evaluated the effects of long-term treatment with CHF5074, a new γ-secretase modulator, on hippocampal neurogenesis, cortical synaptophysin levels, and contextual memory in transgenic mice carrying the double Swedish mutation of AβPP (Tg2576).  Six-month old Tg2576 mice were treated with CHF5074 (375 ppm in the diet) up to 15 mo of age.  Age-matched control transgenic and wild-type mice received std. diet.  Compared to wild-type animals, transgenic controls showed a significant decrease in the no. of doublecortin-pos. neuroblasts in dentate gyrus, synaptophysin intensity in the cortex, freezing to context in the contextual fear conditioning test.  Compared to transgenic controls, CHF5074 treatment of Tg2576 mice resulted in a significant attenuation of the neurogenesis impairment in hippocampus (p = 0.036), normalization of synaptophysin levels in cortex (p < 0.001), attenuation of plaque burden in the cortex (p = 0.033), increases astroglial reaction around plaques (p = 0.001), and attenuation of activated microglia (p = 0.040).  These effects were assocd. to a complete reversal of contextual memory deficit (p = 0.006).  Contextual memory significantly correlated with synaptophysin immunoreactivity in the cortex (r = 0.548, p = 0.0038).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRiJ8sF7Dma7Vg90H21EOLACvtfcHk0lgCMi1O7dl0uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksV2msL0%253D&md5=4b2951020a64f23915ed492812335bfc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DGiardino%26aufirst%3DL.%26aulast%3DSivilia%26aufirst%3DS.%26aulast%3DGiuliani%26aufirst%3DA.%26aulast%3DGusciglio%26aufirst%3DM.%26aulast%3DPietrini%26aufirst%3DV.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DA.%26aulast%3DLeon%26aufirst%3DA.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DCalza%26aufirst%3DL.%26atitle%3DCHF5074%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520restores%2520hippocampal%2520neurogenesis%2520potential%2520and%2520reverses%2520contextual%2520memory%2520deficit%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D159%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">MacNaughton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span> </span><span class="NLM_article-title">Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1869</span><span class="NLM_x">–</span> <span class="NLM_lpage">1876</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=1869-1876&author=W.+K.+MacNaughtonauthor=G.+Cirinoauthor=J.+L.+Wallace&title=Endothelium-derived+relaxing+factor+%28nitric+oxide%29+has+protective+actions+in+the+stomach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacNaughton%26aufirst%3DW.%2BK.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26atitle%3DEndothelium-derived%2520relaxing%2520factor%2520%2528nitric%2520oxide%2529%2520has%2520protective%2520actions%2520in%2520the%2520stomach%26jtitle%3DLife%2520Sci.%26date%3D1989%26volume%3D45%26spage%3D1869%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chiroli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Soldato, P.</span><span> </span><span class="NLM_article-title">Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=441-446&author=V.+Chiroliauthor=F.+Benediniauthor=E.+Onginiauthor=P.+Del+Soldato&title=Nitric+oxide-donating+non-steroidal+anti-inflammatory+drugs%3A+the+case+of+nitroderivatives+of+aspirin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiroli%26aufirst%3DV.%26aulast%3DBenedini%26aufirst%3DF.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DDel%2BSoldato%26aufirst%3DP.%26atitle%3DNitric%2520oxide-donating%2520non-steroidal%2520anti-inflammatory%2520drugs%253A%2520the%2520case%2520of%2520nitroderivatives%2520of%2520aspirin%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">van Groen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadish, I.</span><span> </span><span class="NLM_article-title">Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology</span> <span class="citation_source-journal">Brain Res. Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=370-378&author=T.+van+Groenauthor=I.+Kadish&title=Transgenic+AD+model+mice%2C+effects+of+potential+anti-AD+treatments+on+inflammation+and+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGroen%26aufirst%3DT.%26aulast%3DKadish%26aufirst%3DI.%26atitle%3DTransgenic%2520AD%2520model%2520mice%252C%2520effects%2520of%2520potential%2520anti-AD%2520treatments%2520on%2520inflammation%2520and%2520pathology%26jtitle%3DBrain%2520Res.%2520Brain%2520Res.%2520Rev.%26date%3D2005%26volume%3D48%26spage%3D370%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashghodom, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1471-4159.2009.06353.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19702655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=766-776&author=S.+O.+Abdul-Hayauthor=J.+Luoauthor=R.+T.+Ashghodomauthor=G.+R.+Thatcher&title=NO-flurbiprofen+reduces+amyloid-beta%2C+is+neuroprotective+in+cell+culture%2C+and+enhances+cognition+in+response+to+cholinergic+blockade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">NO-flurbiprofen reduces amyloid-β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade</span></div><div class="casAuthors">Abdul-Hay, Samer O.; Luo, Jia; Ashghodom, Rezene T.; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">766-776</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The non-steroidal anti-inflammatory drug flurbiprofen is a selective amyloid lowering agent which has been studied clin. in Alzheimer's disease.  HCT-1026 is an ester prodrug of flurbiprofen incorporating a nitrate carrier moiety that in vivo provides NO bioactivity and an improved safety profile.  In vitro, HCT-1026 retained the cyclooxygenase inhibitory and non-steroidal anti-inflammatory drug activity of flurbiprofen, but at concns. at which levels of amyloid-β 1-42 amino acid were lowered by flurbiprofen, amyloid-β 1-42 amino acid levels were elevated 200% by HCT-1026.  Conversely, at lower concns., HCT-1026 behaved as a selective amyloid lowering agent with greater potency than flurbiprofen.  The difference in concn.-responses between flurbiprofen and HCT-1026 in vitro suggests different cellular targets; and in no case did a combination of nitrate drug with flurbiprofen provide similar actions.  In vivo, HCT-1026 was obsd. to reverse cognitive deficits induced by scopolamine in two behavioral assays; activity that was also shown by a classical nitrate drug, but not by flurbiprofen.  The ability to restore aversive memory and spatial working and ref. memory after cholinergic blockade has been demonstrated by other agents that stimulate NO/cGMP signaling.  These observations add pos. to the preclin. profile of HCT-1026 and NO chimeras in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxahYhFj2InbVg90H21EOLACvtfcHk0lhLm6ifYp6R4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfF&md5=1309f39839e328cc6ce8971d4a25d54b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06353.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06353.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DAshghodom%26aufirst%3DR.%2BT.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DNO-flurbiprofen%2520reduces%2520amyloid-beta%252C%2520is%2520neuroprotective%2520in%2520cell%2520culture%252C%2520and%2520enhances%2520cognition%2520in%2520response%2520to%2520cholinergic%2520blockade%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Prosperi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casamenti, F.</span><span> </span><span class="NLM_article-title">Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1−42)-induced brain inflammation and neuronal damage in the rat</span> <span class="citation_source-journal">Int. J. Immunopathol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=15461866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCqu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=317-330&author=C.+Prosperiauthor=C.+Scaliauthor=M.+Barbaauthor=A.+Bellucciauthor=M.+G.+Giovanniniauthor=G.+Pepeuauthor=F.+Casamenti&title=Comparison+between+flurbiprofen+and+its+nitric+oxide-releasing+derivatives+HCT-1026+and+NCX-2216+on+Abeta%281%E2%88%9242%29-induced+brain+inflammation+and+neuronal+damage+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Aβ(1-42)-induced brain inflammation and neuronal damage in the rat</span></div><div class="casAuthors">Prosperi, C.; Scali, C.; Barba, M.; Bellucci, A.; Giovannini, M. G.; Pepeu, G.; Casamenti, F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopathology and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">IJIPE4</span>;
        ISSN:<span class="NLM_cas:issn">0394-6320</span>.
    
            (<span class="NLM_cas:orgname">Biolife s.a.s.</span>)
        </div><div class="casAbstract">Brain inflammation is an underlying factor in the pathogenesis of Alzheimer's disease (AD) and epidemiol. studies indicate that a sustained use of non-steroidal anti-inflammatory drugs (NSAIDs) has a protective effect on the disease.  We investigated, in vivo, whether differences exist in the antiinflammatory and neuroprotective actions of flurbiprofen and its two nitric oxide-donor derivs., HCT-1026 and NCX-2216, and the ability of these two derivs. to release nitric oxide in the brain.  In adult rats injected into the nucleus basalis with preaggregated Aβ(1-42) we investigated by immunohistochem. methods glia reaction, the induction of inducible nitric oxide synthase (iNOS), the activation of p38 mitogen-activated protein kinase (p38MAPK) pathway and the no. of choline acetyltransferase (ChAT)-pos. neurons and, in nave rats we investigated, by microdialysis, cortical extracellular levels of nitrite.  Injection of Aβ(1-42) induced iNOS at the injection site, activated p38MAPK 7 days after injection and brought about an intense microglia and astrocyte reaction along with a marked redn. in the no. of ChAT-pos. neurons, persisting up to at least up to 21 days.  Flurbiprofen, HCT-1026 and NCX-2216 (15 mg/kg) significantly attenuated the Aβ(1-42)-induced glia reaction, iNOS induction and p38MAPK activation 7 days after treatment and astrocytes reaction 21 days after treatment.  On an equimolar basis, HCT-1026 resulted the most active agent in reducing the Aβ(1-42)-induced microglia reaction.  The cholinergic cell loss was also significantly reduced by 21 days of HCT-1026 treatment.  No differences in the body wt. were found between the animals treated for 21 days with 15 mg/kg of either HCT-1026 or NCX-2216 and the controls.  An oral administration of HCT-1026 (15 mg/kg) or NCX-2216 (100 mg/kg) to naiive rats was followed by significant and long long-lasting increases in cortical nitrite levels.  These findings indicate that the addn. of a nitric oxide donor potentiates the anti-inflammatory activity of flurbiprofen in a model of brain inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1R9At6KF8DbVg90H21EOLACvtfcHk0lhLm6ifYp6R4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCqu7fF&md5=d1b996e7e664e0605ab0862cdbdb1bc5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProsperi%26aufirst%3DC.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DBarba%26aufirst%3DM.%26aulast%3DBellucci%26aufirst%3DA.%26aulast%3DGiovannini%26aufirst%3DM.%2BG.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DCasamenti%26aufirst%3DF.%26atitle%3DComparison%2520between%2520flurbiprofen%2520and%2520its%2520nitric%2520oxide-releasing%2520derivatives%2520HCT-1026%2520and%2520NCX-2216%2520on%2520Abeta%25281%25E2%2588%259242%2529-induced%2520brain%2520inflammation%2520and%2520neuronal%2520damage%2520in%2520the%2520rat%26jtitle%3DInt.%2520J.%2520Immunopathol.%2520Pharmacol.%26date%3D2004%26volume%3D17%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1−42 lowering agents</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.phrs.2006.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=17292621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=318-328&author=B.+P.+Imbimboauthor=E.+Del+Giudiceauthor=V.+Cenacchiauthor=R.+Voltaauthor=G.+Villettiauthor=F.+Facchinettiauthor=B.+Riccardiauthor=P.+Pucciniauthor=N.+Morettoauthor=F.+Grassiauthor=S.+Ottonelloauthor=A.+Leon&title=In+vitro+and+in+vivo+profiling+of+CHF5022+and+CHF5074+Two+beta-amyloid1%E2%88%9242+lowering+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo profiling of CHF5022 and CHF5074: Two β-amyloid1-42 lowering agents</span></div><div class="casAuthors">Imbimbo, Bruno P.; Del Giudice, Elda; Cenacchi, Valentina; Volta, Roberta; Villetti, Gino; Facchinetti, Fabrizio; Riccardi, Benedetta; Puccini, Paola; Moretto, Nadia; Grassi, Francesca; Ottonello, Simone; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may delay or prevent the onset of Alzheimer's disease (AD).  A subset of NSAIDs, including flurbiprofen, has been shown to selectively inhibit the prodn. of β-amyloid1-42 (Aβ42), independently from their cyclooxygenase (COX) inhibiting activity.  We evaluated the in vitro and in vivo profiles of CHF5022 and CHF5074, two flurbiprofen analogs.  The in vitro Aβ inhibiting activity was evaluated in a human neuroglioma cell line (H4) carrying the double Swedish mutation (K595N/M596L) of the human amyloid precursor protein (APPsw).  The in vitro anti-COX activity was evaluated using human recombinant enzymes isolated from transfected Sf-9 cells.  The in vivo pharmacokinetic and pharmacodynamic profiles of the two compds. were evaluated in young APPsw transgenic mice (Tg2576) after oral gavage (100 or 300 mg kg-1 day-1 for 4-5 days) and after medicated diet (375 ppm for 4 wk).  R-Flurbiprofen was used as comparator.  In vitro, CHF5022 and CHF5074 were found to be 3- and 7-fold more potent than R-flurbiprofen in inhibiting Aβ42 secretion (IC50s of 92, 40 and 268 μM, resp.).  Differently from R-flurbiprofen, CHF5022 and CHF5074 did not affect COX-1 (at 100 μM) and COX-2 (at 300 μM) activity.  Similarly to R-flurbiprofen, no significant alteration in the expression profile of a subset of Notch intracellular domain-responsive genes was obsd. with either CHF5022 or CHF5074.  In Tg2576 mice, CHF5022 was well tolerated when administered by oral gavage (100 mg kg-1 day-1 for 5 days) or by medicated diet (56 mg kg-1 day-1 for 4 wk).  R-Flurbiprofen was poorly tolerated in the diet (32 mg kg-1 day-1) with 55% of the animals dying during the first week of treatment.  After 4-5 days of oral gavage, CHF5022 and CHF5074 plasma and brain levels at 3 h were found to increase with the dose, leading to brain concns. of about 10% and 5% of the corresponding plasma concns., resp.  In animals fed for 4 wk with compd.-supplemented diet, mean plasma (580 μM) and brain (20 μ[n.1052]) concns. of CHF5022 were 8 and 15 times higher than those of R-flurbiprofen.  Plasma Aβ42 concn. was dose-dependently decreased by CHF5022 and CHF5074.  Brain Aβ levels (formic acid-extractable) were not significantly affected by either compd., although Aβ42 levels tended to inversely correlate (P = 0.105) with CHF5022 concn. in the brain.  CHF5022 and CHF5074 thus appear to have a promising in vitro and in vivo profile.  This warrants further evaluation of their long-term effects on Aβ brain pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqOFdo5MZ1r7Vg90H21EOLACvtfcHk0lhLm6ifYp6R4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D&md5=dbcb906a0f3ed14249a65783b3718a70</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2006.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2006.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DGrassi%26aufirst%3DF.%26aulast%3DOttonello%26aufirst%3DS.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520profiling%2520of%2520CHF5022%2520and%2520CHF5074%2520Two%2520beta-amyloid1%25E2%2588%259242%2520lowering%2520agents%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D55%26spage%3D318%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hagos, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edirisinghe, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Anti-inflammatory, antiproliferative, and cytoprotective activity of NO chimera nitrates of use in cancer chemoprevention</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1381-1391&author=G.+K.+Hagosauthor=S.+O.+Abdul-Hayauthor=J.+Sohnauthor=P.+D.+Edirisingheauthor=R.+E.+Chandrasenaauthor=Z.+Wangauthor=Q.+Liauthor=G.+R.+J.+Thatcher&title=Anti-inflammatory%2C+antiproliferative%2C+and+cytoprotective+activity+of+NO+chimera+nitrates+of+use+in+cancer+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHagos%26aufirst%3DG.%2BK.%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DSohn%26aufirst%3DJ.%26aulast%3DEdirisinghe%26aufirst%3DP.%2BD.%26aulast%3DChandrasena%26aufirst%3DR.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DAnti-inflammatory%252C%2520antiproliferative%252C%2520and%2520cytoprotective%2520activity%2520of%2520NO%2520chimera%2520nitrates%2520of%2520use%2520in%2520cancer%2520chemoprevention%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1381%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hinz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahl, A.</span><span> </span><span class="NLM_article-title">Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=151-156&author=B.+Hinzauthor=K.+Bruneauthor=T.+Rauauthor=A.+Pahl&title=Flurbiprofen+enantiomers+inhibit+inducible+nitric+oxide+synthase+expression+in+RAW+264.7+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinz%26aufirst%3DB.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DRau%26aufirst%3DT.%26aulast%3DPahl%26aufirst%3DA.%26atitle%3DFlurbiprofen%2520enantiomers%2520inhibit%2520inducible%2520nitric%2520oxide%2520synthase%2520expression%2520in%2520RAW%2520264.7%2520macrophages%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26spage%3D151%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tegeder, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guhring, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euchenhofer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span> </span><span class="NLM_article-title">Inhibition of NF-kappaB and AP-1 activation by <i>R</i>- and <i>S</i>-flurbiprofen</span> <span class="citation_source-journal">FASEB J</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=2-4&author=I.+Tegederauthor=E.+Niederbergerauthor=E.+Israrauthor=H.+Guhringauthor=K.+Bruneauthor=C.+Euchenhoferauthor=S.+Groschauthor=G.+Geisslinger&title=Inhibition+of+NF-kappaB+and+AP-1+activation+by+R-+and+S-flurbiprofen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTegeder%26aufirst%3DI.%26aulast%3DNiederberger%26aufirst%3DE.%26aulast%3DIsrar%26aufirst%3DE.%26aulast%3DGuhring%26aufirst%3DH.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DEuchenhofer%26aufirst%3DC.%26aulast%3DGrosch%26aufirst%3DS.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520NF-kappaB%2520and%2520AP-1%2520activation%2520by%2520R-%2520and%2520S-flurbiprofen%26jtitle%3DFASEB%2520J%26date%3D2001%26volume%3D15%26spage%3D2%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolescu, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, V.</span><span> </span><span class="NLM_article-title">Nitrates and NO release: contemporary aspects in biological and medicinal chemistry</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.freeradbiomed.2004.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=15451053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=1122-1143&author=G.+R.+J.+Thatcherauthor=A.+C.+Nicolescuauthor=B.+M.+Bennettauthor=V.+Toader&title=Nitrates+and+NO+release%3A+contemporary+aspects+in+biological+and+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrates and NO release: Contemporary aspects in biological and medicinal chemistry</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Nicolescu, Adrian C.; Bennett, Brian M.; Toader, Violeta</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1122-1143</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nitroglycerin has been used clin. in the treatment of angina for 130 yr, yet important details on the mechanism of action, biotransformation, and the assocd. phenomenon of nitrate tolerance remain unanswered.  The biol. activity of org. nitrates can be said to be nitric oxide mimetic, leading to recent, exciting progress in realizing the therapeutic potential of nitrates.  Unequivocally, nitroglycerin and most other org. nitrates, including NO-NSAIDs, do not behave as NO donors in the most fundamental action: in vitro activation of sGC to produce cGMP.  The question as to whether the biol. activity of nitrates results primarily or exclusively from NO donation will not be satisfactorily answered until the location, the app., and the mechanism of redn. of nitrates to NO are defined.  Similarly, the therapeutic potential of nitrates will not be unlocked until this knowledge is attained.  Aspects of the therapeutic and biol. activity of nitrates are reviewed in the context of the chem. of nitrates and the elusive efficient 3e- redn. required to generate NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9yTqvI4h67Vg90H21EOLACvtfcHk0lgqA-AA6fx1xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D&md5=4cf397615197ffc1a76d3eec5f5c9bb6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2004.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2004.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DNicolescu%26aufirst%3DA.%2BC.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DToader%26aufirst%3DV.%26atitle%3DNitrates%2520and%2520NO%2520release%253A%2520contemporary%2520aspects%2520in%2520biological%2520and%2520medicinal%2520chemistry%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2004%26volume%3D37%26spage%3D1122%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Gasparini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Soldato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1471-4159.2004.02154.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14690522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=337-348&author=L.+Gaspariniauthor=L.+Rusconiauthor=H.+Xuauthor=P.+del+Soldatoauthor=E.+Ongini&title=Modulation+of+beta-amyloid+metabolism+by+non-steroidal+anti-inflammatory+drugs+in+neuronal+cell+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of β-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures</span></div><div class="casAuthors">Gasparini, Laura; Rusconi, Laura; Xu, Huaxi; del Soldato, Piero; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is characterized by cerebral deposits of β-amyloid (Aβ) peptides, which are surrounded by neuroinflammatory cells.  Epidemiol. studies have shown that prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk of developing AD.  In addn., biol. data indicate that certain NSAIDs specifically lower Aβ42 levels in cultures of peripheral cells independently of cyclooxygenase (COX) activity and reduce cerebral Aβ levels in AD transgenic mice.  Whether other NSAIDs, including COX-selective compds., modulate Aβ levels in neuronal cells remains unexploited.  Here, we investigated the effects of compds. from every chem. class of NSAIDs on Aβ40 and Aβ42 secretion using both Neuro-2a cells and rat primary cortical neurons.  Among non-selective NSAIDs, flurbiprofen and sulindac sulfide concn.-dependently reduced the secretion not only of Aβ42 but also of Aβ40.  Surprisingly, both COX-2 (celecoxib; s.c.-125) or COX-1 (s.c.-560) selective compds. significantly increased Aβ42 secretion, and either did not alter (s.c.-560; s.c.-125) or reduced (celecoxib) Aβ40 levels.  The levels of βAPP C-terminal fragments and Notch cleavage were not altered by any of the NSAIDs, indicating that γ-secretase activity was not overall changed by these drugs.  The present findings show that only a few non-selective NSAIDs possess Aβ-lowering properties and therefore have a profile potentially relevant to their clin. use in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL05FA74pK4LVg90H21EOLACvtfcHk0lgqA-AA6fx1xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlSqsQ%253D%253D&md5=bfe1c128f5ee985dfe50fbe47a37c372</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02154.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02154.x%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DL.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DH.%26aulast%3Ddel%2BSoldato%26aufirst%3DP.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DModulation%2520of%2520beta-amyloid%2520metabolism%2520by%2520non-steroidal%2520anti-inflammatory%2520drugs%2520in%2520neuronal%2520cell%2520cultures%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D88%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Imbimbo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzillotta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windisch, M.</span><span> </span><span class="NLM_article-title">CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1476-5381.2008.00097.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19239474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=982-993&issue=6&author=B.+Imbimboauthor=B.+Hutter-Paierauthor=G.+Villettiauthor=F.+Facchinettiauthor=V.+Cenacchiauthor=R.+Voltaauthor=A.+Lanzillottaauthor=M.+Pizziauthor=M.+Windisch&title=CHF5074%2C+a+novel+gamma-secretase+modulator%2C+attenuates+brain+beta-amyloid+pathology+and+learning+deficit+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Imbimbo, B. P.; Hutter-Paier, B.; Villetti, G.; Facchinetti, F.; Cenacchi, V.; Volta, R.; Lanzillotta, A.; Pizzi, M.; Windisch, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-993</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: We evaluated the effects of 1-(3',4'-dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a new γ-secretase modulator, on brain β-amyloid pathol. and spatial memory in transgenic mice expressing the Swedish and London mutations of human amyloid precursor protein (hAPP).  Exptl. approach: Sixty 6-mo-old hAPP mice were treated for 6 mo with CHF5074 or ibuprofen (375 ppm in the diet) or std. diet.  Twenty-one wild-type mice received std. diet.  Key results: Compared with transgenic controls, CHF5074 treatment significantly reduced the area occupied by plaques in cortex (P = 0.003) and hippocampus (P = 0.004).  The no. of plaques were also reduced by CHF5074 in both cortex (P = 0.022) and hippocampus (P = 0.005).  Plaque-assocd. microglia in CHF5074-treated animals was lower than in transgenic controls in cortex (P = 0.008) and hippocampus (P = 0.002).  Ibuprofen treatment significantly reduced microglia area in cortex and hippocampus but not β-amyloid burden.  On the last day of the Morris water maze, transgenic controls performed significantly worse than the non-transgenic animals and the CHF5074-treated transgenic mice, on the swimming path to reach the hidden platform.  Ibuprofen-treated animals did not perform significantly better than transgenic controls.  Conclusions and implications: Chronic CHF5074 treatment reduced brain β-amyloid burden, assocd. microglia inflammation and attenuated spatial memory deficit in hAPP mice.  This novel γ-secretase modulator is a promising therapeutic agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-YuDC46zcG7Vg90H21EOLACvtfcHk0lg9VbTwfybh8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7g%253D&md5=5acebb8295cba69be5addf46b248845d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00097.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00097.x%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DLanzillotta%26aufirst%3DA.%26aulast%3DPizzi%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26atitle%3DCHF5074%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520attenuates%2520brain%2520beta-amyloid%2520pathology%2520and%2520learning%2520deficit%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26issue%3D6%26spage%3D982%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Idris, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van’t Hof, R. J.</span><span> </span><span class="NLM_article-title">The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">602</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.ejphar.2008.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19046964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=602&publication_year=2009&pages=215-222&author=A.+I.+Idrisauthor=S.+H.+Ralstonauthor=R.+J.+van%E2%80%99t+Hof&title=The+nitrosylated+flurbiprofen+derivative+HCT1026+inhibits+cytokine-induced+signalling+through+a+novel+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action</span></div><div class="casAuthors">Idris, Aymen I.; Ralston, Stuart H.; van't Hof, Rob J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">602</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">215-222</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously shown that the nitrosylated flurbiprofen deriv. HCT1026 inhibits bone resorption, both in vivo and in vitro, and that its mechanism of action is independent of nitric oxide release and prostaglandin synthesis inhibition.  Here we describe the effects of HCT1026 on osteoclast formation, activity, survival and cell signaling in vitro.  HCT1026 strongly inhibited osteoclast formation, activity and survival in murine osteoclast cultures, whereas macrophages and osteoblasts were unaffected.  HCT1026 induced osteoclast apoptosis, and this was partially prevented by increasing the concn. of receptor activator of nuclear factor kappa B ligand (RANKL).  This suggests that HCT1026 inhibits bone resorption by inhibiting the effects of RANKL.  In agreement with this we found that HCT1026 inhibited RANKL-induced activation of the nuclear factor kappa B (NFκB) and extracellular signal-regulated kinase (ERK) pathways in both osteoclast and macrophage cultures, whereas its parent compd. flurbiprofen did not.  In addn., HCT1026 also inhibited tumor necrosis factor (TNF)-, interleukin-1 (IL1)- and LPS-induced signaling, but not macrophage colony stimulating factor induced signaling.  The pathways that are inhibited by HCT1026 all share a similar kinase complex upstream of the NFκB and ERK pathways, and this is the most likely target for the actions of HCT1026.  Although the rationale for the modification of flurbiprofen with a nitric oxide donor group was to prevent gastro-intestinal toxicity, the resulting compd. HCT1026 gained unexpected addnl. cytokine-inhibitory properties.  As RANKL, TNF and IL1 are all important mediators of inflammation and joint destruction, compds. like HCT1026 could represent a novel class of anti-inflammatory compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFIj9cuNr9s7Vg90H21EOLACvtfcHk0lg9VbTwfybh8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWrtw%253D%253D&md5=1235f421eafc2621cc1fa3d2be3ebc6e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DIdris%26aufirst%3DA.%2BI.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3Dvan%25E2%2580%2599t%2BHof%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520nitrosylated%2520flurbiprofen%2520derivative%2520HCT1026%2520inhibits%2520cytokine-induced%2520signalling%2520through%2520a%2520novel%2520mechanism%2520of%2520action%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D602%26spage%3D215%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscara, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Nucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamuner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Soldato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1′-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1124%2Fjpet.103.063453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14755007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=626-633&author=J.+L.+Wallaceauthor=M.+N.+Muscaraauthor=G.+de+Nucciauthor=S.+Zamunerauthor=G.+Cirinoauthor=P.+del+Soldatoauthor=E.+Ongini&title=Gastric+tolerability+and+prolonged+prostaglandin+inhibition+in+the+brain+with+a+nitric+oxide-releasing+flurbiprofen+derivative%2C+NCX-2216+%5B3-%5B4-%282-fluoro-alpha-methyl-%5B1%2C1%E2%80%B2-biphenyl%5D-4-acetyloxy%29-3-methoxyphenyl%5D-2-propenoic+acid+4-nitrooxy+butyl+ester%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-α-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester]</span></div><div class="casAuthors">Wallace, John L.; Muscara, Marcelo N.; De Nucci, Gilberto; Zamuner, Stella; Cirino, Giuseppe; Del Soldato, Piero; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">626-633</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NCX-2216 [3-[4-(2-fluoro-α-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy Bu ester] is an NO-releasing flurbiprofen deriv. that also contains a ferulic acid (antioxidant) moiety.  NCX-2216 has been shown to be effective in reducing β-amyloid deposition in a transgenic mouse model of Alzheimer's disease.  The tolerability of this compd. in the stomach and its ability to suppress prostaglandin synthesis in the brain are not known.  The purpose of this study was to assess the contribution of nitric oxide (NO) and ferulic acid to the pharmacol. properties of NCX-2216 vs. flurbiprofen; thus, we compared their gastric tolerability and suppression of prostaglandin synthesis, peripherally and centrally.  Oral flurbiprofen produced extensive gastric damage and suppressed gastric prostaglandin synthesis.  In contrast, while suppressing prostaglandin prodn., equimolar doses of NCX-2216 did not cause detectable gastric injury.  The NO-releasing moiety of NCX-2216 (but not the ferulic acid moiety) was crucial for the gastric safety of this compd.  NCX-2216 substantially inhibited prostanoid synthesis despite not being detectable in plasma and despite producing only low amts. of flurbiprofen in plasma and in the brain.  Inhibition of brain prostaglandin synthesis by NCX-2216 (22 mg/kg) persisted for a much longer period of time (up to 48 h) than was seen with flurbiprofen (≤12 h).  These results demonstrate that a single administration of NCX-2216 can produce prolonged suppression of brain prostaglandin synthesis without causing gastric injury.  It is likely that an active metabolite of NCX-2216 contributes to the suppression of cyclooxygenase activity.  NCX-2216 may represent an attractive alternative to conventional nonsteroidal anti-inflammatory drugs for long-term treatment of a variety of inflammatory disorders, esp. those occurring in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8rOtiAvh4LbVg90H21EOLACvtfcHk0lg9VbTwfybh8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu74%253D&md5=df36ef1ab30dc197855f6ef6388c4976</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.063453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.063453%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3DMuscara%26aufirst%3DM.%2BN.%26aulast%3Dde%2BNucci%26aufirst%3DG.%26aulast%3DZamuner%26aufirst%3DS.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3Ddel%2BSoldato%26aufirst%3DP.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DGastric%2520tolerability%2520and%2520prolonged%2520prostaglandin%2520inhibition%2520in%2520the%2520brain%2520with%2520a%2520nitric%2520oxide-releasing%2520flurbiprofen%2520derivative%252C%2520NCX-2216%2520%255B3-%255B4-%25282-fluoro-alpha-methyl-%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-acetyloxy%2529-3-methoxyphenyl%255D-2-propenoic%2520acid%25204-nitrooxy%2520butyl%2520ester%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D626%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Govoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maucci, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiroli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tocchetti, P.</span><span> </span><span class="NLM_article-title">In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1124%2Fjpet.105.097469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=16424150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=752-761&author=M.+Govoniauthor=S.+Casagrandeauthor=R.+Maucciauthor=V.+Chiroliauthor=P.+Tocchetti&title=In+vitro+metabolism+of+%28nitrooxy%29butyl+ester+nitric+oxide-releasing+compounds%3A+comparison+with+glyceryl+trinitrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate</span></div><div class="casAuthors">Govoni, Mirco; Casagrande, Simona; Maucci, Raffaella; Chiroli, Valerio; Tocchetti, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">752-761</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We investigated the in vitro metab. of two (nitrooxy)butyl ester nitric oxide (NO) donor derivs. of flurbiprofen and ferulic acid, [1,1'-biphenyl]-4-acetic acid-2-fluoro-α-methyl-4-(nitrooxy)butyl ester (HCT 1026) and 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid 4-(nitrooxy)butyl ester (NCX 2057), resp., in rat blood plasma and liver subcellular fractions compared with (nitrooxy)butyl alc. (NOBA) and glyceryl trinitrate (GTN).  HCT 1026 and NCX 2057 undergo rapid ubiquitous carboxyl ester hydrolysis to their resp. parent compds. and NOBA.  The nitrate moiety of this latter is subsequently metabolized to inorg. nitrogen oxides (NOx), predominantly in liver cytosol by glutathione S-transferase (GST) and to a lesser extent in liver mitochondria.  If, however, in liver cytosol, the carboxyl ester hydrolysis is prevented by an esterase inhibitor, the metab. at the nitrate moiety level does not occur.  In blood plasma, HCT 1026 and NCX 2057 are not metabolized to NOx, whereas a slow but sustained NO generation in deoxygenated whole blood as detected by ESR indicates the involvement of erythrocytes in the bioactivation of these compds.  Differently from NOBA, GTN is also metabolized in blood plasma and more quickly metabolized by different GST isoforms in liver cytosol.  The cytosolic GST-mediated denitration of these org. nitrates in liver limits their interaction with other intracellular compartments to possible generation of NO and/or their subsequent availability and bioactivation in the systemic circulation and extrahepatic tissues.  We show the possibility of modulating the activity of hepatic cytosolic enzymes involved in the metab. of (nitrooxy)butyl ester compds., thus increasing the therapeutic potential of this class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0eFExgPHUObVg90H21EOLACvtfcHk0ljpSURaFOVMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamu7w%253D&md5=5ea141c9276c0ef225220e183f4182dc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097469%26sid%3Dliteratum%253Aachs%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DCasagrande%26aufirst%3DS.%26aulast%3DMaucci%26aufirst%3DR.%26aulast%3DChiroli%26aufirst%3DV.%26aulast%3DTocchetti%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520%2528nitrooxy%2529butyl%2520ester%2520nitric%2520oxide-releasing%2520compounds%253A%2520comparison%2520with%2520glyceryl%2520trinitrate%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D752%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Prosperi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casamenti, F.</span><span> </span><span class="NLM_article-title">NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain</span> <span class="citation_source-journal">Jpn J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1254%2Fjjp.86.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=11459126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=230-235&author=C.+Prosperiauthor=C.+Scaliauthor=G.+Pepeuauthor=F.+Casamenti&title=NO-flurbiprofen+attenuates+excitotoxin-induced+brain+inflammation%2C+and+releases+nitric+oxide+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain</span></div><div class="casAuthors">Prosperi, Costanza; Scali, Carla; Pepeu, Giancarlo; Casamenti, Fiorella</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">230-235</span>CODEN:
                <span class="NLM_cas:coden">JJPAAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-5198</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Brain inflammation underlies the pathogenesis of Alzheimer's disease (AD) and nonsteroidal anti-inflammatory drug therapy may delay the onset of AD.  We investigated, in vivo, the effects of NO-flurbiprofen on brain inflammation in rats injected with quisqualic acid into the nucleus basalis and on the release of nitric oxide from the drug in naive rat brains.  We showed that the excitotoxin-induced microglia reaction, the expression of inducible nitric oxide synthase-pos. cells and the prodn. of interleukin-1β and prostaglandin-E2 in the injected area were attenuated by the NO-flurbiprofen (15 mg/kg, p.o.) treatment.  An oral administration of NO-flurbiprofen (25, 50 and 100 mg/kg) to naive rats was followed by significant increases in cortical nitrite levels.  This drug may have important therapeutic implications for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1k2fRjQJSNrVg90H21EOLACvtfcHk0ljpSURaFOVMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslehsrs%253D&md5=bf724e13de3ffa8a9c358de58304f4ab</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1254%2Fjjp.86.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjjp.86.230%26sid%3Dliteratum%253Aachs%26aulast%3DProsperi%26aufirst%3DC.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DCasamenti%26aufirst%3DF.%26atitle%3DNO-flurbiprofen%2520attenuates%2520excitotoxin-induced%2520brain%2520inflammation%252C%2520and%2520releases%2520nitric%2520oxide%2520in%2520the%2520brain%26jtitle%3DJpn%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D86%26spage%3D230%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kache, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasiadis, P. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=545-550&author=T.+Kukarauthor=M.+P.+Murphyauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=S.+Weggenauthor=T.+E.+Smithauthor=T.+Laddauthor=M.+A.+Khanauthor=R.+Kacheauthor=J.+Beardauthor=M.+Dodsonauthor=S.+Meritauthor=V.+V.+Ozolsauthor=P.+Z.+Anastasiadisauthor=P.+Dasauthor=A.+Fauqauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Diverse+compounds+mimic+Alzheimer+disease-causing+mutations+by+augmenting+Abeta42+production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DLadd%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DKache%26aufirst%3DR.%26aulast%3DBeard%26aufirst%3DJ.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DMerit%26aufirst%3DS.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DAnastasiadis%26aufirst%3DP.%2BZ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDiverse%2520compounds%2520mimic%2520Alzheimer%2520disease-causing%2520mutations%2520by%2520augmenting%2520Abeta42%2520production%26jtitle%3DNature%2520Med.%26date%3D2005%26volume%3D11%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kukar, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraering, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narlawar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharvi, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangachari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen-West, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeeck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torpey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Substrate-targeting gamma-secretase modulators</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1038%2Fnature07055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=18548070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVCqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2008&pages=925-929&author=T.+L.+Kukarauthor=T.+B.+Laddauthor=M.+A.+Bannauthor=P.+C.+Fraeringauthor=R.+Narlawarauthor=G.+M.+Maharviauthor=B.+Healyauthor=R.+Chapmanauthor=A.+T.+Welzelauthor=R.+W.+Priceauthor=B.+Mooreauthor=V.+Rangachariauthor=B.+Cusackauthor=J.+Eriksenauthor=K.+Jansen-Westauthor=C.+Verbeeckauthor=D.+Yagerauthor=C.+Eckmanauthor=W.+Yeauthor=S.+Sagiauthor=B.+A.+Cottrellauthor=J.+Torpeyauthor=T.+L.+Rosenberryauthor=A.+Fauqauthor=M.+S.+Wolfeauthor=B.+Schmidtauthor=D.+M.+Walshauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Substrate-targeting+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-targeting γ-secretase modulators</span></div><div class="casAuthors">Kukar, Thomas L.; Ladd, Thomas B.; Bann, Maralyssa A.; Fraering, Patrick C.; Narlawar, Rajeshwar; Maharvi, Ghulam M.; Healy, Brent; Chapman, Robert; Welzel, Alfred T.; Price, Robert W.; Moore, Brenda; Rangachari, Vijayaraghavan; Cusack, Bernadette; Eriksen, Jason; Jansen-West, Karen; Verbeeck, Christophe; Yager, Debra; Eckman, Christopher; Ye, Wenjuan; Sagi, Sarah; Cottrell, Barbara A.; Torpey, Justin; Rosenberry, Terrone L.; Fauq, Abdul; Wolfe, Michael S.; Schmidt, Boris; Walsh, Dominic M.; Koo, Edward H.; Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">7197</span>),
    <span class="NLM_cas:pages">925-929</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Selective lowering of Aβ42 levels (the 42-residue isoform of the amyloid-β peptide) with small-mol. γ-secretase modulators (GSMs), such as some non-steroidal anti-inflammatory drugs, is a promising therapeutic approach for Alzheimer's disease.  To identify the target of these agents we developed biotinylated photoactivatable GSMs.  GSM photoprobes did not label the core proteins of the γ-secretase complex, but instead labeled the β-amyloid precursor protein (APP), APP carboxy-terminal fragments and amyloid-β peptide in human neuroglioma H4 cells.  Substrate labeling was competed by other GSMs, and labeling of an APP γ-secretase substrate was more efficient than a Notch substrate.  GSM interaction was localized to residues 28-36 of amyloid-β, a region crit. for aggregation.  We also demonstrate that compds. known to interact with this region of amyloid-β act as GSMs, and some GSMs alter the prodn. of cell-derived amyloid-β oligomers.  Furthermore, mutation of the GSM binding site in the APP alters the sensitivity of the substrate to GSMs.  These findings indicate that substrate targeting by GSMs mechanistically links two therapeutic actions: alteration in Aβ42 prodn. and inhibition of amyloid-β aggregation, which may synergistically reduce amyloid-β deposition in Alzheimer's disease.  These data also demonstrate the existence and feasibility of substrate targeting' by small-mol. effectors of proteolytic enzymes, which if generally applicable may significantly broaden the current notion ofdruggable' targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI94fdiPOnirVg90H21EOLACvtfcHk0ljpSURaFOVMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVCqu74%253D&md5=959f0ca309abe7039cd3848ad079a35a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnature07055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07055%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%2BL.%26aulast%3DLadd%26aufirst%3DT.%2BB.%26aulast%3DBann%26aufirst%3DM.%2BA.%26aulast%3DFraering%26aufirst%3DP.%2BC.%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DMaharvi%26aufirst%3DG.%2BM.%26aulast%3DHealy%26aufirst%3DB.%26aulast%3DChapman%26aufirst%3DR.%26aulast%3DWelzel%26aufirst%3DA.%2BT.%26aulast%3DPrice%26aufirst%3DR.%2BW.%26aulast%3DMoore%26aufirst%3DB.%26aulast%3DRangachari%26aufirst%3DV.%26aulast%3DCusack%26aufirst%3DB.%26aulast%3DEriksen%26aufirst%3DJ.%26aulast%3DJansen-West%26aufirst%3DK.%26aulast%3DVerbeeck%26aufirst%3DC.%26aulast%3DYager%26aufirst%3DD.%26aulast%3DEckman%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DSagi%26aufirst%3DS.%26aulast%3DCottrell%26aufirst%3DB.%2BA.%26aulast%3DTorpey%26aufirst%3DJ.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DSubstrate-targeting%2520gamma-secretase%2520modulators%26jtitle%3DNature%26date%3D2008%26volume%3D453%26spage%3D925%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=677-683&author=R.+M.+Pageauthor=K.+Baumannauthor=M.+Tomiokaauthor=B.+I.+Perez-Revueltaauthor=A.+Fukumoriauthor=H.+Jacobsenauthor=A.+Flohrauthor=T.+Luebbersauthor=L.+Ozmenauthor=H.+Steinerauthor=C.+Haass&title=Generation+of+Abeta38+and+Abeta42+is+independently+and+differentially+affected+by+familial+Alzheimer+disease-associated+presenilin+mutations+and+gamma-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DPerez-Revuelta%26aufirst%3DB.%2BI.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520Abeta38%2520and%2520Abeta42%2520is%2520independently%2520and%2520differentially%2520affected%2520by%2520familial%2520Alzheimer%2520disease-associated%2520presenilin%2520mutations%2520and%2520gamma-secretase%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D677%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominari, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rikimaru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natsugari, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">18664</span><span class="NLM_x">–</span> <span class="NLM_lpage">18670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=18664-18670&author=Y.+Takahashiauthor=I.+Hayashiauthor=Y.+Tominariauthor=K.+Rikimaruauthor=Y.+Morohashiauthor=T.+Kanauthor=H.+Natsugariauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Sulindac+sulfide+is+a+noncompetitive+gamma-secretase+inhibitor+that+preferentially+reduces+Abeta+42+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DI.%26aulast%3DTominari%26aufirst%3DY.%26aulast%3DRikimaru%26aufirst%3DK.%26aulast%3DMorohashi%26aufirst%3DY.%26aulast%3DKan%26aufirst%3DT.%26aulast%3DNatsugari%26aufirst%3DH.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DSulindac%2520sulfide%2520is%2520a%2520noncompetitive%2520gamma-secretase%2520inhibitor%2520that%2520preferentially%2520reduces%2520Abeta%252042%2520generation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D18664%26epage%3D18670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raveglia, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigogno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biscaioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catinella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzoni, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGiudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid1−42 secretion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5705</span><span class="NLM_x">–</span> <span class="NLM_lpage">5720</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5705-5720&author=I.+Perettoauthor=S.+Radaelliauthor=C.+Pariniauthor=M.+Zandiauthor=L.+F.+Ravegliaauthor=G.+Dondioauthor=L.+Fontanellaauthor=P.+Misianoauthor=C.+Bigognoauthor=A.+Rizziauthor=B.+Riccardiauthor=M.+Biscaioliauthor=S.+Marchettiauthor=P.+Pucciniauthor=S.+Catinellaauthor=I.+Rondelliauthor=V.+Cenacchiauthor=P.+T.+Bolzoniauthor=P.+Carusoauthor=G.+Villettiauthor=F.+Facchinettiauthor=E.+DelGiudiceauthor=N.+Morettoauthor=B.+P.+Imbimbo&title=Synthesis+and+biological+activity+of+flurbiprofen+analogues+as+selective+inhibitors+of+beta-amyloid1%E2%88%9242+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0502541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502541%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DParini%26aufirst%3DC.%26aulast%3DZandi%26aufirst%3DM.%26aulast%3DRaveglia%26aufirst%3DL.%2BF.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DFontanella%26aufirst%3DL.%26aulast%3DMisiano%26aufirst%3DP.%26aulast%3DBigogno%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DBiscaioli%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DS.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DCatinella%26aufirst%3DS.%26aulast%3DRondelli%26aufirst%3DI.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DBolzoni%26aufirst%3DP.%2BT.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DDelGiudice%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520flurbiprofen%2520analogues%2520as%2520selective%2520inhibitors%2520of%2520beta-amyloid1%25E2%2588%259242%2520secretion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5705%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kotoris, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. D.</span><span> </span><span class="NLM_article-title">Preparation of benzylic Î±,Î±-difluoronitriles, -tetrazoles, and -sulfonates via electrophilic fluorination</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">8052</span><span class="NLM_x">–</span> <span class="NLM_lpage">8057</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo981163x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=8052-8057&author=C.+C.+Kotorisauthor=M.-J.+Chenauthor=S.+D.+Taylor&title=Preparation+of+benzylic+%C3%8E%C2%B1%2C%C3%8E%C2%B1-difluoronitriles%2C+-tetrazoles%2C+and+-sulfonates+via+electrophilic+fluorination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo981163x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981163x%26sid%3Dliteratum%253Aachs%26aulast%3DKotoris%26aufirst%3DC.%2BC.%26aulast%3DChen%26aufirst%3DM.-J.%26aulast%3DTaylor%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520benzylic%2520%25C3%258E%25C2%25B1%252C%25C3%258E%25C2%25B1-difluoronitriles%252C%2520-tetrazoles%252C%2520and%2520-sulfonates%2520via%2520electrophilic%2520fluorination%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D8052%26epage%3D8057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. Z.</span><span> </span><span class="NLM_article-title">A novel general method for preparation of [alpha]-fluoro-[alpha]-arylcarboxylic acid. Direct fluorination of silyl ketene acetals with Selectfluor</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">7641</span><span class="NLM_x">–</span> <span class="NLM_lpage">7644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=7641-7644&author=F.+Zhangauthor=J.+Z.+Song&title=A+novel+general+method+for+preparation+of+%5Balpha%5D-fluoro-%5Balpha%5D-arylcarboxylic+acid.+Direct+fluorination+of+silyl+ketene+acetals+with+Selectfluor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%2BZ.%26atitle%3DA%2520novel%2520general%2520method%2520for%2520preparation%2520of%2520%255Balpha%255D-fluoro-%255Balpha%255D-arylcarboxylic%2520acid.%2520Direct%2520fluorination%2520of%2520silyl%2520ketene%2520acetals%2520with%2520Selectfluor%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D7641%26epage%3D7644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Jianfei  Sun</span>, <span class="hlFld-ContribAuthor ">Lei  Fang</span>, <span class="hlFld-ContribAuthor ">Mei  Liu</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Hong  Liao</span>, <span class="hlFld-ContribAuthor ">Jochen  Lehmann</span>, and <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Tacrine–Ferulic Acid–Nitric Oxide (NO) Donor Trihybrids as Potent, Multifunctional Acetyl- and Butyrylcholinesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (9)
                                     , 4309-4321. <a href="https://doi.org/10.1021/jm300106z" title="DOI URL">https://doi.org/10.1021/jm300106z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300106z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300106z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTacrine%2525E2%252580%252593Ferulic%252BAcid%2525E2%252580%252593Nitric%252BOxide%252B%252528NO%252529%252BDonor%252BTrihybrids%252Bas%252BPotent%25252C%252BMultifunctional%252BAcetyl-%252Band%252BButyrylcholinesterase%252BInhibitors%26aulast%3DChen%26aufirst%3DYao%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25012012%26date%3D27042012%26date%3D10052012%26date%3D18042012%26volume%3D55%26issue%3D9%26spage%3D4309%26epage%3D4321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Shane  O’Sullivan</span>, <span class="hlFld-ContribAuthor ">Shona  Harmon</span>, <span class="hlFld-ContribAuthor ">Ray  Keaveny</span>, <span class="hlFld-ContribAuthor ">Marek W.  Radomski</span>, <span class="hlFld-ContribAuthor ">Carlos  Medina</span>, and <span class="hlFld-ContribAuthor ">John F.  Gilmer</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Barbiturate–Nitrate Hybrids that Inhibit MMP-9 Activity and Secretion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2154-2162. <a href="https://doi.org/10.1021/jm201352k" title="DOI URL">https://doi.org/10.1021/jm201352k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201352k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201352k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BBarbiturate%2525E2%252580%252593Nitrate%252BHybrids%252Bthat%252BInhibit%252BMMP-9%252BActivity%252Band%252BSecretion%26aulast%3DWang%26aufirst%3DJun%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D09102011%26date%3D23022012%26date%3D08032012%26date%3D16012012%26volume%3D55%26issue%3D5%26spage%3D2154%26epage%3D2162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samer  Abdul-Hay</span>, <span class="hlFld-ContribAuthor ">Isaac T.  Schiefer</span>, <span class="hlFld-ContribAuthor ">R. Esala P.  Chandrasena</span>, <span class="hlFld-ContribAuthor ">Min  Li</span>, <span class="hlFld-ContribAuthor ">Ramy  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Yue-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Ehsan  Tavassoli</span>, <span class="hlFld-ContribAuthor ">Bradley  Michalsen</span>, <span class="hlFld-ContribAuthor ">Rezene T.  Asghodom</span>, <span class="hlFld-ContribAuthor ">Jia  Luo</span>, and <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>  . </span><span class="cited-content_cbyCitation_article-title">NO-SSRIs: Nitric Oxide Chimera Drugs Incorporating a Selective Serotonin Reuptake Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (9)
                                     , 656-661. <a href="https://doi.org/10.1021/ml2000033" title="DOI URL">https://doi.org/10.1021/ml2000033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml2000033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml2000033%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNO-SSRIs%25253A%252BNitric%252BOxide%252BChimera%252BDrugs%252BIncorporating%252Ba%252BSelective%252BSerotonin%252BReuptake%252BInhibitor%26aulast%3DAbdul-Hay%26aufirst%3DSamer%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D15012011%26date%3D25072011%26date%3D01082011%26date%3D08092011%26date%3D26072011%26volume%3D2%26issue%3D9%26spage%3D656%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filip  Kalčic</span>, <span class="hlFld-ContribAuthor ">Viktor  Kolman</span>, <span class="hlFld-ContribAuthor ">Haresh  Ajani</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Zídek</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>. </span><span class="cited-content_cbyCitation_article-title">Polysubstituted Pyrimidines as mPGES‐1 Inhibitors: Discovery of Potent Inhibitors of PGE
              2
              Production with Strong Anti‐inflammatory Effects in Carrageenan‐Induced Rat Paw Edema. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (15)
                                     , 1398-1407. <a href="https://doi.org/10.1002/cmdc.202000258" title="DOI URL">https://doi.org/10.1002/cmdc.202000258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000258%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPolysubstituted%252BPyrimidines%252Bas%252BmPGES%2525E2%252580%2525901%252BInhibitors%25253A%252BDiscovery%252Bof%252BPotent%252BInhibitors%252Bof%252BPGE%252B2%252BProduction%252Bwith%252BStrong%252BAnti%2525E2%252580%252590inflammatory%252BEffects%252Bin%252BCarrageenan%2525E2%252580%252590Induced%252BRat%252BPaw%252BEdema%26aulast%3DKal%25C4%258Dic%26aufirst%3DFilip%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D15%26spage%3D1398%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon D.  Eden</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Rice</span>, <span class="hlFld-ContribAuthor ">Troy D.  Lovett</span>, <span class="hlFld-ContribAuthor ">Olivia M.  Toner</span>, <span class="hlFld-ContribAuthor ">Evan P.  Geissler</span>, <span class="hlFld-ContribAuthor ">William E.  Bowman</span>, <span class="hlFld-ContribAuthor ">Sherri C.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis and in vitro stability of N-benzylamide non-steroidal anti-inflammatory drug conjugates for CNS delivery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1487-1491. <a href="https://doi.org/10.1016/j.bmcl.2019.04.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMicrowave-assisted%252Bsynthesis%252Band%252Bin%252Bvitro%252Bstability%252Bof%252BN-benzylamide%252Bnon-steroidal%252Banti-inflammatory%252Bdrug%252Bconjugates%252Bfor%252BCNS%252Bdelivery%26aulast%3DEden%26aufirst%3DBrandon%2BD.%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1487%26epage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Izabela  Muszalska</span>, <span class="hlFld-ContribAuthor ">Monika A.  Lesniewska‐Kowiel</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Becla</span>, <span class="hlFld-ContribAuthor ">Wojciech  Duda</span>, <span class="hlFld-ContribAuthor ">Anna  Pawełczyk</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Sowa‐Kasprzak</span>, <span class="hlFld-ContribAuthor ">Dorota  Olender</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and enzymatic stability of the oleanoyl oxime ibuprofenate. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Chemical Kinetics</span><span> <strong>2019,</strong> <em>51 </em>
                                    (5)
                                     , 346-357. <a href="https://doi.org/10.1002/kin.21258" title="DOI URL">https://doi.org/10.1002/kin.21258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/kin.21258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fkin.21258%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Chemical%2520Kinetics%26atitle%3DChemical%252Band%252Benzymatic%252Bstability%252Bof%252Bthe%252Boleanoyl%252Boxime%252Bibuprofenate%26aulast%3DMuszalska%26aufirst%3DIzabela%26date%3D2019%26date%3D2019%26volume%3D51%26issue%3D5%26spage%3D346%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Austin  Horton</span>, <span class="hlFld-ContribAuthor ">Isaac T.  Schiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>84 </em>, 69-78. <a href="https://doi.org/10.1016/j.niox.2019.01.001" title="DOI URL">https://doi.org/10.1016/j.niox.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2019.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DPharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Bnitric%252Boxide%252Bmimetic%252Bagents%26aulast%3DHorton%26aufirst%3DAustin%26date%3D2019%26volume%3D84%26spage%3D69%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Hollas</span>, <span class="hlFld-ContribAuthor ">Manel  Ben Aissa</span>, <span class="hlFld-ContribAuthor ">Sue H.  Lee</span>, <span class="hlFld-ContribAuthor ">Jesse M.  Gordon-Blake</span>, <span class="hlFld-ContribAuthor ">Gregory R.J.  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>82 </em>, 59-74. <a href="https://doi.org/10.1016/j.niox.2018.10.006" title="DOI URL">https://doi.org/10.1016/j.niox.2018.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2018.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DPharmacological%252Bmanipulation%252Bof%252BcGMP%252Band%252BNO%25252FcGMP%252Bin%252BCNS%252Bdrug%252Bdiscovery%26aulast%3DHollas%26aufirst%3DMichael%2BA.%26date%3D2019%26volume%3D82%26spage%3D59%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongcheng  Cao</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Qin  Song</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Qiang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (5)
                                     , 1102-1115. <a href="https://doi.org/10.1016/j.bmc.2018.01.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B4%2525E2%252580%2525B2-OH-flurbiprofen-chalcone%252Bhybrids%252Bas%252Bpotential%252Bmultifunctional%252Bagents%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btreatment%26aulast%3DCao%26aufirst%3DZhongcheng%26date%3D2018%26volume%3D26%26issue%3D5%26spage%3D1102%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Shao-wei  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Ling-xiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong-qun  Liu</span>, <span class="hlFld-ContribAuthor ">Mei  Ji</span>, <span class="hlFld-ContribAuthor ">Wei-yun  Wang</span>, <span class="hlFld-ContribAuthor ">Rui-tian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2017,</strong> <em>591 </em>
                                    (21)
                                     , 3615-3624. <a href="https://doi.org/10.1002/1873-3468.12871" title="DOI URL">https://doi.org/10.1002/1873-3468.12871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1873-3468.12871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1873-3468.12871%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DA%252Bmimotope%252Bof%252BA%2525CE%2525B2%252Boligomers%252Bmay%252Balso%252Bbehave%252Bas%252Ba%252B%2525CE%2525B2-sheet%252Binhibitor%26aulast%3DZhang%26aufirst%3DYang-xin%26date%3D2017%26date%3D2017%26volume%3D591%26issue%3D21%26spage%3D3615%26epage%3D3624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazutaka  Shibatomi</span>, <span class="hlFld-ContribAuthor ">Kazumasa  Kitahara</span>, <span class="hlFld-ContribAuthor ">Takuya  Okimi</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Abe</span>, <span class="hlFld-ContribAuthor ">Seiji  Iwasa</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective fluorination of α-branched aldehydes and subsequent conversion to α-hydroxyacetals via stereospecific C–F bond cleavage. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (2)
                                     , 1388-1392. <a href="https://doi.org/10.1039/C5SC03486H" title="DOI URL">https://doi.org/10.1039/C5SC03486H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5SC03486H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5SC03486H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DEnantioselective%252Bfluorination%252Bof%252B%2525CE%2525B1-branched%252Baldehydes%252Band%252Bsubsequent%252Bconversion%252Bto%252B%2525CE%2525B1-hydroxyacetals%252Bvia%252Bstereospecific%252BC%2525E2%252580%252593F%252Bbond%252Bcleavage%26aulast%3DShibatomi%26aufirst%3DKazutaka%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D1388%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yu</span>, <span class="hlFld-ContribAuthor ">Xiu-Hua  Xu</span>, <span class="hlFld-ContribAuthor ">Feng-Ling  Qing</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light-induced monofluoromethylenation of heteroarenes with ethyl bromofluoroacetate. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2016,</strong> <em>40 </em>
                                    (8)
                                     , 6564-6567. <a href="https://doi.org/10.1039/C6NJ00281A" title="DOI URL">https://doi.org/10.1039/C6NJ00281A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ00281A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ00281A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DVisible%252Blight-induced%252Bmonofluoromethylenation%252Bof%252Bheteroarenes%252Bwith%252Bethyl%252Bbromofluoroacetate%26aulast%3DYu%26aufirst%3DWei%26date%3D2016%26date%3D2016%26volume%3D40%26issue%3D8%26spage%3D6564%26epage%3D6567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Ya-jing  Su</span>, <span class="hlFld-ContribAuthor ">Di  Xue</span>, <span class="hlFld-ContribAuthor ">Xiao-lin  Yu</span>, <span class="hlFld-ContribAuthor ">Shao-wei  Wang</span>, <span class="hlFld-ContribAuthor ">He  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng-xin  Xu</span>, <span class="hlFld-ContribAuthor ">Xi-xiu  Xie</span>, <span class="hlFld-ContribAuthor ">Rui-tian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2014,</strong> <em>74 </em>, 50-63. <a href="https://doi.org/10.1016/j.freeradbiomed.2014.06.013" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2014.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2014.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2014.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DDecreasing%252Boxidative%252Bstress%252Band%252Bneuroinflammation%252Bwith%252Ba%252Bmultifunctional%252Bpeptide%252Brescues%252Bmemory%252Bdeficits%252Bin%252Bmice%252Bwith%252BAlzheimer%252Bdisease%26aulast%3DZhou%26aufirst%3DWei-wei%26date%3D2014%26volume%3D74%26spage%3D50%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hirak  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Pukhrambam  Grihanjali Devi</span>, <span class="hlFld-ContribAuthor ">Munna  Sarkar</span>, <span class="hlFld-ContribAuthor ">Dipak  Dasgupta</span>. </span><span class="cited-content_cbyCitation_article-title">New Functions of Old Drugs: Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 3-55. <a href="https://doi.org/10.1016/B978-0-12-803961-8.50001-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-803961-8.50001-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803961-8.50001-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803961-8.50001-4%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BFunctions%252Bof%252BOld%252BDrugs%25253A%252BAureolic%252BAcid%252BGroup%252Bof%252BAnti-Cancer%252BAntibiotics%252Band%252BNon-Steroidal%252BAnti-Inflammatory%252BDrugs%26aulast%3DChakraborty%26aufirst%3DHirak%26date%3D2014%26spage%3D3%26epage%3D55%26pub%3DElsevier%26atitle%3DRecent%252BAdvances%252Bin%252BMedicinal%252BChemistry%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antal  Harsanyi</span>, <span class="hlFld-ContribAuthor ">Graham  Sandford</span>, <span class="hlFld-ContribAuthor ">Dmitri S  Yufit</span>, <span class="hlFld-ContribAuthor ">Judith AK  Howard</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of fluorooxindole and 2-fluoro-2-arylacetic acid derivatives from diethyl 2-fluoromalonate ester. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>10 </em>, 1213-1219. <a href="https://doi.org/10.3762/bjoc.10.119" title="DOI URL">https://doi.org/10.3762/bjoc.10.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.10.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.10.119%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSyntheses%252Bof%252Bfluorooxindole%252Band%252B2-fluoro-2-arylacetic%252Bacid%252Bderivatives%252Bfrom%252Bdiethyl%252B2-fluoromalonate%252Bester%26aulast%3DHarsanyi%26aufirst%3DAntal%26date%3D2014%26date%3D2014%26volume%3D10%26spage%3D1213%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin  Zhihui</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (12)
                                     , 1451-1468. <a href="https://doi.org/10.4155/fmc.13.111" title="DOI URL">https://doi.org/10.4155/fmc.13.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.111%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DModulating%252Bnitric%252Boxide%252Bsignaling%252Bin%252Bthe%252BCNS%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btherapy%26aulast%3DZhihui%26aufirst%3DQin%26date%3D2013%26volume%3D5%26issue%3D12%26spage%3D1451%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amjad  Qandil</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2012,</strong> <em>13 </em>
                                    (12)
                                     , 17244-17274. <a href="https://doi.org/10.3390/ijms131217244" title="DOI URL">https://doi.org/10.3390/ijms131217244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms131217244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms131217244%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DProdrugs%252Bof%252BNonsteroidal%252BAnti-Inflammatory%252BDrugs%252B%252528NSAIDs%252529%25252C%252BMore%252BThan%252BMeets%252Bthe%252BEye%25253A%252BA%252BCritical%252BReview%26aulast%3DQandil%26aufirst%3DAmjad%26date%3D2012%26date%3D2012%26volume%3D13%26issue%3D12%26spage%3D17244%26epage%3D17274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Di  Xue</span>, <span class="hlFld-ContribAuthor ">Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu-jiong  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Shao-wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ran  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Zhao</span>, <span class="hlFld-ContribAuthor ">Rui-tian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2012,</strong> <em>46 </em>
                                    (3)
                                     , 701-709. <a href="https://doi.org/10.1016/j.nbd.2012.03.013" title="DOI URL">https://doi.org/10.1016/j.nbd.2012.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2012.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2012.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DA%252Bmultifunctional%252Bpeptide%252Brescues%252Bmemory%252Bdeficits%252Bin%252BAlzheimer%252527s%252Bdisease%252Btransgenic%252Bmice%252Bby%252Binhibiting%252BA%2525CE%2525B242-induced%252Bcytotoxicity%252Band%252Bincreasing%252Bmicroglial%252Bphagocytosis%26aulast%3DXue%26aufirst%3DDi%26date%3D2012%26volume%3D46%26issue%3D3%26spage%3D701%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) NBS, CCl<sub>4</sub>; (ii) KCN, EtOH; (iii) 1,2 dibromoethane for <b>9a</b> or CH<sub>3</sub>CH<sub>2</sub>I for <b>9b,</b> NaOH, toluene−H<sub>2</sub>O; (iv) NaOH, MeOH, 100 °C; (v) R<sub>1</sub>B(OH)<sub>2</sub>, Pd(OAc)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, TBAB, H<sub>2</sub>O, 120 °C; (vi) NFSi, <i>t</i>-BuLi, THF, −78 °C; (vii) K<sub>2</sub>CO<sub>3</sub>, DMSO, H<sub>2</sub>O<sub>2</sub>, 0 °C yields <b>16a</b>−<b>b</b> and <b>17a</b>−<b>b</b>, or H<sub>2</sub>SO<sub>4</sub> (49%), 90 °C to give <b>18a</b>−<b>b</b>; (viii) K<sub>2</sub>CO<sub>3</sub>, DMSO, H<sub>2</sub>O<sub>2</sub>, 0 °C; (ix) CH<sub>3</sub>CH<sub>2</sub>Br, NaOH, toluene−H<sub>2</sub>O; (x) LiOH, THF/H<sub>2</sub>O/MeOH, 0 °C.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) TBSCl, LiHMDS, THF, 0 °C, 12 h; (ii) Selectfluor, CH<sub>3</sub>CN, <50 °C.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) NaOCH<sub>3</sub>, CH<sub>3</sub>OH; (ii) Br(CH<sub>2</sub>)<sub>4</sub>Br for <b>24a</b>, Br(CH<sub>2</sub>)<sub>2</sub>Br for <b>25a</b>−<b>c</b>, or 4-aminobutanol followed by PPh<sub>3</sub> with CBr<sub>4</sub> for <b>24b</b>, DMF; (iii) AgNO<sub>3</sub>, CH<sub>3</sub>CN, reflux.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Flurbiprofen and derivatives showed varied SALA and SARA activity in neuronal cell incubations. Levels of Aβ<sub>1−42</sub> from N2a/APPsw cell supernatants were measured by ELISA and normalized to DMSO vehicle treated control after incubation with different concentrations of compounds <b>1</b> and <b>11a</b> (A) or <b>1</b> and <b>2</b> (B). The average level of Aβ<sub>1−42</sub> in the DMSO treated groups was ∼500 pg/mL. The data show mean and SEM from at least four separate experiments performed using separate cell passages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hybrid nitrate flurbiprofen derivatives caused biphasic regulation of Aβ<sub>1−42</sub> in neuronal cell incubations, acting as SALAs at lower concentration. Levels of Aβ<sub>1−42</sub> from N2a/APPsw cell supernatants were measured by ELISA and normalized to DMSO vehicle treated control after incubation with different concentrations of compounds <b>2</b> and <b>26a</b> (A), <b>2</b> and <b>38</b> (B), or <b>26a</b> (0.5 μM) and <b>27</b> (0.5 μM) (C). The average level of Aβ<sub>1−42</sub> in DMSO treated group was ∼500 pg/mL. The data show mean and sem from at least four separate experiments performed using separate cell passages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hybrid nitrate <b>27</b> has brain bioavailaibility and in vivo stability after administration to mice (10 mg/kg ip) 30 or 120 min prior to sacrifice. Quantitation of <b>27</b> by LC-MS/MS used MRM analysis of the <i>m</i>/<i>z</i> transition 361 → 200. (A) Representative MRM chromatogram of <b>27</b> from mouse brain sample 120 min after administration, showing fragment observed as protonated cation (<i>m</i>/<i>z</i> = 200) in MRM. (B) Quantitative analysis of brain and plasma levels at 30 and 120 min using LC-MS/MS detection. Data (<i>N</i> = 4) show mean and SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Quantitative analysis of Aβ<sub>1−37</sub>, Aβ<sub>1−38</sub>, Aβ<sub>1−40</sub>, and Aβ<sub>1−42</sub> in neuronal cell supernatant after drug treatment. For each individual experiment, peak heights from IP-MALDI-TOF spectra were normalized to the peak height of the Aβ<sub>1−43</sub> standard after incubation of drugs with N2a/APPsw cells. These normalized values were then expressed relative to the DMSO vehicle control in each set of experiments. See ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a> for full details. The data show mean and sem from at least four separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/medium/jm-2010-01450p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SALA activity was observed in mixtures of Aβ<sub>1−40</sub> + Aβ<sub>1−42</sub> treated with conditioned media (CM) from drug treated N2a/WT cells. Cells were treated with <b>1</b> (100 μM), <b>2</b> (1 μM), and <b>28</b> (10 μM) for 24 h before the collection of the CM. CM was added to a mixture of Aβ<sub>1−40</sub> + Aβ<sub>1−42</sub> and incubated for 8 h. CM from cell free wells (media) was used as the control. Aβ was quantified by IP-MALDI-TOF and normalized to “media” control. Data show mean and sd from two separate cell cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-7/jm101450p/production/images/large/jm-2010-01450p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101450p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">The disordered neuronal cytoskeleton in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=653-656&author=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=The+disordered+neuronal+cytoskeleton+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DThe%2520disordered%2520neuronal%2520cytoskeleton%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1992%26volume%3D2%26spage%3D653%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgIxayw_ixKaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+Abeta42+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520Abeta42%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Findeis, M. A.</span><span> </span><span class="NLM_article-title">The role of amyloid beta peptide 42 in Alzheimer’s disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.pharmthera.2007.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=17716740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSltLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=266-286&author=M.+A.+Findeis&title=The+role+of+amyloid+beta+peptide+42+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amyloid β peptide 42 in Alzheimer's disease</span></div><div class="casAuthors">Findeis, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">266-286</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  During the last 20 years, an expanding body of research has elucidated the central role of amyloid precursor protein (APP) processing and amyloid β peptide (Aβ) prodn. in the risk, onset, and progression of the neurodegenerative disorder Alzheimer's disease (AD), the most common form of dementia.  Ongoing research is establishing a greater level of detail for our understanding of the normal functions of APP, its proteolysis products, and the mechanisms by which this processing occurs.  The importance of this processing machinery in normal cellular function, such as Notch processing, has revealed specific concerns about targeting APP processing for therapeutic purposes.  Aspects of AD that are now well studied include direct and indirect genetic and other risk factors for AD, APP processing, and Aβ prodn.  Emerging from these studies is the particular importance of the long form of Aβ, Aβ42.  Elevated Aβ42 levels, as well as particularly the elevation of the ratio of Aβ42 to the shorter major form Aβ40, has been identified as important in early events in the pathogenesis of AD.  The specific pathol. importance of Aβ42 has drawn attention to seeking drugs that will selectively lower the levels of this peptide through reduced prodn. or increased clearance while allowing normal protein processing to remain substantially intact.  An increasing variety of compds. that modulate APP processing to reduce Aβ levels are being identified, some with Aβ42 selectivity.  Such compds. are now reaching clin. evaluation to det. how they may be of benefit in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxuc6RpBkbGrVg90H21EOLACvtfcHk0ljytOKOFMMtPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSltLjI&md5=89b760a8dfdc1691a7bfba2d2434fef5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DFindeis%26aufirst%3DM.%2BA.%26atitle%3DThe%2520role%2520of%2520amyloid%2520beta%2520peptide%252042%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D116%26spage%3D266%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Reinhard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid-beta precursor protein: integrating structure with biological function</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3996</span><span class="NLM_x">–</span> <span class="NLM_lpage">4006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=3996-4006&author=C.+Reinhardauthor=S.+S.+Hebertauthor=B.+De+Strooper&title=The+amyloid-beta+precursor+protein%3A+integrating+structure+with+biological+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinhard%26aufirst%3DC.%26aulast%3DHebert%26aufirst%3DS.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid-beta%2520precursor%2520protein%253A%2520integrating%2520structure%2520with%2520biological%2520function%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26spage%3D3996%26epage%3D4006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=440-449&author=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=T.+E.+Smithauthor=S.+Weggenauthor=P.+Dasauthor=D.+C.+McLendonauthor=V.+V.+Ozolsauthor=K.+W.+Jessingauthor=K.+H.+Zavitzauthor=E.+H.+Kooauthor=T.+E.+Golde&title=NSAIDs+and+enantiomers+of+flurbiprofen+target+gamma-secretase+and+lower+Abeta+42+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DMcLendon%26aufirst%3DD.%2BC.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DJessing%26aufirst%3DK.%2BW.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DNSAIDs%2520and%2520enantiomers%2520of%2520flurbiprofen%2520target%2520gamma-secretase%2520and%2520lower%2520Abeta%252042%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D440%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Narlawar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span> </span><span class="NLM_article-title">Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7588</span><span class="NLM_x">–</span> <span class="NLM_lpage">7591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7588-7591&author=R.+Narlawarauthor=B.+I.+Perez+Revueltaauthor=C.+Haassauthor=H.+Steinerauthor=B.+Schmidtauthor=K.+Baumann&title=Scaffold+of+the+cyclooxygenase-2+%28COX-2%29+inhibitor+carprofen+provides+Alzheimer+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0610200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610200%26sid%3Dliteratum%253Aachs%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DPerez%2BRevuelta%26aufirst%3DB.%2BI.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DK.%26atitle%3DScaffold%2520of%2520the%2520cyclooxygenase-2%2520%2528COX-2%2529%2520inhibitor%2520carprofen%2520provides%2520Alzheimer%2520gamma-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7588%26epage%3D7591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colavito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arrigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalle Carbonare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroc, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">1-(3′,4′-Dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer’s disease without causing peripheral toxicity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1124%2Fjpet.107.129007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=17895400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=822-830&author=B.+P.+Imbimboauthor=E.+Del+Giudiceauthor=D.+Colavitoauthor=A.+D%E2%80%99Arrigoauthor=M.+Dalle+Carbonareauthor=G.+Villettiauthor=F.+Facchinettiauthor=R.+Voltaauthor=V.+Pietriniauthor=M.+F.+Barocauthor=L.+Serneelsauthor=B.+De+Strooperauthor=A.+Leon&title=1-%283%E2%80%B2%2C4%E2%80%B2-Dichloro-2-fluoro%5B1%2C1%E2%80%B2-biphenyl%5D-4-yl%29-cyclopropanecarboxylic+acid+%28CHF5074%29%2C+a+novel+gamma-secretase+modulator%2C+reduces+brain+beta-amyloid+pathology+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease+without+causing+peripheral+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity</span></div><div class="casAuthors">Imbimbo, Bruno P.; Del Giudice, Elda; Colavito, Davide; D'Arrigo, Antonello; Dalle Carbonare, Maurizio; Villetti, Gino; Facchinetti, Fabrizio; Volta, Roberta; Pietrini, Vladimiro; Baroc, Maria F.; Serneels, Lutgarde; De Strooper, Bart; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Some nonsteroidal anti-inflammatory drugs has been shown to allosterically modulate the activity of γ-secretase, the enzymic complex responsible for the formation of β-amyloid (Aβ).  1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074) is a new γ-secretase modulator, devoid of anticyclooxygenase (COX) and Notch-interfering activities in vitro.  We evaluated the effects of chronic CHF5074 treatment on brain Aβ pathol. in Tg2576 transgenic mice.  Twenty-eight animals of 9.5 to 10.5 mo of age received CHF5074-medicated diet (375 ppm) or std. diet for 17 wk.  Compared with controls, CHF5074 treatment significantly reduced the area occupied by plaques and the no. of plaques in cortex (-52.2±5.6%, p = 0.0003 and -48.9±6.6%, p = 0.0004, resp.) and hippocampus (-76.7±6.4%, p = 0.004 and -66.2±10.3%, p = 0.037, resp.).  Biochem. anal. confirmed the histopathol. measures, with CHF5074-treated animals showing reduced total brain Aβ40 (-49.2±9.2%, p = 0.017) and Aβ42 (-43.5±9.7%, p = 0.027) levels.  In a human neuroglioma cell line expressing Swedish mutated form of amyloid precursor protein (H4swe), CHF5074 reduced Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, resp., values consistent with those measured in the brain of the CHF5074-treated Tg2576 mice (6.4±0.4 μM).  At 5 μM, no effects were obsd. on Notch intracellular cleavage in human embryonic kidney 293swe cells.  CHF5074 was well tolerated by Tg2576 mice.  No abnormal findings were obsd. upon histopathol. examn. of the gastrointestinal tract, indicating the absence of COX-related toxicity.  Semiquant. histochem. evaluation of goblet cells in the ileum of vehicle- and CHF5074-treated animals yielded similar results, suggesting no effects on Notch pathway.  CHF5074 is therefore a promising therapeutic agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0R1sOAuyJCrVg90H21EOLACvtfcHk0liXp1oPHuWPDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgsLvI&md5=6c20484e0d8f696858d459fdea0b9c1d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.129007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.129007%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DColavito%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DA.%26aulast%3DDalle%2BCarbonare%26aufirst%3DM.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DPietrini%26aufirst%3DV.%26aulast%3DBaroc%26aufirst%3DM.%2BF.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3D1-%25283%25E2%2580%25B2%252C4%25E2%2580%25B2-Dichloro-2-fluoro%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-yl%2529-cyclopropanecarboxylic%2520acid%2520%2528CHF5074%2529%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520reduces%2520brain%2520beta-amyloid%2520pathology%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520without%2520causing%2520peripheral%2520toxicity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D822%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peachey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jacques, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer’s disease modifying agent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2219</span><span class="NLM_x">–</span> <span class="NLM_lpage">2223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2219-2223&author=N.+Stockauthor=B.+Munozauthor=J.+D.+Wrigleyauthor=M.+S.+Shearmanauthor=D.+Beherauthor=J.+Peacheyauthor=T.+L.+Williamsonauthor=G.+Bainauthor=W.+Chenauthor=X.+Jiangauthor=R.+St-Jacquesauthor=P.+Prasit&title=The+geminal+dimethyl+analogue+of+Flurbiprofen+as+a+novel+Abeta42+inhibitor+and+potential+Alzheimer%E2%80%99s+disease+modifying+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DPeachey%26aufirst%3DJ.%26aulast%3DWilliamson%26aufirst%3DT.%2BL.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSt-Jacques%26aufirst%3DR.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DThe%2520geminal%2520dimethyl%2520analogue%2520of%2520Flurbiprofen%2520as%2520a%2520novel%2520Abeta42%2520inhibitor%2520and%2520potential%2520Alzheimer%25E2%2580%2599s%2520disease%2520modifying%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2219%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raveglia, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigogno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biscaioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catinella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzoni, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(−)(42) secretion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5705</span><span class="NLM_x">–</span> <span class="NLM_lpage">5720</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5705-5720&author=I.+Perettoauthor=S.+Radaelliauthor=C.+Pariniauthor=M.+Zandiauthor=L.+F.+Ravegliaauthor=G.+Dondioauthor=L.+Fontanellaauthor=P.+Misianoauthor=C.+Bigognoauthor=A.+Rizziauthor=B.+Riccardiauthor=M.+Biscaioliauthor=S.+Marchettiauthor=P.+Pucciniauthor=S.+Catinellaauthor=I.+Rondelliauthor=V.+Cenacchiauthor=P.+T.+Bolzoniauthor=P.+Carusoauthor=G.+Villettiauthor=F.+Facchinettiauthor=E.+Del+Giudiceauthor=N.+Morettoauthor=B.+P.+Imbimbo&title=Synthesis+and+biological+activity+of+flurbiprofen+analogues+as+selective+inhibitors+of+beta-amyloid%281%29%28%E2%88%92%29%2842%29+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DParini%26aufirst%3DC.%26aulast%3DZandi%26aufirst%3DM.%26aulast%3DRaveglia%26aufirst%3DL.%2BF.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DFontanella%26aufirst%3DL.%26aulast%3DMisiano%26aufirst%3DP.%26aulast%3DBigogno%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DBiscaioli%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DS.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DCatinella%26aufirst%3DS.%26aulast%3DRondelli%26aufirst%3DI.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DBolzoni%26aufirst%3DP.%2BT.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520flurbiprofen%2520analogues%2520as%2520selective%2520inhibitors%2520of%2520beta-amyloid%25281%2529%2528%25E2%2588%2592%2529%252842%2529%2520secretion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5705%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14586007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=9796-9804&author=M.+Sastreauthor=I.+Dewachterauthor=G.+E.+Landrethauthor=T.+M.+Willsonauthor=T.+Klockgetherauthor=F.+van+Leuvenauthor=M.+T.+Heneka&title=Nonsteroidal+anti-inflammatory+drugs+and+peroxisome+proliferator-activated+receptor-gamma+agonists+modulate+immunostimulated+processing+of+amyloid+precursor+protein+through+regulation+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase</span></div><div class="casAuthors">Sastre, Magdalena; Dewachter, Ilse; Landreth, Gary E.; Willson, Timothy M.; Klockgether, Thomas; van Leuven, Fred; Heneka, Michael T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk for Alzheimer's disease (AD).  To det. the mechanisms by which inflammation affects AD and how NSAIDs protect against it, we stimulated neuroblastoma cells stably transfected with amyloid precursor protein (APP) with proinflammatory cytokines, which increased the secretion of amyloid-β and APP ectodomain.  Addn. of ibuprofen, indomethacin, peroxisome proliferator-activated receptor-γ (PPARγ) agonists, or cotransfection with PPARγ cDNA reversed this effect.  The inhibitory action of ibuprofen and indomethacin was suppressed by PPARγ antagonists.  Finally, we obsd. that the mRNA levels, expression, and enzymic activity of β-secretase were increased by immunostimulation and normalized by NSAIDs.  In conclusion, proinflammatory cytokines activate β-secretase, and NSAIDs inhibit this effect through PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOe3IumnqzorVg90H21EOLACvtfcHk0lhXhO_HZ4SQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKis7w%253D&md5=b7e010a3cc3774b7f42444da3a49324a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3Dvan%2BLeuven%26aufirst%3DF.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520and%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520agonists%2520modulate%2520immunostimulated%2520processing%2520of%2520amyloid%2520precursor%2520protein%2520through%2520regulation%2520of%2520beta-secretase%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghgraef, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evert, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumitrescu-Ozimek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=443-448&author=M.+Sastreauthor=I.+Dewachterauthor=S.+Rossnerauthor=N.+Bogdanovicauthor=E.+Rosenauthor=P.+Borghgraefauthor=B.+O.+Evertauthor=L.+Dumitrescu-Ozimekauthor=D.+R.+Thalauthor=G.+Landrethauthor=J.+Walterauthor=T.+Klockgetherauthor=F.+van+Leuvenauthor=M.+T.+Heneka&title=Nonsteroidal+anti-inflammatory+drugs+repress+beta-secretase+gene+promoter+activity+by+the+activation+of+PPARgamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DE.%26aulast%3DBorghgraef%26aufirst%3DP.%26aulast%3DEvert%26aufirst%3DB.%2BO.%26aulast%3DDumitrescu-Ozimek%26aufirst%3DL.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3Dvan%2BLeuven%26aufirst%3DF.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520repress%2520beta-secretase%2520gene%2520promoter%2520activity%2520by%2520the%2520activation%2520of%2520PPARgamma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D2006%26volume%3D103%26spage%3D443%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-DeWhitt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfanova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1215-1217&author=Y.+Zhouauthor=Y.+Suauthor=B.+Liauthor=F.+Liuauthor=J.+W.+Ryderauthor=X.+Wuauthor=P.+A.+Gonzalez-DeWhittauthor=V.+Gelfanovaauthor=J.+E.+Haleauthor=P.+C.+Mayauthor=S.+M.+Paulauthor=B.+Ni&title=Nonsteroidal+anti-inflammatory+drugs+can+lower+amyloidogenic+Abeta42+by+inhibiting+Rho"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGonzalez-DeWhitt%26aufirst%3DP.%2BA.%26aulast%3DGelfanova%26aufirst%3DV.%26aulast%3DHale%26aufirst%3DJ.%2BE.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DNi%26aufirst%3DB.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520can%2520lower%2520amyloidogenic%2520Abeta42%2520by%2520inhibiting%2520Rho%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1215%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Miller, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekijima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1038%2Flabinvest.3700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14968122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=545-552&author=S.+R.+Millerauthor=Y.+Sekijimaauthor=J.+W.+Kelly&title=Native+state+stabilization+by+NSAIDs+inhibits+transthyretin+amyloidogenesis+from+the+most+common+familial+disease+variants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants</span></div><div class="casAuthors">Miller, Sean R.; Sekijima, Yoshiki; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-552</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transthyretin (TTR) tetramer dissocn. and misfolding affords a monomeric amyloidogenic intermediate that misassembles into aggregates including amyloid fibrils.  Amyloidogenesis of wild-type (WT) TTR causes senile systemic amyloidosis (SSA), whereas fibril formation from one of the more than 80 TTR variants leads to familial amyloidosis, typically with earlier onset than SSA.  Several nonsteroidal anti-inflammatory drugs (NSAIDs) stabilize the native tetramer, strongly inhibiting TTR amyloid fibril formation in vitro.  Structure-based designed NSAID analogs are even more potent amyloid inhibitors.  The effectiveness of several NSAIDs, including diclofenac, diflunisal, and flufenamic acid, as well as the diclofenac analog, 2-[(3,5-dichlorophenyl) amino] benzoic acid (inhibitor 1), has been demonstrated against WT TTR amyloidogenesis.  Herein, the efficacy of these compds. at preventing acid-induced fibril formation and urea-induced tetramer dissocn. of the most common disease-assocd. TTR variants (V30M, V122I, T60A, L58H, and I84S) was evaluated.  Homotetramers of these variants were employed for the studies within, realizing that the tetramers in compd. heterozygote patients are normally composed of a mixt. of WT and variant subunits.  The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmLSOJy5npbLVg90H21EOLACvtfcHk0lhXhO_HZ4SQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtF2isb8%253D&md5=d219c5af68d3a6e65f033b88e5b23201</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3700059%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BR.%26aulast%3DSekijima%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DNative%2520state%2520stabilization%2520by%2520NSAIDs%2520inhibits%2520transthyretin%2520amyloidogenesis%2520from%2520the%2520most%2520common%2520familial%2520disease%2520variants%26jtitle%3DLab.%2520Invest.%26date%3D2004%26volume%3D84%26spage%3D545%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edirisinghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1471-4159.2009.06355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19702658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=683-695&author=S.+O.+Abdul-Hayauthor=P.+Edirisingheauthor=G.+R.+Thatcher&title=Selective+modulation+of+amyloid-beta+peptide+degradation+by+flurbiprofen%2C+fenofibrate%2C+and+related+compounds+regulates+Abeta+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels</span></div><div class="casAuthors">Abdul-Hay, Samer O.; Edirisinghe, Praneeth; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">683-695</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gamma-secretase modulators (GSMs) include selected non-steroidal anti-inflammatory drugs such as flurbiprofen that selectively lowers the neurotoxic amyloid-β peptide Aβ1-42.  GSMs are attractive targets for Alzheimer's disease, in contrast to 'inverse GSMs,' such as fenofibrate, which selectively increase the level of Aβ1-42.  A methodol. for screening of Aβ modulating drugs was developed utilizing an Aβ-producing neuroblastoma cell line stably transfected with mutant human amyloid precursor protein, immunopptn. of Aβ peptides, and mass spectroscopic quantitation of Aβ1-37/Aβ1-38/Aβ1-40/Aβ1-42 using an Aβ internal std.  The unexpected conclusion of this work was that in this system, drug effects are independent of γ-secretase.  The methodol. recapitulated reported results for modulation of Aβ by GSMs.  However, control expts. in which exogenous Aβ1-40/Aβ1-42 was added (i) to drug-treated wild-type cells or (ii) to conditioned media from these wild-type cells, gave comparable patterns of Aβ modulation.  These results, suggesting that drugs modulate the ability of cell-derived factors to degrade Aβ, was interrogated by adding protease inhibitors and performing mol. wt. cut-off fractionation.  The results confirmed that modulation of Aβ1-40/Aβ1-42 was mediated by selective proteolysis.  Treatment of N2a cells with flurbiprofen or fenofibric acid selectively enhanced Aβ1-42 clearance by extracellular proteolysis; treatment with HCT-1026 or fenofibrate (esters of flurbiprofen and fenobric acid) inhibited clearance of Aβ1-40 and Aβ1-42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVSboU5xjr9LVg90H21EOLACvtfcHk0ljwVPQzd0gLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfN&md5=57d300269647eb3336290c27f7b7b574</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06355.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DEdirisinghe%26aufirst%3DP.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DSelective%2520modulation%2520of%2520amyloid-beta%2520peptide%2520degradation%2520by%2520flurbiprofen%252C%2520fenofibrate%252C%2520and%2520related%2520compounds%2520regulates%2520Abeta%2520levels%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D683%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1152%2Fphysrev.00023.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20393191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=465-494&author=B.+De+Strooper&title=Proteases+and+proteolysis+in+Alzheimer+disease%3A+a+multifactorial+view+on+the+disease+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-494</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is characterized by the accumulation of abnormally folded protein fragments, i.e., amyloid beta peptide (Aβ) and tau that ppt. in amyloid plaques and neuronal tangles, resp.  In this review we discuss the complicated proteolytic pathways that are responsible for the generation and clearance of these fragments, and how disturbances in these pathways interact and provide a background for a novel understanding of Alzheimer disease as a multifactorial disorder.  Recent insights evolve from the static view that the morphol. defined plaques and tangles are disease driving towards a more dynamic, biochem. view in which the intermediary sol. Aβ oligomers and sol. tau fragments are considered as the main mediators of neurotoxicity.  The relevance of proteolytic pathways, centered on the generation and clearance of toxic Aβ, on the cleavage and nucleation of tau, and on the general proteostasis of the neurons, then becomes obvious.  Blocking or stimulating these pathways provide, or have the potential to provide, interesting drug targets, which raises the hope that we will be able to provide a cure for this dreadful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrstXCXtuTzCrVg90H21EOLACvtfcHk0ljwVPQzd0gLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF&md5=be45257bc56a5779b6ef7e18e98b0738</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DProteases%2520and%2520proteolysis%2520in%2520Alzheimer%2520disease%253A%2520a%2520multifactorial%2520view%2520on%2520the%2520disease%2520process%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D465%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chow, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleichmann, M.</span><span> </span><span class="NLM_article-title">An overview of APP processing enzymes and products</span> <span class="citation_source-journal">Neuromol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1007%2Fs12017-009-8104-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20232515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislyktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1-12&author=V.+W.+Chowauthor=M.+P.+Mattsonauthor=P.+C.+Wongauthor=M.+Gleichmann&title=An+overview+of+APP+processing+enzymes+and+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of APP Processing Enzymes and Products</span></div><div class="casAuthors">Chow, Vivian W.; Mattson, Mark P.; Wong, Philip C.; Gleichmann, Marc</div><div class="citationInfo"><span class="NLM_cas:title">NeuroMolecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">NMEEAN</span>;
        ISSN:<span class="NLM_cas:issn">1535-1084</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The generation of amyloid β-peptide (Aβ) by enzymic cleavages of the β-amyloid precursor protein (APP) has been at the center of Alzheimer's disease (AD) research.  While the basic process of β- and γ-secretase-mediated generation of Aβ is text book knowledge, new aspects of Aβ and other cleavage products have emerged in recent years.  Also our understanding of the enzymes involved in APP proteolysis has increased dramatically.  All of these discoveries contribute to a more complete understanding of APP processing and the physiol. and pathol. roles of its secreted and intracellular protein products.  Understanding APP processing is important for any therapeutic strategy aimed at reducing Aβ levels in AD.  In this review, we provide a concise description of the current state of understanding the enzymes involved in APP processing, the cleavage products generated by different processing patterns, and the potential functions of those cleavage products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlnCFJkMuULVg90H21EOLACvtfcHk0ljwVPQzd0gLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislyktrs%253D&md5=2df203edd1ac0e3073498753067a75a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs12017-009-8104-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12017-009-8104-z%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DV.%2BW.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DGleichmann%26aufirst%3DM.%26atitle%3DAn%2520overview%2520of%2520APP%2520processing%2520enzymes%2520and%2520products%26jtitle%3DNeuromol.%2520Med.%26date%3D2010%26volume%3D12%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rich, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmusson, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1995&pages=51-55&author=J.+B.+Richauthor=D.+X.+Rasmussonauthor=M.+F.+Folsteinauthor=K.+A.+Carsonauthor=C.+Kawasauthor=J.+Brandt&title=Nonsteroidal+anti-inflammatory+drugs+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DJ.%2BB.%26aulast%3DRasmusson%26aufirst%3DD.%2BX.%26aulast%3DFolstein%26aufirst%3DM.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BA.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3DBrandt%26aufirst%3DJ.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1995%26volume%3D45%26spage%3D51%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stewart, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metter, E. J.</span><span> </span><span class="NLM_article-title">Risk of Alzheimer’s disease and duration of NSAID use</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1997&pages=626-632&author=W.+F.+Stewartauthor=C.+Kawasauthor=M.+Corradaauthor=E.+J.+Metter&title=Risk+of+Alzheimer%E2%80%99s+disease+and+duration+of+NSAID+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DW.%2BF.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3DCorrada%26aufirst%3DM.%26aulast%3DMetter%26aufirst%3DE.%2BJ.%26atitle%3DRisk%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520duration%2520of%2520NSAID%2520use%26jtitle%3DNeurology%26date%3D1997%26volume%3D48%26spage%3D626%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">in t’ Veld, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stijnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breteler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, B. H.</span><span> </span><span class="NLM_article-title">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1056%2FNEJMoa010178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=11794217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2001&pages=1515-1521&author=B.+A.+in+t%E2%80%99+Veldauthor=A.+Ruitenbergauthor=A.+Hofmanauthor=L.+J.+Launerauthor=C.+M.+van+Duijnauthor=T.+Stijnenauthor=M.+M.+Bretelerauthor=B.+H.+Stricker&title=Nonsteroidal+antiinflammatory+drugs+and+the+risk+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease</span></div><div class="casAuthors">In't Veld, Bas A.; Ruitenberg, Annemieke; Hofman, Albert; Launer, Lenore J.; van Duijn, Cornelia M.; Stijnen, Theo; Bretteler, Monique M. B.; Stricker, Bruno H. C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1515-1521</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease.  The results, however, have been inconsistent.  Methods: We studied the assocn. between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 yr of age or older who were free of dementia at base line.  The risk of Alzheimer's disease was estd. in relation to the use of NSAIDs as documented in pharmacy records.  We defined four mutually exclusive categories of use: non-use, short-term use (1 mo or less of cumulative use), intermediate-term use (more than 1 but less than 24 mo of cumulative use), and long-term use (24 mo or more of cumulative use).  Adjustments were made by Cox regression anal. for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H2-receptor antagonists, antihypertensive agents, and hypoglycemic agents.  Results: During an av. follow-up period of 6.8 yr, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia.  The relative risk of Alzheimer's disease was 0.95 (95% confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95% confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95% confidence interval, 0.05 to 0.83) in those with long-term use.  The risk did not vary according to age.  The use of NSAIDs was not assocd. with a redn. in the risk of vascular dementia.  Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Ao_Olp-rxrVg90H21EOLACvtfcHk0ljYZyUMyYjBLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D&md5=d9c721051ba69eb547622be825531202</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa010178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa010178%26sid%3Dliteratum%253Aachs%26aulast%3Din%2Bt%25E2%2580%2599%2BVeld%26aufirst%3DB.%2BA.%26aulast%3DRuitenberg%26aufirst%3DA.%26aulast%3DHofman%26aufirst%3DA.%26aulast%3DLauner%26aufirst%3DL.%2BJ.%26aulast%3Dvan%2BDuijn%26aufirst%3DC.%2BM.%26aulast%3DStijnen%26aufirst%3DT.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%26aulast%3DStricker%26aufirst%3DB.%2BH.%26atitle%3DNonsteroidal%2520antiinflammatory%2520drugs%2520and%2520the%2520risk%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D345%26spage%3D1515%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wilcock, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swabb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, M. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of tarenflurbil in mild to moderate Alzheimer’s disease: a randomised phase II trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2FS1474-4422%2808%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=18450517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlSjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=483-493&author=G.+K.+Wilcockauthor=S.+E.+Blackauthor=S.+B.+Hendrixauthor=K.+H.+Zavitzauthor=E.+A.+Swabbauthor=M.+A.+Laughlin&title=Efficacy+and+safety+of+tarenflurbil+in+mild+to+moderate+Alzheimer%E2%80%99s+disease%3A+a+randomised+phase+II+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomized phase II trial</span></div><div class="casAuthors">Wilcock, Gordon K.; Black, Sandra E.; Hendrix, Suzanne B.; Zavitz, Kenton H.; Swabb, Edward A.; Laughlin, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">483-493</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The amyloid-β peptide Aβ42 has been implicated in the pathogenesis of Alzheimer's disease (AD).  We aimed to test the effects of tarenflurbil, a selective Aβ42-lowering agent (SALA), on cognition and function in patients with mild to moderate AD.  210 patients living in the community who had a mini-mental state examn. (MMSE) score of 15-26 were randomly assigned to receive tarenflurbil twice per day (400 mg [n=69] or 800 mg [n=70]) or placebo (n=71) for 12 mo in a phase II, multicentre, double-blind study.  Primary efficacy outcomes were the AD assessment scale cognitive subscale (ADAS-cog), the Alzheimer's Disease Cooperative Study activities of daily living scale (ADCS-ADL), and the clin. dementia rating sum of boxes (CDR-sb).  In a 12-mo extended treatment phase, patients who had received tarenflurbil continued to receive the same dose, and patients who had received placebo were randomly assigned to tarenflurbil at 800 mg or 400 mg twice per day.  Primary efficacy analyses were done by intention to treat.  This trial is registered with Health Canada (084527) and the Medicines and Healthcare products Regulatory Agency in the UK (20365/0001/A 69316).  A prespecified interaction anal. revealed that patients with mild AD (baseline MMSE 20-26) and moderate AD (baseline MMSE 15-19) responded differently to tarenflurbil in the ADAS-cog and the ADCS-ADL (p≤0.10); therefore, these groups were analyzed sep.  Patients with mild AD in the 800 mg tarenflurbil group had lower rates of decline than did those in the placebo group in activities of daily living (ADCS-ADL difference in slope 3.98 [95% CI 0.33 to 7.62] points per yr, effect size [redn. from placebo decline rate] 46.4%, Cohen's d 0.45; p=0.033) and global function (CDR-sb difference -0.80 [-1.57 to -0.03] points per yr, effect size 35.7%, Cohen's d 0.42; p=0.042); slowing of cognitive decline did not differ significantly (ADAS-cog difference -1.36 [-4.07 to 1.36] points per yr, effect size 33.7%, Cohen's d 0.20; p=0.327).  In patients with moderate AD, 800 mg tarenflurbil twice per day had no significant effects on ADCS-ADL and ADAS-cog and had a neg. effect on CDR-sb (-52%, Cohen's d -1.08; p=0.003).  The most common adverse events were diarrhea (in seven, nine, and five patients in the 800 mg, 400 mg, and placebo groups, resp.), nausea (in seven, seven, and four patients), and dizziness (in five, nine, and four patients).  Patients with mild AD who were in the 800 mg tarenflurbil group for 24 mo had lower rates of decline for all three primary outcomes than did patients who were in the placebo group for months 0-12 and a tarenflurbil group for months 12-24 (all p<0.001), and had better outcomes than did patients who were in the placebo group for months 0-12 and the 800 mg tarenflurbil group for months 12-24 (all p<0.05).  800 mg tarenflurbil twice per day was well tolerated for up to 24 mo of treatment, with evidence of a dose-related effect on measures of daily activities and global function in patients with mild AD.  Funding: Myriad Pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZrgbwtQWpU7Vg90H21EOLACvtfcHk0ljYZyUMyYjBLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlSjtL8%253D&md5=9006d4e44b3134ba2b2bea39c6c4d09a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2808%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252808%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DWilcock%26aufirst%3DG.%2BK.%26aulast%3DBlack%26aufirst%3DS.%2BE.%26aulast%3DHendrix%26aufirst%3DS.%2BB.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DLaughlin%26aufirst%3DM.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520tarenflurbil%2520in%2520mild%2520to%2520moderate%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520randomised%2520phase%2520II%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2008%26volume%3D7%26spage%3D483%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Marder, K.</span><span> </span><span class="NLM_article-title">Tarenflurbil in patients with mild Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1007%2Fs11910-010-0130-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20571933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A280%3ADC%252BC3cnnvVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=336-337&author=K.+Marder&title=Tarenflurbil+in+patients+with+mild+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tarenflurbil in patients with mild Alzheimer's disease</span></div><div class="casAuthors">Marder Karen</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">336-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgW4uTixYl1z69zv1FsJFMfW6udTcc2eZXr2TTJ-XZRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnnvVOhsQ%253D%253D&md5=608f7af70d41fed0332407a6184773ff</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11910-010-0130-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-010-0130-6%26sid%3Dliteratum%253Aachs%26aulast%3DMarder%26aufirst%3DK.%26atitle%3DTarenflurbil%2520in%2520patients%2520with%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2010%26volume%3D10%26spage%3D336%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivilia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gusciglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arrigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calza, L.</span><span> </span><span class="NLM_article-title">CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=20164581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksV2msL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=159-173&author=B.+P.+Imbimboauthor=L.+Giardinoauthor=S.+Siviliaauthor=A.+Giulianiauthor=M.+Gusciglioauthor=V.+Pietriniauthor=E.+Del+Giudiceauthor=A.+D%E2%80%99Arrigoauthor=A.+Leonauthor=G.+Villettiauthor=L.+Calza&title=CHF5074%2C+a+novel+gamma-secretase+modulator%2C+restores+hippocampal+neurogenesis+potential+and+reverses+contextual+memory+deficit+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">CHF5074, a Novel γ-Secretase Modulator, Restores Hippocampal Neurogenesis Potential and Reverses Contextual Memory Deficit in a Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Imbimbo, Bruno P.; Giardino, Luciana; Sivilia, Sandra; Giuliani, Alessandro; Gusciglio, Marco; Pietrini, Vladimiro; Del Giudice, Elda; D'Arrigo, Antonello; Leon, Alberta; Villetti, Gino; Calza, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The effects of compds. interfering with γ-secretase, the enzymic complex responsible of the formation of the amyloid-β (Aβ) peptide from amyloid-β protein precursor (AβPP), on plaque deposition in transgenic mouse models of Alzheimer's disease are known but scanty data are available on the effects of these drugs on brain plasticity.  We evaluated the effects of long-term treatment with CHF5074, a new γ-secretase modulator, on hippocampal neurogenesis, cortical synaptophysin levels, and contextual memory in transgenic mice carrying the double Swedish mutation of AβPP (Tg2576).  Six-month old Tg2576 mice were treated with CHF5074 (375 ppm in the diet) up to 15 mo of age.  Age-matched control transgenic and wild-type mice received std. diet.  Compared to wild-type animals, transgenic controls showed a significant decrease in the no. of doublecortin-pos. neuroblasts in dentate gyrus, synaptophysin intensity in the cortex, freezing to context in the contextual fear conditioning test.  Compared to transgenic controls, CHF5074 treatment of Tg2576 mice resulted in a significant attenuation of the neurogenesis impairment in hippocampus (p = 0.036), normalization of synaptophysin levels in cortex (p < 0.001), attenuation of plaque burden in the cortex (p = 0.033), increases astroglial reaction around plaques (p = 0.001), and attenuation of activated microglia (p = 0.040).  These effects were assocd. to a complete reversal of contextual memory deficit (p = 0.006).  Contextual memory significantly correlated with synaptophysin immunoreactivity in the cortex (r = 0.548, p = 0.0038).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRiJ8sF7Dma7Vg90H21EOLACvtfcHk0ljMg7rURtuYaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksV2msL0%253D&md5=4b2951020a64f23915ed492812335bfc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DGiardino%26aufirst%3DL.%26aulast%3DSivilia%26aufirst%3DS.%26aulast%3DGiuliani%26aufirst%3DA.%26aulast%3DGusciglio%26aufirst%3DM.%26aulast%3DPietrini%26aufirst%3DV.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DA.%26aulast%3DLeon%26aufirst%3DA.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DCalza%26aufirst%3DL.%26atitle%3DCHF5074%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520restores%2520hippocampal%2520neurogenesis%2520potential%2520and%2520reverses%2520contextual%2520memory%2520deficit%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D159%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">MacNaughton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span> </span><span class="NLM_article-title">Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1869</span><span class="NLM_x">–</span> <span class="NLM_lpage">1876</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=1869-1876&author=W.+K.+MacNaughtonauthor=G.+Cirinoauthor=J.+L.+Wallace&title=Endothelium-derived+relaxing+factor+%28nitric+oxide%29+has+protective+actions+in+the+stomach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacNaughton%26aufirst%3DW.%2BK.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26atitle%3DEndothelium-derived%2520relaxing%2520factor%2520%2528nitric%2520oxide%2529%2520has%2520protective%2520actions%2520in%2520the%2520stomach%26jtitle%3DLife%2520Sci.%26date%3D1989%26volume%3D45%26spage%3D1869%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chiroli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Soldato, P.</span><span> </span><span class="NLM_article-title">Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=441-446&author=V.+Chiroliauthor=F.+Benediniauthor=E.+Onginiauthor=P.+Del+Soldato&title=Nitric+oxide-donating+non-steroidal+anti-inflammatory+drugs%3A+the+case+of+nitroderivatives+of+aspirin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiroli%26aufirst%3DV.%26aulast%3DBenedini%26aufirst%3DF.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DDel%2BSoldato%26aufirst%3DP.%26atitle%3DNitric%2520oxide-donating%2520non-steroidal%2520anti-inflammatory%2520drugs%253A%2520the%2520case%2520of%2520nitroderivatives%2520of%2520aspirin%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">van Groen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadish, I.</span><span> </span><span class="NLM_article-title">Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology</span> <span class="citation_source-journal">Brain Res. Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=370-378&author=T.+van+Groenauthor=I.+Kadish&title=Transgenic+AD+model+mice%2C+effects+of+potential+anti-AD+treatments+on+inflammation+and+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGroen%26aufirst%3DT.%26aulast%3DKadish%26aufirst%3DI.%26atitle%3DTransgenic%2520AD%2520model%2520mice%252C%2520effects%2520of%2520potential%2520anti-AD%2520treatments%2520on%2520inflammation%2520and%2520pathology%26jtitle%3DBrain%2520Res.%2520Brain%2520Res.%2520Rev.%26date%3D2005%26volume%3D48%26spage%3D370%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashghodom, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1471-4159.2009.06353.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19702655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=766-776&author=S.+O.+Abdul-Hayauthor=J.+Luoauthor=R.+T.+Ashghodomauthor=G.+R.+Thatcher&title=NO-flurbiprofen+reduces+amyloid-beta%2C+is+neuroprotective+in+cell+culture%2C+and+enhances+cognition+in+response+to+cholinergic+blockade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">NO-flurbiprofen reduces amyloid-β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade</span></div><div class="casAuthors">Abdul-Hay, Samer O.; Luo, Jia; Ashghodom, Rezene T.; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">766-776</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The non-steroidal anti-inflammatory drug flurbiprofen is a selective amyloid lowering agent which has been studied clin. in Alzheimer's disease.  HCT-1026 is an ester prodrug of flurbiprofen incorporating a nitrate carrier moiety that in vivo provides NO bioactivity and an improved safety profile.  In vitro, HCT-1026 retained the cyclooxygenase inhibitory and non-steroidal anti-inflammatory drug activity of flurbiprofen, but at concns. at which levels of amyloid-β 1-42 amino acid were lowered by flurbiprofen, amyloid-β 1-42 amino acid levels were elevated 200% by HCT-1026.  Conversely, at lower concns., HCT-1026 behaved as a selective amyloid lowering agent with greater potency than flurbiprofen.  The difference in concn.-responses between flurbiprofen and HCT-1026 in vitro suggests different cellular targets; and in no case did a combination of nitrate drug with flurbiprofen provide similar actions.  In vivo, HCT-1026 was obsd. to reverse cognitive deficits induced by scopolamine in two behavioral assays; activity that was also shown by a classical nitrate drug, but not by flurbiprofen.  The ability to restore aversive memory and spatial working and ref. memory after cholinergic blockade has been demonstrated by other agents that stimulate NO/cGMP signaling.  These observations add pos. to the preclin. profile of HCT-1026 and NO chimeras in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxahYhFj2InbVg90H21EOLACvtfcHk0lhDUyjwO__5ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOqtLfF&md5=1309f39839e328cc6ce8971d4a25d54b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06353.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06353.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DAshghodom%26aufirst%3DR.%2BT.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DNO-flurbiprofen%2520reduces%2520amyloid-beta%252C%2520is%2520neuroprotective%2520in%2520cell%2520culture%252C%2520and%2520enhances%2520cognition%2520in%2520response%2520to%2520cholinergic%2520blockade%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Prosperi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casamenti, F.</span><span> </span><span class="NLM_article-title">Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1−42)-induced brain inflammation and neuronal damage in the rat</span> <span class="citation_source-journal">Int. J. Immunopathol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=15461866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCqu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=317-330&author=C.+Prosperiauthor=C.+Scaliauthor=M.+Barbaauthor=A.+Bellucciauthor=M.+G.+Giovanniniauthor=G.+Pepeuauthor=F.+Casamenti&title=Comparison+between+flurbiprofen+and+its+nitric+oxide-releasing+derivatives+HCT-1026+and+NCX-2216+on+Abeta%281%E2%88%9242%29-induced+brain+inflammation+and+neuronal+damage+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Aβ(1-42)-induced brain inflammation and neuronal damage in the rat</span></div><div class="casAuthors">Prosperi, C.; Scali, C.; Barba, M.; Bellucci, A.; Giovannini, M. G.; Pepeu, G.; Casamenti, F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopathology and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">IJIPE4</span>;
        ISSN:<span class="NLM_cas:issn">0394-6320</span>.
    
            (<span class="NLM_cas:orgname">Biolife s.a.s.</span>)
        </div><div class="casAbstract">Brain inflammation is an underlying factor in the pathogenesis of Alzheimer's disease (AD) and epidemiol. studies indicate that a sustained use of non-steroidal anti-inflammatory drugs (NSAIDs) has a protective effect on the disease.  We investigated, in vivo, whether differences exist in the antiinflammatory and neuroprotective actions of flurbiprofen and its two nitric oxide-donor derivs., HCT-1026 and NCX-2216, and the ability of these two derivs. to release nitric oxide in the brain.  In adult rats injected into the nucleus basalis with preaggregated Aβ(1-42) we investigated by immunohistochem. methods glia reaction, the induction of inducible nitric oxide synthase (iNOS), the activation of p38 mitogen-activated protein kinase (p38MAPK) pathway and the no. of choline acetyltransferase (ChAT)-pos. neurons and, in nave rats we investigated, by microdialysis, cortical extracellular levels of nitrite.  Injection of Aβ(1-42) induced iNOS at the injection site, activated p38MAPK 7 days after injection and brought about an intense microglia and astrocyte reaction along with a marked redn. in the no. of ChAT-pos. neurons, persisting up to at least up to 21 days.  Flurbiprofen, HCT-1026 and NCX-2216 (15 mg/kg) significantly attenuated the Aβ(1-42)-induced glia reaction, iNOS induction and p38MAPK activation 7 days after treatment and astrocytes reaction 21 days after treatment.  On an equimolar basis, HCT-1026 resulted the most active agent in reducing the Aβ(1-42)-induced microglia reaction.  The cholinergic cell loss was also significantly reduced by 21 days of HCT-1026 treatment.  No differences in the body wt. were found between the animals treated for 21 days with 15 mg/kg of either HCT-1026 or NCX-2216 and the controls.  An oral administration of HCT-1026 (15 mg/kg) or NCX-2216 (100 mg/kg) to naiive rats was followed by significant and long long-lasting increases in cortical nitrite levels.  These findings indicate that the addn. of a nitric oxide donor potentiates the anti-inflammatory activity of flurbiprofen in a model of brain inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1R9At6KF8DbVg90H21EOLACvtfcHk0lhDUyjwO__5ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCqu7fF&md5=d1b996e7e664e0605ab0862cdbdb1bc5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProsperi%26aufirst%3DC.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DBarba%26aufirst%3DM.%26aulast%3DBellucci%26aufirst%3DA.%26aulast%3DGiovannini%26aufirst%3DM.%2BG.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DCasamenti%26aufirst%3DF.%26atitle%3DComparison%2520between%2520flurbiprofen%2520and%2520its%2520nitric%2520oxide-releasing%2520derivatives%2520HCT-1026%2520and%2520NCX-2216%2520on%2520Abeta%25281%25E2%2588%259242%2529-induced%2520brain%2520inflammation%2520and%2520neuronal%2520damage%2520in%2520the%2520rat%26jtitle%3DInt.%2520J.%2520Immunopathol.%2520Pharmacol.%26date%3D2004%26volume%3D17%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1−42 lowering agents</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.phrs.2006.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=17292621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=318-328&author=B.+P.+Imbimboauthor=E.+Del+Giudiceauthor=V.+Cenacchiauthor=R.+Voltaauthor=G.+Villettiauthor=F.+Facchinettiauthor=B.+Riccardiauthor=P.+Pucciniauthor=N.+Morettoauthor=F.+Grassiauthor=S.+Ottonelloauthor=A.+Leon&title=In+vitro+and+in+vivo+profiling+of+CHF5022+and+CHF5074+Two+beta-amyloid1%E2%88%9242+lowering+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo profiling of CHF5022 and CHF5074: Two β-amyloid1-42 lowering agents</span></div><div class="casAuthors">Imbimbo, Bruno P.; Del Giudice, Elda; Cenacchi, Valentina; Volta, Roberta; Villetti, Gino; Facchinetti, Fabrizio; Riccardi, Benedetta; Puccini, Paola; Moretto, Nadia; Grassi, Francesca; Ottonello, Simone; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may delay or prevent the onset of Alzheimer's disease (AD).  A subset of NSAIDs, including flurbiprofen, has been shown to selectively inhibit the prodn. of β-amyloid1-42 (Aβ42), independently from their cyclooxygenase (COX) inhibiting activity.  We evaluated the in vitro and in vivo profiles of CHF5022 and CHF5074, two flurbiprofen analogs.  The in vitro Aβ inhibiting activity was evaluated in a human neuroglioma cell line (H4) carrying the double Swedish mutation (K595N/M596L) of the human amyloid precursor protein (APPsw).  The in vitro anti-COX activity was evaluated using human recombinant enzymes isolated from transfected Sf-9 cells.  The in vivo pharmacokinetic and pharmacodynamic profiles of the two compds. were evaluated in young APPsw transgenic mice (Tg2576) after oral gavage (100 or 300 mg kg-1 day-1 for 4-5 days) and after medicated diet (375 ppm for 4 wk).  R-Flurbiprofen was used as comparator.  In vitro, CHF5022 and CHF5074 were found to be 3- and 7-fold more potent than R-flurbiprofen in inhibiting Aβ42 secretion (IC50s of 92, 40 and 268 μM, resp.).  Differently from R-flurbiprofen, CHF5022 and CHF5074 did not affect COX-1 (at 100 μM) and COX-2 (at 300 μM) activity.  Similarly to R-flurbiprofen, no significant alteration in the expression profile of a subset of Notch intracellular domain-responsive genes was obsd. with either CHF5022 or CHF5074.  In Tg2576 mice, CHF5022 was well tolerated when administered by oral gavage (100 mg kg-1 day-1 for 5 days) or by medicated diet (56 mg kg-1 day-1 for 4 wk).  R-Flurbiprofen was poorly tolerated in the diet (32 mg kg-1 day-1) with 55% of the animals dying during the first week of treatment.  After 4-5 days of oral gavage, CHF5022 and CHF5074 plasma and brain levels at 3 h were found to increase with the dose, leading to brain concns. of about 10% and 5% of the corresponding plasma concns., resp.  In animals fed for 4 wk with compd.-supplemented diet, mean plasma (580 μM) and brain (20 μ[n.1052]) concns. of CHF5022 were 8 and 15 times higher than those of R-flurbiprofen.  Plasma Aβ42 concn. was dose-dependently decreased by CHF5022 and CHF5074.  Brain Aβ levels (formic acid-extractable) were not significantly affected by either compd., although Aβ42 levels tended to inversely correlate (P = 0.105) with CHF5022 concn. in the brain.  CHF5022 and CHF5074 thus appear to have a promising in vitro and in vivo profile.  This warrants further evaluation of their long-term effects on Aβ brain pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqOFdo5MZ1r7Vg90H21EOLACvtfcHk0liifxUrVzZq0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGnsbY%253D&md5=dbcb906a0f3ed14249a65783b3718a70</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2006.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2006.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DGrassi%26aufirst%3DF.%26aulast%3DOttonello%26aufirst%3DS.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520profiling%2520of%2520CHF5022%2520and%2520CHF5074%2520Two%2520beta-amyloid1%25E2%2588%259242%2520lowering%2520agents%26jtitle%3DPharmacol.%2520Res.%26date%3D2007%26volume%3D55%26spage%3D318%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hagos, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdul-Hay, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edirisinghe, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Anti-inflammatory, antiproliferative, and cytoprotective activity of NO chimera nitrates of use in cancer chemoprevention</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1381-1391&author=G.+K.+Hagosauthor=S.+O.+Abdul-Hayauthor=J.+Sohnauthor=P.+D.+Edirisingheauthor=R.+E.+Chandrasenaauthor=Z.+Wangauthor=Q.+Liauthor=G.+R.+J.+Thatcher&title=Anti-inflammatory%2C+antiproliferative%2C+and+cytoprotective+activity+of+NO+chimera+nitrates+of+use+in+cancer+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHagos%26aufirst%3DG.%2BK.%26aulast%3DAbdul-Hay%26aufirst%3DS.%2BO.%26aulast%3DSohn%26aufirst%3DJ.%26aulast%3DEdirisinghe%26aufirst%3DP.%2BD.%26aulast%3DChandrasena%26aufirst%3DR.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DAnti-inflammatory%252C%2520antiproliferative%252C%2520and%2520cytoprotective%2520activity%2520of%2520NO%2520chimera%2520nitrates%2520of%2520use%2520in%2520cancer%2520chemoprevention%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1381%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hinz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahl, A.</span><span> </span><span class="NLM_article-title">Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=151-156&author=B.+Hinzauthor=K.+Bruneauthor=T.+Rauauthor=A.+Pahl&title=Flurbiprofen+enantiomers+inhibit+inducible+nitric+oxide+synthase+expression+in+RAW+264.7+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinz%26aufirst%3DB.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DRau%26aufirst%3DT.%26aulast%3DPahl%26aufirst%3DA.%26atitle%3DFlurbiprofen%2520enantiomers%2520inhibit%2520inducible%2520nitric%2520oxide%2520synthase%2520expression%2520in%2520RAW%2520264.7%2520macrophages%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26spage%3D151%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tegeder, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guhring, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euchenhofer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span> </span><span class="NLM_article-title">Inhibition of NF-kappaB and AP-1 activation by <i>R</i>- and <i>S</i>-flurbiprofen</span> <span class="citation_source-journal">FASEB J</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=2-4&author=I.+Tegederauthor=E.+Niederbergerauthor=E.+Israrauthor=H.+Guhringauthor=K.+Bruneauthor=C.+Euchenhoferauthor=S.+Groschauthor=G.+Geisslinger&title=Inhibition+of+NF-kappaB+and+AP-1+activation+by+R-+and+S-flurbiprofen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTegeder%26aufirst%3DI.%26aulast%3DNiederberger%26aufirst%3DE.%26aulast%3DIsrar%26aufirst%3DE.%26aulast%3DGuhring%26aufirst%3DH.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DEuchenhofer%26aufirst%3DC.%26aulast%3DGrosch%26aufirst%3DS.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520NF-kappaB%2520and%2520AP-1%2520activation%2520by%2520R-%2520and%2520S-flurbiprofen%26jtitle%3DFASEB%2520J%26date%3D2001%26volume%3D15%26spage%3D2%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolescu, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, V.</span><span> </span><span class="NLM_article-title">Nitrates and NO release: contemporary aspects in biological and medicinal chemistry</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.freeradbiomed.2004.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=15451053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=1122-1143&author=G.+R.+J.+Thatcherauthor=A.+C.+Nicolescuauthor=B.+M.+Bennettauthor=V.+Toader&title=Nitrates+and+NO+release%3A+contemporary+aspects+in+biological+and+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrates and NO release: Contemporary aspects in biological and medicinal chemistry</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Nicolescu, Adrian C.; Bennett, Brian M.; Toader, Violeta</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1122-1143</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nitroglycerin has been used clin. in the treatment of angina for 130 yr, yet important details on the mechanism of action, biotransformation, and the assocd. phenomenon of nitrate tolerance remain unanswered.  The biol. activity of org. nitrates can be said to be nitric oxide mimetic, leading to recent, exciting progress in realizing the therapeutic potential of nitrates.  Unequivocally, nitroglycerin and most other org. nitrates, including NO-NSAIDs, do not behave as NO donors in the most fundamental action: in vitro activation of sGC to produce cGMP.  The question as to whether the biol. activity of nitrates results primarily or exclusively from NO donation will not be satisfactorily answered until the location, the app., and the mechanism of redn. of nitrates to NO are defined.  Similarly, the therapeutic potential of nitrates will not be unlocked until this knowledge is attained.  Aspects of the therapeutic and biol. activity of nitrates are reviewed in the context of the chem. of nitrates and the elusive efficient 3e- redn. required to generate NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9yTqvI4h67Vg90H21EOLACvtfcHk0lh-1Xm076LNiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D&md5=4cf397615197ffc1a76d3eec5f5c9bb6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2004.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2004.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DNicolescu%26aufirst%3DA.%2BC.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DToader%26aufirst%3DV.%26atitle%3DNitrates%2520and%2520NO%2520release%253A%2520contemporary%2520aspects%2520in%2520biological%2520and%2520medicinal%2520chemistry%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2004%26volume%3D37%26spage%3D1122%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Gasparini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Soldato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1471-4159.2004.02154.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14690522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=337-348&author=L.+Gaspariniauthor=L.+Rusconiauthor=H.+Xuauthor=P.+del+Soldatoauthor=E.+Ongini&title=Modulation+of+beta-amyloid+metabolism+by+non-steroidal+anti-inflammatory+drugs+in+neuronal+cell+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of β-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures</span></div><div class="casAuthors">Gasparini, Laura; Rusconi, Laura; Xu, Huaxi; del Soldato, Piero; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is characterized by cerebral deposits of β-amyloid (Aβ) peptides, which are surrounded by neuroinflammatory cells.  Epidemiol. studies have shown that prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk of developing AD.  In addn., biol. data indicate that certain NSAIDs specifically lower Aβ42 levels in cultures of peripheral cells independently of cyclooxygenase (COX) activity and reduce cerebral Aβ levels in AD transgenic mice.  Whether other NSAIDs, including COX-selective compds., modulate Aβ levels in neuronal cells remains unexploited.  Here, we investigated the effects of compds. from every chem. class of NSAIDs on Aβ40 and Aβ42 secretion using both Neuro-2a cells and rat primary cortical neurons.  Among non-selective NSAIDs, flurbiprofen and sulindac sulfide concn.-dependently reduced the secretion not only of Aβ42 but also of Aβ40.  Surprisingly, both COX-2 (celecoxib; s.c.-125) or COX-1 (s.c.-560) selective compds. significantly increased Aβ42 secretion, and either did not alter (s.c.-560; s.c.-125) or reduced (celecoxib) Aβ40 levels.  The levels of βAPP C-terminal fragments and Notch cleavage were not altered by any of the NSAIDs, indicating that γ-secretase activity was not overall changed by these drugs.  The present findings show that only a few non-selective NSAIDs possess Aβ-lowering properties and therefore have a profile potentially relevant to their clin. use in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL05FA74pK4LVg90H21EOLACvtfcHk0lh-1Xm076LNiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlSqsQ%253D%253D&md5=bfe1c128f5ee985dfe50fbe47a37c372</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02154.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02154.x%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DL.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DH.%26aulast%3Ddel%2BSoldato%26aufirst%3DP.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DModulation%2520of%2520beta-amyloid%2520metabolism%2520by%2520non-steroidal%2520anti-inflammatory%2520drugs%2520in%2520neuronal%2520cell%2520cultures%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D88%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Imbimbo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzillotta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windisch, M.</span><span> </span><span class="NLM_article-title">CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1111%2Fj.1476-5381.2008.00097.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19239474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=982-993&issue=6&author=B.+Imbimboauthor=B.+Hutter-Paierauthor=G.+Villettiauthor=F.+Facchinettiauthor=V.+Cenacchiauthor=R.+Voltaauthor=A.+Lanzillottaauthor=M.+Pizziauthor=M.+Windisch&title=CHF5074%2C+a+novel+gamma-secretase+modulator%2C+attenuates+brain+beta-amyloid+pathology+and+learning+deficit+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Imbimbo, B. P.; Hutter-Paier, B.; Villetti, G.; Facchinetti, F.; Cenacchi, V.; Volta, R.; Lanzillotta, A.; Pizzi, M.; Windisch, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-993</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: We evaluated the effects of 1-(3',4'-dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a new γ-secretase modulator, on brain β-amyloid pathol. and spatial memory in transgenic mice expressing the Swedish and London mutations of human amyloid precursor protein (hAPP).  Exptl. approach: Sixty 6-mo-old hAPP mice were treated for 6 mo with CHF5074 or ibuprofen (375 ppm in the diet) or std. diet.  Twenty-one wild-type mice received std. diet.  Key results: Compared with transgenic controls, CHF5074 treatment significantly reduced the area occupied by plaques in cortex (P = 0.003) and hippocampus (P = 0.004).  The no. of plaques were also reduced by CHF5074 in both cortex (P = 0.022) and hippocampus (P = 0.005).  Plaque-assocd. microglia in CHF5074-treated animals was lower than in transgenic controls in cortex (P = 0.008) and hippocampus (P = 0.002).  Ibuprofen treatment significantly reduced microglia area in cortex and hippocampus but not β-amyloid burden.  On the last day of the Morris water maze, transgenic controls performed significantly worse than the non-transgenic animals and the CHF5074-treated transgenic mice, on the swimming path to reach the hidden platform.  Ibuprofen-treated animals did not perform significantly better than transgenic controls.  Conclusions and implications: Chronic CHF5074 treatment reduced brain β-amyloid burden, assocd. microglia inflammation and attenuated spatial memory deficit in hAPP mice.  This novel γ-secretase modulator is a promising therapeutic agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-YuDC46zcG7Vg90H21EOLACvtfcHk0lh-1Xm076LNiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7g%253D&md5=5acebb8295cba69be5addf46b248845d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00097.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00097.x%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DVolta%26aufirst%3DR.%26aulast%3DLanzillotta%26aufirst%3DA.%26aulast%3DPizzi%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26atitle%3DCHF5074%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520attenuates%2520brain%2520beta-amyloid%2520pathology%2520and%2520learning%2520deficit%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26issue%3D6%26spage%3D982%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Idris, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van’t Hof, R. J.</span><span> </span><span class="NLM_article-title">The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">602</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1016%2Fj.ejphar.2008.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=19046964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=602&publication_year=2009&pages=215-222&author=A.+I.+Idrisauthor=S.+H.+Ralstonauthor=R.+J.+van%E2%80%99t+Hof&title=The+nitrosylated+flurbiprofen+derivative+HCT1026+inhibits+cytokine-induced+signalling+through+a+novel+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action</span></div><div class="casAuthors">Idris, Aymen I.; Ralston, Stuart H.; van't Hof, Rob J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">602</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">215-222</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously shown that the nitrosylated flurbiprofen deriv. HCT1026 inhibits bone resorption, both in vivo and in vitro, and that its mechanism of action is independent of nitric oxide release and prostaglandin synthesis inhibition.  Here we describe the effects of HCT1026 on osteoclast formation, activity, survival and cell signaling in vitro.  HCT1026 strongly inhibited osteoclast formation, activity and survival in murine osteoclast cultures, whereas macrophages and osteoblasts were unaffected.  HCT1026 induced osteoclast apoptosis, and this was partially prevented by increasing the concn. of receptor activator of nuclear factor kappa B ligand (RANKL).  This suggests that HCT1026 inhibits bone resorption by inhibiting the effects of RANKL.  In agreement with this we found that HCT1026 inhibited RANKL-induced activation of the nuclear factor kappa B (NFκB) and extracellular signal-regulated kinase (ERK) pathways in both osteoclast and macrophage cultures, whereas its parent compd. flurbiprofen did not.  In addn., HCT1026 also inhibited tumor necrosis factor (TNF)-, interleukin-1 (IL1)- and LPS-induced signaling, but not macrophage colony stimulating factor induced signaling.  The pathways that are inhibited by HCT1026 all share a similar kinase complex upstream of the NFκB and ERK pathways, and this is the most likely target for the actions of HCT1026.  Although the rationale for the modification of flurbiprofen with a nitric oxide donor group was to prevent gastro-intestinal toxicity, the resulting compd. HCT1026 gained unexpected addnl. cytokine-inhibitory properties.  As RANKL, TNF and IL1 are all important mediators of inflammation and joint destruction, compds. like HCT1026 could represent a novel class of anti-inflammatory compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFIj9cuNr9s7Vg90H21EOLACvtfcHk0lg5MjmdKh0vdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWrtw%253D%253D&md5=1235f421eafc2621cc1fa3d2be3ebc6e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DIdris%26aufirst%3DA.%2BI.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3Dvan%25E2%2580%2599t%2BHof%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520nitrosylated%2520flurbiprofen%2520derivative%2520HCT1026%2520inhibits%2520cytokine-induced%2520signalling%2520through%2520a%2520novel%2520mechanism%2520of%2520action%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D602%26spage%3D215%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscara, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Nucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamuner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Soldato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1′-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1124%2Fjpet.103.063453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=14755007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=626-633&author=J.+L.+Wallaceauthor=M.+N.+Muscaraauthor=G.+de+Nucciauthor=S.+Zamunerauthor=G.+Cirinoauthor=P.+del+Soldatoauthor=E.+Ongini&title=Gastric+tolerability+and+prolonged+prostaglandin+inhibition+in+the+brain+with+a+nitric+oxide-releasing+flurbiprofen+derivative%2C+NCX-2216+%5B3-%5B4-%282-fluoro-alpha-methyl-%5B1%2C1%E2%80%B2-biphenyl%5D-4-acetyloxy%29-3-methoxyphenyl%5D-2-propenoic+acid+4-nitrooxy+butyl+ester%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-α-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester]</span></div><div class="casAuthors">Wallace, John L.; Muscara, Marcelo N.; De Nucci, Gilberto; Zamuner, Stella; Cirino, Giuseppe; Del Soldato, Piero; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">626-633</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NCX-2216 [3-[4-(2-fluoro-α-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy Bu ester] is an NO-releasing flurbiprofen deriv. that also contains a ferulic acid (antioxidant) moiety.  NCX-2216 has been shown to be effective in reducing β-amyloid deposition in a transgenic mouse model of Alzheimer's disease.  The tolerability of this compd. in the stomach and its ability to suppress prostaglandin synthesis in the brain are not known.  The purpose of this study was to assess the contribution of nitric oxide (NO) and ferulic acid to the pharmacol. properties of NCX-2216 vs. flurbiprofen; thus, we compared their gastric tolerability and suppression of prostaglandin synthesis, peripherally and centrally.  Oral flurbiprofen produced extensive gastric damage and suppressed gastric prostaglandin synthesis.  In contrast, while suppressing prostaglandin prodn., equimolar doses of NCX-2216 did not cause detectable gastric injury.  The NO-releasing moiety of NCX-2216 (but not the ferulic acid moiety) was crucial for the gastric safety of this compd.  NCX-2216 substantially inhibited prostanoid synthesis despite not being detectable in plasma and despite producing only low amts. of flurbiprofen in plasma and in the brain.  Inhibition of brain prostaglandin synthesis by NCX-2216 (22 mg/kg) persisted for a much longer period of time (up to 48 h) than was seen with flurbiprofen (≤12 h).  These results demonstrate that a single administration of NCX-2216 can produce prolonged suppression of brain prostaglandin synthesis without causing gastric injury.  It is likely that an active metabolite of NCX-2216 contributes to the suppression of cyclooxygenase activity.  NCX-2216 may represent an attractive alternative to conventional nonsteroidal anti-inflammatory drugs for long-term treatment of a variety of inflammatory disorders, esp. those occurring in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8rOtiAvh4LbVg90H21EOLACvtfcHk0lg5MjmdKh0vdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu74%253D&md5=df36ef1ab30dc197855f6ef6388c4976</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.063453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.063453%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3DMuscara%26aufirst%3DM.%2BN.%26aulast%3Dde%2BNucci%26aufirst%3DG.%26aulast%3DZamuner%26aufirst%3DS.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3Ddel%2BSoldato%26aufirst%3DP.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DGastric%2520tolerability%2520and%2520prolonged%2520prostaglandin%2520inhibition%2520in%2520the%2520brain%2520with%2520a%2520nitric%2520oxide-releasing%2520flurbiprofen%2520derivative%252C%2520NCX-2216%2520%255B3-%255B4-%25282-fluoro-alpha-methyl-%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-acetyloxy%2529-3-methoxyphenyl%255D-2-propenoic%2520acid%25204-nitrooxy%2520butyl%2520ester%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D626%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Govoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maucci, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiroli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tocchetti, P.</span><span> </span><span class="NLM_article-title">In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1124%2Fjpet.105.097469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=16424150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=752-761&author=M.+Govoniauthor=S.+Casagrandeauthor=R.+Maucciauthor=V.+Chiroliauthor=P.+Tocchetti&title=In+vitro+metabolism+of+%28nitrooxy%29butyl+ester+nitric+oxide-releasing+compounds%3A+comparison+with+glyceryl+trinitrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate</span></div><div class="casAuthors">Govoni, Mirco; Casagrande, Simona; Maucci, Raffaella; Chiroli, Valerio; Tocchetti, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">752-761</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We investigated the in vitro metab. of two (nitrooxy)butyl ester nitric oxide (NO) donor derivs. of flurbiprofen and ferulic acid, [1,1'-biphenyl]-4-acetic acid-2-fluoro-α-methyl-4-(nitrooxy)butyl ester (HCT 1026) and 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid 4-(nitrooxy)butyl ester (NCX 2057), resp., in rat blood plasma and liver subcellular fractions compared with (nitrooxy)butyl alc. (NOBA) and glyceryl trinitrate (GTN).  HCT 1026 and NCX 2057 undergo rapid ubiquitous carboxyl ester hydrolysis to their resp. parent compds. and NOBA.  The nitrate moiety of this latter is subsequently metabolized to inorg. nitrogen oxides (NOx), predominantly in liver cytosol by glutathione S-transferase (GST) and to a lesser extent in liver mitochondria.  If, however, in liver cytosol, the carboxyl ester hydrolysis is prevented by an esterase inhibitor, the metab. at the nitrate moiety level does not occur.  In blood plasma, HCT 1026 and NCX 2057 are not metabolized to NOx, whereas a slow but sustained NO generation in deoxygenated whole blood as detected by ESR indicates the involvement of erythrocytes in the bioactivation of these compds.  Differently from NOBA, GTN is also metabolized in blood plasma and more quickly metabolized by different GST isoforms in liver cytosol.  The cytosolic GST-mediated denitration of these org. nitrates in liver limits their interaction with other intracellular compartments to possible generation of NO and/or their subsequent availability and bioactivation in the systemic circulation and extrahepatic tissues.  We show the possibility of modulating the activity of hepatic cytosolic enzymes involved in the metab. of (nitrooxy)butyl ester compds., thus increasing the therapeutic potential of this class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0eFExgPHUObVg90H21EOLACvtfcHk0lg5MjmdKh0vdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamu7w%253D&md5=5ea141c9276c0ef225220e183f4182dc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097469%26sid%3Dliteratum%253Aachs%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DCasagrande%26aufirst%3DS.%26aulast%3DMaucci%26aufirst%3DR.%26aulast%3DChiroli%26aufirst%3DV.%26aulast%3DTocchetti%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520%2528nitrooxy%2529butyl%2520ester%2520nitric%2520oxide-releasing%2520compounds%253A%2520comparison%2520with%2520glyceryl%2520trinitrate%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D752%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Prosperi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casamenti, F.</span><span> </span><span class="NLM_article-title">NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain</span> <span class="citation_source-journal">Jpn J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1254%2Fjjp.86.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=11459126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=230-235&author=C.+Prosperiauthor=C.+Scaliauthor=G.+Pepeuauthor=F.+Casamenti&title=NO-flurbiprofen+attenuates+excitotoxin-induced+brain+inflammation%2C+and+releases+nitric+oxide+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain</span></div><div class="casAuthors">Prosperi, Costanza; Scali, Carla; Pepeu, Giancarlo; Casamenti, Fiorella</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">230-235</span>CODEN:
                <span class="NLM_cas:coden">JJPAAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-5198</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Brain inflammation underlies the pathogenesis of Alzheimer's disease (AD) and nonsteroidal anti-inflammatory drug therapy may delay the onset of AD.  We investigated, in vivo, the effects of NO-flurbiprofen on brain inflammation in rats injected with quisqualic acid into the nucleus basalis and on the release of nitric oxide from the drug in naive rat brains.  We showed that the excitotoxin-induced microglia reaction, the expression of inducible nitric oxide synthase-pos. cells and the prodn. of interleukin-1β and prostaglandin-E2 in the injected area were attenuated by the NO-flurbiprofen (15 mg/kg, p.o.) treatment.  An oral administration of NO-flurbiprofen (25, 50 and 100 mg/kg) to naive rats was followed by significant increases in cortical nitrite levels.  This drug may have important therapeutic implications for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1k2fRjQJSNrVg90H21EOLACvtfcHk0lj-X98qR0zz3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslehsrs%253D&md5=bf724e13de3ffa8a9c358de58304f4ab</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1254%2Fjjp.86.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjjp.86.230%26sid%3Dliteratum%253Aachs%26aulast%3DProsperi%26aufirst%3DC.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DCasamenti%26aufirst%3DF.%26atitle%3DNO-flurbiprofen%2520attenuates%2520excitotoxin-induced%2520brain%2520inflammation%252C%2520and%2520releases%2520nitric%2520oxide%2520in%2520the%2520brain%26jtitle%3DJpn%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D86%26spage%3D230%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kache, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasiadis, P. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=545-550&author=T.+Kukarauthor=M.+P.+Murphyauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=S.+Weggenauthor=T.+E.+Smithauthor=T.+Laddauthor=M.+A.+Khanauthor=R.+Kacheauthor=J.+Beardauthor=M.+Dodsonauthor=S.+Meritauthor=V.+V.+Ozolsauthor=P.+Z.+Anastasiadisauthor=P.+Dasauthor=A.+Fauqauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Diverse+compounds+mimic+Alzheimer+disease-causing+mutations+by+augmenting+Abeta42+production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DLadd%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DKache%26aufirst%3DR.%26aulast%3DBeard%26aufirst%3DJ.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DMerit%26aufirst%3DS.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DAnastasiadis%26aufirst%3DP.%2BZ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDiverse%2520compounds%2520mimic%2520Alzheimer%2520disease-causing%2520mutations%2520by%2520augmenting%2520Abeta42%2520production%26jtitle%3DNature%2520Med.%26date%3D2005%26volume%3D11%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kukar, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraering, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narlawar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharvi, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangachari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen-West, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeeck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torpey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Substrate-targeting gamma-secretase modulators</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm101450p&amp;key=10.1038%2Fnature07055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm101450p&amp;key=18548070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm101450p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVCqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2008&pages=925-929&author=T.+L.+Kukarauthor=T.+B.+Laddauthor=M.+A.+Bannauthor=P.+C.+Fraeringauthor=R.+Narlawarauthor=G.+M.+Maharviauthor=B.+Healyauthor=R.+Chapmanauthor=A.+T.+Welzelauthor=R.+W.+Priceauthor=B.+Mooreauthor=V.+Rangachariauthor=B.+Cusackauthor=J.+Eriksenauthor=K.+Jansen-Westauthor=C.+Verbeeckauthor=D.+Yagerauthor=C.+Eckmanauthor=W.+Yeauthor=S.+Sagiauthor=B.+A.+Cottrellauthor=J.+Torpeyauthor=T.+L.+Rosenberryauthor=A.+Fauqauthor=M.+S.+Wolfeauthor=B.+Schmidtauthor=D.+M.+Walshauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Substrate-targeting+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-targeting γ-secretase modulators</span></div><div class="casAuthors">Kukar, Thomas L.; Ladd, Thomas B.; Bann, Maralyssa A.; Fraering, Patrick C.; Narlawar, Rajeshwar; Maharvi, Ghulam M.; Healy, Brent; Chapman, Robert; Welzel, Alfred T.; Price, Robert W.; Moore, Brenda; Rangachari, Vijayaraghavan; Cusack, Bernadette; Eriksen, Jason; Jansen-West, Karen; Verbeeck, Christophe; Yager, Debra; Eckman, Christopher; Ye, Wenjuan; Sagi, Sarah; Cottrell, Barbara A.; Torpey, Justin; Rosenberry, Terrone L.; Fauq, Abdul; Wolfe, Michael S.; Schmidt, Boris; Walsh, Dominic M.; Koo, Edward H.; Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">7197</span>),
    <span class="NLM_cas:pages">925-929</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Selective lowering of Aβ42 levels (the 42-residue isoform of the amyloid-β peptide) with small-mol. γ-secretase modulators (GSMs), such as some non-steroidal anti-inflammatory drugs, is a promising therapeutic approach for Alzheimer's disease.  To identify the target of these agents we developed biotinylated photoactivatable GSMs.  GSM photoprobes did not label the core proteins of the γ-secretase complex, but instead labeled the β-amyloid precursor protein (APP), APP carboxy-terminal fragments and amyloid-β peptide in human neuroglioma H4 cells.  Substrate labeling was competed by other GSMs, and labeling of an APP γ-secretase substrate was more efficient than a Notch substrate.  GSM interaction was localized to residues 28-36 of amyloid-β, a region crit. for aggregation.  We also demonstrate that compds. known to interact with this region of amyloid-β act as GSMs, and some GSMs alter the prodn. of cell-derived amyloid-β oligomers.  Furthermore, mutation of the GSM binding site in the APP alters the sensitivity of the substrate to GSMs.  These findings indicate that substrate targeting by GSMs mechanistically links two therapeutic actions: alteration in Aβ42 prodn. and inhibition of amyloid-β aggregation, which may synergistically reduce amyloid-β deposition in Alzheimer's disease.  These data also demonstrate the existence and feasibility of substrate targeting' by small-mol. effectors of proteolytic enzymes, which if generally applicable may significantly broaden the current notion ofdruggable' targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI94fdiPOnirVg90H21EOLACvtfcHk0lj-X98qR0zz3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVCqu74%253D&md5=959f0ca309abe7039cd3848ad079a35a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnature07055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07055%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%2BL.%26aulast%3DLadd%26aufirst%3DT.%2BB.%26aulast%3DBann%26aufirst%3DM.%2BA.%26aulast%3DFraering%26aufirst%3DP.%2BC.%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DMaharvi%26aufirst%3DG.%2BM.%26aulast%3DHealy%26aufirst%3DB.%26aulast%3DChapman%26aufirst%3DR.%26aulast%3DWelzel%26aufirst%3DA.%2BT.%26aulast%3DPrice%26aufirst%3DR.%2BW.%26aulast%3DMoore%26aufirst%3DB.%26aulast%3DRangachari%26aufirst%3DV.%26aulast%3DCusack%26aufirst%3DB.%26aulast%3DEriksen%26aufirst%3DJ.%26aulast%3DJansen-West%26aufirst%3DK.%26aulast%3DVerbeeck%26aufirst%3DC.%26aulast%3DYager%26aufirst%3DD.%26aulast%3DEckman%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DSagi%26aufirst%3DS.%26aulast%3DCottrell%26aufirst%3DB.%2BA.%26aulast%3DTorpey%26aufirst%3DJ.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DSubstrate-targeting%2520gamma-secretase%2520modulators%26jtitle%3DNature%26date%3D2008%26volume%3D453%26spage%3D925%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=677-683&author=R.+M.+Pageauthor=K.+Baumannauthor=M.+Tomiokaauthor=B.+I.+Perez-Revueltaauthor=A.+Fukumoriauthor=H.+Jacobsenauthor=A.+Flohrauthor=T.+Luebbersauthor=L.+Ozmenauthor=H.+Steinerauthor=C.+Haass&title=Generation+of+Abeta38+and+Abeta42+is+independently+and+differentially+affected+by+familial+Alzheimer+disease-associated+presenilin+mutations+and+gamma-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DPerez-Revuelta%26aufirst%3DB.%2BI.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520Abeta38%2520and%2520Abeta42%2520is%2520independently%2520and%2520differentially%2520affected%2520by%2520familial%2520Alzheimer%2520disease-associated%2520presenilin%2520mutations%2520and%2520gamma-secretase%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D677%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominari, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rikimaru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natsugari, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">18664</span><span class="NLM_x">–</span> <span class="NLM_lpage">18670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=18664-18670&author=Y.+Takahashiauthor=I.+Hayashiauthor=Y.+Tominariauthor=K.+Rikimaruauthor=Y.+Morohashiauthor=T.+Kanauthor=H.+Natsugariauthor=T.+Fukuyamaauthor=T.+Tomitaauthor=T.+Iwatsubo&title=Sulindac+sulfide+is+a+noncompetitive+gamma-secretase+inhibitor+that+preferentially+reduces+Abeta+42+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DI.%26aulast%3DTominari%26aufirst%3DY.%26aulast%3DRikimaru%26aufirst%3DK.%26aulast%3DMorohashi%26aufirst%3DY.%26aulast%3DKan%26aufirst%3DT.%26aulast%3DNatsugari%26aufirst%3DH.%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DSulindac%2520sulfide%2520is%2520a%2520noncompetitive%2520gamma-secretase%2520inhibitor%2520that%2520preferentially%2520reduces%2520Abeta%252042%2520generation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D18664%26epage%3D18670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raveglia, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigogno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biscaioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catinella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzoni, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGiudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid1−42 secretion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5705</span><span class="NLM_x">–</span> <span class="NLM_lpage">5720</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5705-5720&author=I.+Perettoauthor=S.+Radaelliauthor=C.+Pariniauthor=M.+Zandiauthor=L.+F.+Ravegliaauthor=G.+Dondioauthor=L.+Fontanellaauthor=P.+Misianoauthor=C.+Bigognoauthor=A.+Rizziauthor=B.+Riccardiauthor=M.+Biscaioliauthor=S.+Marchettiauthor=P.+Pucciniauthor=S.+Catinellaauthor=I.+Rondelliauthor=V.+Cenacchiauthor=P.+T.+Bolzoniauthor=P.+Carusoauthor=G.+Villettiauthor=F.+Facchinettiauthor=E.+DelGiudiceauthor=N.+Morettoauthor=B.+P.+Imbimbo&title=Synthesis+and+biological+activity+of+flurbiprofen+analogues+as+selective+inhibitors+of+beta-amyloid1%E2%88%9242+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0502541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502541%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DParini%26aufirst%3DC.%26aulast%3DZandi%26aufirst%3DM.%26aulast%3DRaveglia%26aufirst%3DL.%2BF.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DFontanella%26aufirst%3DL.%26aulast%3DMisiano%26aufirst%3DP.%26aulast%3DBigogno%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DBiscaioli%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DS.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DCatinella%26aufirst%3DS.%26aulast%3DRondelli%26aufirst%3DI.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DBolzoni%26aufirst%3DP.%2BT.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DDelGiudice%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520flurbiprofen%2520analogues%2520as%2520selective%2520inhibitors%2520of%2520beta-amyloid1%25E2%2588%259242%2520secretion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5705%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kotoris, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. D.</span><span> </span><span class="NLM_article-title">Preparation of benzylic Î±,Î±-difluoronitriles, -tetrazoles, and -sulfonates via electrophilic fluorination</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">8052</span><span class="NLM_x">–</span> <span class="NLM_lpage">8057</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo981163x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=8052-8057&author=C.+C.+Kotorisauthor=M.-J.+Chenauthor=S.+D.+Taylor&title=Preparation+of+benzylic+%C3%8E%C2%B1%2C%C3%8E%C2%B1-difluoronitriles%2C+-tetrazoles%2C+and+-sulfonates+via+electrophilic+fluorination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo981163x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981163x%26sid%3Dliteratum%253Aachs%26aulast%3DKotoris%26aufirst%3DC.%2BC.%26aulast%3DChen%26aufirst%3DM.-J.%26aulast%3DTaylor%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520benzylic%2520%25C3%258E%25C2%25B1%252C%25C3%258E%25C2%25B1-difluoronitriles%252C%2520-tetrazoles%252C%2520and%2520-sulfonates%2520via%2520electrophilic%2520fluorination%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D8052%26epage%3D8057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. Z.</span><span> </span><span class="NLM_article-title">A novel general method for preparation of [alpha]-fluoro-[alpha]-arylcarboxylic acid. Direct fluorination of silyl ketene acetals with Selectfluor</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">7641</span><span class="NLM_x">–</span> <span class="NLM_lpage">7644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=7641-7644&author=F.+Zhangauthor=J.+Z.+Song&title=A+novel+general+method+for+preparation+of+%5Balpha%5D-fluoro-%5Balpha%5D-arylcarboxylic+acid.+Direct+fluorination+of+silyl+ketene+acetals+with+Selectfluor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%2BZ.%26atitle%3DA%2520novel%2520general%2520method%2520for%2520preparation%2520of%2520%255Balpha%255D-fluoro-%255Balpha%255D-arylcarboxylic%2520acid.%2520Direct%2520fluorination%2520of%2520silyl%2520ketene%2520acetals%2520with%2520Selectfluor%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D7641%26epage%3D7644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101450p&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm101450p%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-7%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101450p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990c6bafe93c6a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
